
<html lang="en"     class="pb-page"  data-request-id="c02db0ce-ecb7-476f-95f3-952469932c77"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b00052;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase" /></meta><meta name="dc.Creator" content="Sarah&#xA;E.  Winterton" /></meta><meta name="dc.Creator" content="Emanuela  Capota" /></meta><meta name="dc.Creator" content="Xiaoyu  Wang" /></meta><meta name="dc.Creator" content="Hong  Chen" /></meta><meta name="dc.Creator" content="Prema L.  Mallipeddi" /></meta><meta name="dc.Creator" content="Noelle S.  Williams" /></meta><meta name="dc.Creator" content="Bruce A.  Posner" /></meta><meta name="dc.Creator" content="Deepak  Nijhawan" /></meta><meta name="dc.Creator" content="Joseph M.  Ready" /></meta><meta name="dc.Description" content="Stearoyl-CoA desaturase (SCD) catalyzes the first step in the conversion of saturated fatty acids to unsaturated fatty acids. Unsaturated fatty acids are required for membrane integrity and for cel..." /></meta><meta name="Description" content="Stearoyl-CoA desaturase (SCD) catalyzes the first step in the conversion of saturated fatty acids to unsaturated fatty acids. Unsaturated fatty acids are required for membrane integrity and for cel..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 5, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00052" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00052" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00052" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00052" /></link>
        
    
    

<title>Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00052" /></meta><meta property="og:title" content="Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0019.jpeg" /></meta><meta property="og:description" content="Stearoyl-CoA desaturase (SCD) catalyzes the first step in the conversion of saturated fatty acids to unsaturated fatty acids. Unsaturated fatty acids are required for membrane integrity and for cell proliferation. For these reasons, inhibitors of SCD represent potential treatments for cancer. However, systemically active SCD inhibitors result in skin toxicity, which presents an obstacle to their development. We recently described a series of oxalic acid diamides that are converted into active SCD inhibitors within a subset of cancers by CYP4F11-mediated metabolism. Herein, we describe the optimization of the oxalic acid diamides and related N-acyl ureas and an analysis of the structure–activity relationships related to metabolic activation and SCD inhibition." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00052"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00052">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00052&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00052&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00052&amp;href=/doi/10.1021/acs.jmedchem.8b00052" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5199-5221</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00042" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00026" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Sarah E. Winterton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah E. Winterton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah%0AE.++Winterton">Sarah E. Winterton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emanuela Capota</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emanuela Capota</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Internal Medicine, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emanuela++Capota">Emanuela Capota</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaoyu Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoyu Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoyu++Wang">Xiaoyu Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hong Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hong Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Chen">Hong Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Prema L. Mallipeddi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Prema L. Mallipeddi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Prema+L.++Mallipeddi">Prema L. Mallipeddi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Noelle S. Williams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Noelle S. Williams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Noelle+S.++Williams">Noelle S. Williams</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bruce A. Posner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruce A. Posner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+A.++Posner">Bruce A. Posner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deepak Nijhawan</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deepak Nijhawan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry,  Department of Internal Medicine, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#325657574253591c5c5b585a5345535c724746415d47465a4557414657405c1c575647"><span class="__cf_email__" data-cfemail="95f1f0f0e5f4febbfbfcfffdf4e2f4fbd5e0e1e6fae0e1fde2f0e6e1f0e7fbbbf0f1e0">[email protected]</span></a> (D.N.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deepak++Nijhawan">Deepak Nijhawan</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Joseph M. Ready</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph M. Ready</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390-9038, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#274d485442574f09554246435e675253544852534f5042545342554909424352"><span class="__cf_email__" data-cfemail="cca6a3bfa9bca4e2bea9ada8b58cb9b8bfa3b9b8a4bba9bfb8a9bea2e2a9a8b9">[email protected]</span></a> (J.M.R.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+M.++Ready">Joseph M. Ready</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1305-9581" title="Orcid link">http://orcid.org/0000-0003-1305-9581</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00052&amp;href=/doi/10.1021%2Facs.jmedchem.8b00052" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5199–5221</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 5, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 January 2018</li><li><span class="item_label"><b>Published</b> online</span>5 June 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00052" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00052</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5199%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSarah%250AE.%2BWinterton%252C%2BEmanuela%2BCapota%252C%2BXiaoyu%2BWang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D12%26contentID%3Dacs.jmedchem.8b00052%26title%3DDiscovery%2Bof%2BCytochrome%2BP450%2B4F11%2BActivated%2BInhibitors%2Bof%2BStearoyl%2BCoenzyme%2BA%2BDesaturase%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5221%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00052"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2986</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00052" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sarah\nE.&quot;,&quot;last_name&quot;:&quot;Winterton&quot;},{&quot;first_name&quot;:&quot;Emanuela&quot;,&quot;last_name&quot;:&quot;Capota&quot;},{&quot;first_name&quot;:&quot;Xiaoyu&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Prema&quot;,&quot;last_name&quot;:&quot;L. Mallipeddi&quot;},{&quot;first_name&quot;:&quot;Noelle&quot;,&quot;last_name&quot;:&quot;S. Williams&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;A. Posner&quot;},{&quot;first_name&quot;:&quot;Deepak&quot;,&quot;last_name&quot;:&quot;Nijhawan&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;M. Ready&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5199-5221&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00052&quot;},&quot;abstract&quot;:&quot;Stearoyl-CoA desaturase (SCD) catalyzes the first step in the conversion of saturated fatty acids to unsaturated fatty acids. Unsaturated fatty acids are required for membrane integrity and for cell proliferation. For these reasons, inhibitors of SCD represent potential treatments for cancer. However, systemically active SCD inhibitors result in skin toxicity, which presents an obstacle to their development. We recently described a series of oxalic acid diamides that are converted into active SCD inhibitors within a subset of cancers by CYP4F11-mediated metabolism. Herein, we describe the optimization of the oxalic acid diamides and related N-acyl ureas and an analysis of the structure–activity relationships related to metabolic activation and SCD inhibition.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00052&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00052" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00052&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00052" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00052&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00052" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00052&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00052&amp;href=/doi/10.1021/acs.jmedchem.8b00052" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00052" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00052" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00052%26sid%3Dliteratum%253Aachs%26pmid%3D29869888%26genre%3Darticle%26aulast%3DWinterton%26date%3D2018%26atitle%3DDiscovery%2Bof%2BCytochrome%2BP450%2B4F11%2BActivated%2BInhibitors%2Bof%2BStearoyl%2BCoenzyme%2BA%2BDesaturase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D12%26spage%3D5199%26epage%3D5221%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a>,</li><li><a href="/action/doSearch?ConceptID=291594" title="Silica">Silica</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/jmcmar.2018.61.issue-12/20180628/jmcmar.2018.61.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Stearoyl-CoA desaturase (SCD) catalyzes the first step in the conversion of saturated fatty acids to unsaturated fatty acids. Unsaturated fatty acids are required for membrane integrity and for cell proliferation. For these reasons, inhibitors of SCD represent potential treatments for cancer. However, systemically active SCD inhibitors result in skin toxicity, which presents an obstacle to their development. We recently described a series of oxalic acid diamides that are converted into active SCD inhibitors within a subset of cancers by CYP4F11-mediated metabolism. Herein, we describe the optimization of the oxalic acid diamides and related <i>N</i>-acyl ureas and an analysis of the structure–activity relationships related to metabolic activation and SCD inhibition.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cells require unsaturated fatty acids (UFAs) for properly functioning membranes. Dividing cells utilize UFAs to form new membranes, and UFAs can be obtained either through uptake from the environment or from de novo synthesis. Tumor cells in particular rely on UFA biosynthesis because they frequently exist in a nutrient-poor environments. They synthesize UFAs to maintain membrane fluidity and to buffer the cell from the toxic effects of saturated fatty acids and free cholesterol.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> For these reasons, inhibition of de novo UFA biosynthesis represents an attractive approach to treating solid tumors.</div><div class="NLM_p">The enzyme stearoyl-CoA desaturase (SCD) catalyzes the introduction of unsaturation at the C9–C10 position of saturated fatty acids (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Humans express two isoforms, SCD1 and SCD5.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Human SCD1 is highly homologous to the mouse and rat isoforms and is ubiquitously expressed. In humans, SCD1 appears to play the predominant biological role.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> For simplicity, we will refer to SCD1 as SCD hereafter. SCD is a nonheme diiron oxidase that functions in the endoplasmic reticulum. It primarily converts stearoyl-CoA and palmitoyl-CoA to oleate and palmitoleate, respectively. Because of its role in the generation of UFAs, SCD has emerged as an attractive target for treating cancer. Indeed, a recent functional genomic screen of 66 genes involved in lipid biosynthesis identified SCD as essential in breast- and prostate-cancer cells.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Similarly, patient samples from clear-cell-renal-cell-carcinoma tumors showed elevated expression of SCD and increased amounts of unsaturated fatty acids, and the levels of both enzyme and lipids were correlated with tumor growth rates.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SCD enzymatic reaction and inhibition by tumor-activated oxalamides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibitors of SCD have been developed for the treatment of metabolic diseases and cancer. Several pharmaceutical companies have developed potent and bioavailable inhibitors of SCD, and the area has been reviewed recently.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> For example, Abbott disclosed urea <b>3</b> as a low-nanomolar inhibitor of SCD (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Scientists from Bristol-Myers Squibb reported that this SCD inhibitor slowed the growth of gastric cancers in tumor-xenograft experiments.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In similar studies, <b>3</b> slowed the growth of a tumor xenograft derived from a renal-cell-carcinoma line when dosed in combination with an mTOR inhibitor.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Additional studies from Abbott led to pyridazine <b>4</b>, a potent and orally bioavailable SCD inhibitor,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which was found to slow the growth of a tumor xenograft derived from the human colorectal-cancer cell line HCT116.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> CV Therapeutics described a series of quinazolin-4-ones, exemplified by compound <b>5</b>, with an EC<sub>50</sub> of 119 nM against human SCD and excellent oral bioavailability.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> These inhibitors blocked proliferation of lung-cancer H460 cells without affecting fibroblasts under the same conditions.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Finally, several potent SCD inhibitors have been shown to affect triglyceride levels in vivo, including thiazolylpyridinone <b>6</b> from Novartis and Xenon Pharmaceuticals,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> isoxazole <b>7</b> (MK-8245) from Merck,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and pyridazine <b>8</b> from Xenon Pharmaceuticals.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibitors of SCD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Inhibition of SCD in the skin results in toxicity that presents an obstacle to the clinical development of conventional SCD inhibitors. Specifically, mice treated with known inhibitors suffer atrophy of sebocytes.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> These skin cells require SCD to synthesize sebum, which contains esters of fatty acids and fatty alcohols. Sebum is excreted onto the skin by hair follicles to reduce heat loss and onto the eyes and eyelids for lubrication. As a result of sebocyte atrophy, mice treated with SCD inhibitors suffer from dry eye, dry skin, and hypothermia. These effects are severe: the global-SCD-knockout mouse shows alopecia and closed eyes and will die from hypothermia after only a few hours at 4 °C.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> By contrast, inhibition of SCD in the liver appears well tolerated, as mice with liver-specific SCD knockouts were indistinguishable from wild-type mice.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Similarly, Merck reported no toxicity in a Phase II trial of an SCD inhibitor that utilizes organic anion transporters to accumulate in the liver.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">We recently described the discovery of tumor-targeted inhibitors of SCD.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> These compounds emerged from a high-throughput screen against 12 non-small-cell-lung-cancer (NSCLC) lines in conjunction with the Cancer Target Discovery and Development Network.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The NSCLC lines were selected to maximize diversity in terms of expression profiles and copy-number variation. In this experiment, each of approximately 200 000 compounds was tested at 2.5 μM against 12 lung-cancer lines, and viability was assessed by measuring ATP levels with CellTiter-Glo. The experiment was designed to reveal small molecules with selective toxicity toward a subset of the NSCLC lines. We therefore developed an algorithm to cluster cells into a “Sensitive” and “Insensitive” groups for each compound. We then identified the compounds with the largest difference between the two groups, reflecting a high degree of selective toxicity. Among the most selective compounds were a series of compounds containing an oxalic acid diamide moiety, referred to herein as oxalamides and exemplified by compound <b>9</b> (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Ultimately, we determined that, in sensitive cells, active oxalamides covalently bound to and inhibited SCD. Consistent with previous reports, inhibition of SCD enzymatic function starved cells for UFAs, leading to cell death. The selective toxicity displayed by the oxalamides arises from the overexpression of cytochrome P450 isoform CYP4F11 within sensitive cells.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This enzyme metabolizes compounds such as <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which are in fact prodrugs, into an active SCD inhibitors (e.g., <b>2</b>) through O-demethylation. The CYP-mediated activation of SCD inhibitors provides a potential means to increase the therapeutic index of SCD inhibitors by minimizing systemic exposure. Herein, we describe the discovery of optimized SCD inhibitors derived from the oxalamide scaffold.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Anilide Substitutions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0008.gif" alt="" id="GRAPHIC-d7e341-autogenerated" /></img><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The HTS experiment described above returned compound <b>9</b> as a selective and modestly potent cytotoxin (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). It showed EC<sub>50</sub> values <1 μM against the H2122, H460, HCC95, and HCC44 NSCLC cell lines with >95% toxicity to each cell line. By contrast, eight other NSCLC cell lines were substantially less sensitive to <b>9</b> (EC<sub>50</sub> > 10 μM; H1155, H1395, H1819, H1993, H2009, H2073, HCC366, and HCC4017). We set out to obtain potent and selective toxins and to generate probe reagents to facilitate mechanism-of-action studies.</div><div class="NLM_p">At the outset of our project, we did not know the biological target of the oxalamides, so we used cytotoxicity to H2122 cells to drive our optimization efforts. The anilide ring of <b>9</b> features a chlorine substituent, and other small substituents in this position (H, F, CN) provided similar activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> However, we found that introduction of an aryl ketone at the 4-position of the anilide improved potency against H2122 cells. For example, the simple benzophenone <b>13</b> and the methoxy-substituted benzophenone <b>14</b> displayed EC<sub>50</sub>’s around 80 nM. We were hopeful to use the benzophenone as a photo-cross-linking agent, so we incorporated a propargyl ether (<b>15</b>) and were gratified to see a further increase in potency to 30 nM, with essentially complete cell killing at >1 μM.</div><div class="NLM_p">We briefly explored substitution at the other positions of the anilide ring. Even small substituents ortho to the nitrogen (<b>18</b>) totally abrogated activity. By contrast, substitution at the meta position was tolerated (<b>20</b>–<b>22</b>), but offered no improvement, whereas 3,5-disubstitution (<b>23</b>–<b>25</b>) was not tolerated. A series of 3,4-disubstituted analogues revealed the SAR within fairly narrow limits. For example, small electron-withdrawing groups at the 3-position (<b>26</b>–<b>30</b>) supported submicromolar EC<sub>50</sub>’s, but larger groups like nitro (<b>31</b>) or electron-donating methoxy (<b>34</b>) groups decreased activity substantially.</div><div class="NLM_p">We attempted to replace the <i>N</i>-aryl ring of <b>9</b> with an <i>N</i>-heteroaryl ring (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Although a 4-pyridine (<b>36</b>) and a pyrazine (<b>37</b>) were not tolerated, 2- and 3-pyridyl rings were viable replacements. In general, the SAR within the 3-aminopyridines (<b>38</b>–<b>42</b>) and the 2-aminopyridines (<b>43</b>–<b>47</b>) was consistent with what we observed in the anilide series. For example, substitution ortho to the exocyclic nitrogen (<b>38</b> and <b>39</b>) was not tolerated. However, small groups meta and para to the nitrogen linker were acceptable (<b>40</b>–<b>42</b>, <b>44</b>, and <b>45</b>), albeit without conferring obvious improvement in activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Heteroaryl Anilide Replacements</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0009.gif" alt="" id="GRAPHIC-d7e479-autogenerated" /></img><div></div></div><div class="NLM_p">In an effort to avoid the aniline substructure, we attempted to cyclize one of the amide groups into a heterocyclic ring. Unfortunately, the heterocyclic replacements shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> were all inactive against H2122 cells. We tested both 5,6- and 6,6-bicyclic structures. Additionally, no activity was observed with heteroaromatic analogues that included (<b>49</b> and <b>51</b>–<b>53</b>) or lacked (<b>48</b>, <b>50</b>, and <b>54</b>) acidic hydrogens to mimic the amide NH.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cyclic Anilide Replacements</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0010.gif" alt="" id="GRAPHIC-d7e511-autogenerated" /></img><div></div></div><div class="NLM_p">Similarly, the anilide group could not be replaced by a simple carboxylic acid (<b>55</b>) or a variety of amides derived from basic amines (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Thus, benzylic amides (<b>56</b> and <b>57</b>) and a series of amides derived from acyclic amines (<b>58</b>–<b>62</b>) showed EC<sub>50</sub> values >50 μM. Tertiary amides derived from cyclic (<b>63</b> and <b>64</b>) or bicyclic (<b>65</b>–<b>67</b>) amines were also inactive.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Attempted Replacement of the Anilide Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0011.gif" alt="" id="GRAPHIC-d7e555-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0012.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values calculated from 12-point dose–response study, in triplicate, following 4 days in cell culture.</p></div></div><div></div></div><div class="NLM_p">Parallel efforts focused on modifying the tyramine side chain (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). These studies revealed a remarkably sharp SAR. The methoxy group on the phenyl ring could not be removed (<b>68</b>) or moved to the 3- or 2-position (<b>69</b> and <b>70</b>, respectively). Neither could it be replaced with a halogen (<b>71</b>–<b>73</b>), an ethoxy group (<b>74</b>), or a methyl group (<b>75</b>). A 3,4-dimethoxy phenyl ring was also not active (<b>76</b>). By contrast, the para-substituted phenol (<b>77</b>) group retained full activity, whereas the 3- and 2-hydroxyl variants (<b>78</b>, <b>79</b>) were approximately 10-fold less active against H2122 cells.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Variation of the Tyramine Side Chain</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0013.gif" alt="" id="GRAPHIC-d7e614-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col /></col><col /></col><col /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> vs H2122 (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>9</b></td><td class="colsep0 rowsep0">OCH<sub>3</sub></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>68</b></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>69</b></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">OCH<sub>3</sub></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>70</b></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>71</b></td><td class="colsep0 rowsep0">Br</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>72</b></td><td class="colsep0 rowsep0">Cl</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>73</b></td><td class="colsep0 rowsep0">F</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>74</b></td><td class="colsep0 rowsep0">OEt</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>75</b></td><td class="colsep0 rowsep0">CH<sub>3</sub></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>76</b></td><td class="colsep0 rowsep0">OCH<sub>3</sub></td><td class="colsep0 rowsep0">OCH<sub>3</sub></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>77</b></td><td class="colsep0 rowsep0">OH</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>78</b></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">OH</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0" align="char" char=".">2.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>79</b></td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">H</td><td class="colsep0 rowsep0">OH</td><td class="colsep0 rowsep0" align="char" char=".">1.72</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values calculated from 12-point dose–response study, in triplicate, following 4 days in cell culture.</p></div></div></div><div class="NLM_p">The final section of the oxalamide cytotoxins to be evaluated was the linking group between the anilide and the methoxyphenyl ring (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Shortening the linker as in oxalamide <b>80</b> provided an inactive compound. Likewise, introducing a methyl group at either position on the ethylene linker (<b>81</b> and <b>82</b>) or on the tyramine nitrogen (<b>83</b>) resulted in at least a 10-fold loss in activity. Similarly, removing a carbonyl oxygen to provide α-aryloxy amide <b>84</b> or α-amino amide <b>85</b> was not successful. Removing the carbonyl CO generated urea <b>86</b>, which was inactive. We reasoned that extending the methylene linker might maintain the spacing between the two aromatic rings, and indeed the extended compound, <b>87</b>, showed modest activity. Low-micromolar EC<sub>50</sub>’s were observed with a simple amide linkage (<b>88</b>–<b>90</b> and <b>93</b>), but these were significantly less active than the initial hit (<b>9</b>). We were excited to discover that the oxalic acid diamide linker could be replaced with an <i>N</i>-acyl urea. Coupling tyramine to a benzoic acid derivative provided an analogue, <b>94</b>, that was >10-fold more potent than its isomer, <b>95</b>. The high activity of <i>N</i>-acyl urea <b>94</b> provided the starting point for additional optimization efforts.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Variation of the Linker</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0014.gif" alt="" id="GRAPHIC-d7e968-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0015.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values calculated from 12-point dose–response study, in triplicate, following 4 days in cell culture.</p></div></div><div></div></div><div class="NLM_p">The SAR of the <i>N</i>-acyl ureas mirrored what was observed in the oxalamide series (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Thus, a variety of nonpolar substituents on the 4-position of benzamide ring, including halogens (<b>96</b>) and a phenyl ring (<b>97</b>), had minimal effects on activity. A 4-methoxy group was modestly deactivating (<b>98</b>), whereas substantial loss of activity was observed with larger polar groups, such as an ester (<b>99</b>), a carboxylic acid (<b>100</b>), or tertiary amides (<b>101</b> and <b>102</b>). By contrast, we observed improved activity when a ketone (<b>103</b>) or ether (<b>104</b>–<b>106</b>) was incorporated in the 4-position. The analogous benzylic alcohol (<b>107</b>) and benzylic amine (<b>108</b>) retained activity, but they were less potent than the ethers, <b>104</b>–<b>106</b>. As described previously (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), the oxalamide series tolerated substitution in the 3-position of the aniline ring. However, in the <i>N</i>-acyl urea series, substitution in the analogous 3-position returned inactive analogues (<b>109</b> and <b>110</b>). The two series overlapped, however, in that <i>N</i>-methylation on the linker resulted in substantial loss of activity (<b>111</b>–<b>113</b>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. <i>N</i>-Acyl Ureas</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0016.gif" alt="" id="GRAPHIC-d7e1063-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0017.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values calculated from 12-point dose–response study, in triplicate, following 4 days in cell culture.</p></div></div><div></div></div><div class="NLM_p">During the course of our optimization efforts, we used propargyl ether <b>15</b> to identify SCD as the functional target of the oxalamides and <i>N</i>-acyl ureas (see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, above). Specifically, as previously described,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> compound <b>15</b> was first incubated with H2122 cells, which were then lysed. The terminal alkyne of <b>15</b> was used as a click tag to introduce a fluorescent dye onto compound-bound proteins. The labeled lysates were resolved on a denaturing gel and visualized with a fluorescence reader, which revealed that oxalamide <b>15</b> formed covalent adducts with two major proteins. Subsequent competition experiments indicated the biological relevance of those binding partners. Next, we used a biotin-azide to immobilize the binding partners on streptavidin-coated beads. Following elution from the beads and purification with SDS-PAGE, mass spectrometry revealed that both the 30 and 37 kDa bands were SCD.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Functional studies using microsomes derived from H2122 cells showed that active oxalamides inhibited SCD’s enzymatic function. Moreover, we confirmed that toxicity was a result of unsaturated fatty acid deficiency in the presence of oxalamides. Thus, inhibition of SCD starved cells of the unsaturated fatty acids needed to maintain membrane fluidity and function. All dividing cells require SCD activity, so the selective toxicity does not result from differential expression or requirement of SCD. Rather the selectivity observed with the oxalamides and <i>N</i>-acyl ureas was found to result from the expression of CYP4F11 enzymes in sensitive cells lines. This metabolic enzyme can demethylate the 4-methoxy group found on all selective compounds to generate an active inhibitor. To summarize, the 4-methoxy forms of the oxalamides and <i>N</i>-acyl ureas act as prodrugs. CYP-mediated demethylation reveals the free phenol, which functions as a covalent and irreversible inhibitor of SCD. The selectivity observed with this series emerges from differential expression of CYP4F11; the hydroxy forms of the drugs are universally toxic.</div><div class="NLM_p">The significance of the CYP-mediated activation emerges from the on-target toxicity associated with known SCD inhibitors. As described above, inhibition of SCD in sebocytes results in hair loss, thermal dysregulation, and dry eyes in mice. CYP4F11 is not expressed in sebocytes, offering the possibility of inhibiting SCD within tumors while sparing sebocytes. Initial studies from our group provide some support for this hypothesis.<a onclick="showRef(event, 'ref18 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref21">(18,21)</a></div><div class="NLM_p">Although the requirement for tumor-mediated activation of the oxalamide SCD inhibitors provides a potential means to enhance their therapeutic index, it complicates the interpretation of our structure–activity relationship. In particular, it was unclear if nontoxic analogues were unable to be metabolized by CYP4F11 or if the resulting metabolite was unable to inhibit SCD. To address this question, we compared the SCD inhibitory activity and toxicity toward H2122 cells for a series of drug (−OH form) and prodrug (−OCH<sub>3</sub> form) analogues (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). Three pairs of compounds were tested in which the −OCH<sub>3</sub> form was inactive against H2122 cells (<b>114</b> vs <b>58</b>, <b>115</b> vs <b>80</b>, and <b>119</b> vs <b>48</b>), and in all three cases, the −OH form was also inactive. For these analogues, the −OH forms showed little to no SCD inhibitory activity. Additionally, we tested a series of moderately active cytotoxins (EC<sub>50</sub> = 0.5–5 μM), including the pairs <b>116</b> and <b>88</b>, <b>117</b> and <b>81</b>, <b>118</b> and <b>82</b>, and <b>120</b> and <b>121</b>, using an in vitro SCD assay. In all of these cases, the activity against H2122 cells of the −OH and −OCH<sub>3</sub> forms was similar in each case. Moreover, the −OH forms generally showed only modest inhibition of SCD activity at 100 nM in an in vitro assay. The lack of SCD inhibition by the simple amide <b>116</b> may suggest that the micromolar toxicity observed with <b>116</b> and <b>88</b> does not arise from SCD inhibition (see below). Finally, a pair of <i>N</i>-acyl ureas (<b>122</b> and <b>106</b>) and oxalamides (<b>123</b> and <b>15</b>) were potent as both the −OCH<sub>3</sub> forms and the respective −OH forms showed nearly complete SCD inhibition under the assay conditions.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Comparison of Phenols and Methyl Ethers</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0018.gif" alt="" id="gr14" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col /></col><col align="center" /></col><col align="center" /></col><col align="char" char="(" /></col><col align="char" char="(" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">drug or prodrug<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> H2122 (μM)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">% SCD inhibition at 100 nM</th><th class="colsep0 rowsep0" align="center" char="(">EC<sub>50</sub> H1155 (μM)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a> (+oleate)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="(">EC<sub>50</sub> H1155+Cyp4F11 (μM)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t8fn4" aria-label="d">d</a> (+oleate)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">stability in H1155 (<i>t</i><sub>1/2</sub>, h)</th><th class="colsep0 rowsep0" align="center">stability in H1155+Cyp4F11 (<i>t</i><sub>1/2</sub>, h)<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">murine S9 stability (<i>t</i><sub>1/2</sub>, min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>77</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">0.26</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">0.39 (37)</td><td class="colsep0 rowsep0" align="char" char="(">0.37 (21)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>9</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">0.22</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">36 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">0.67 (>50)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>114</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>58</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="center">>48</td><td class="colsep0 rowsep0" align="center">4.7</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>115</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="char" char="(">39 (17)</td><td class="colsep0 rowsep0" align="char" char="(">12 (13)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>80</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="center">>48</td><td class="colsep0 rowsep0" align="center">>48</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>116</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">2.7</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="char" char="(">6.3 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">4.9 (>50)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>88</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">0.76</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">3.4 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">2.9 (>50)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>117</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">4.0</td><td class="colsep0 rowsep0" align="center">28</td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>81</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">3.7</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>118</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">5.1</td><td class="colsep0 rowsep0" align="center">24</td><td class="colsep0 rowsep0" align="char" char="(">11.7 (10)</td><td class="colsep0 rowsep0" align="char" char="(">11.2 (13)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>82</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">3.5</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">9.5 (12)</td><td class="colsep0 rowsep0" align="char" char="(">16.4 (7.6)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>119</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">31</td><td class="colsep0 rowsep0" align="char" char="(">18 (46)</td><td class="colsep0 rowsep0" align="char" char="(">17 (35)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>48</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>120</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">57</td><td class="colsep0 rowsep0" align="char" char="("> </td><td class="colsep0 rowsep0" align="char" char="("> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>121</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">0.32</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="("> </td><td class="colsep0 rowsep0" align="char" char="("> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>122</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">0.011</td><td class="colsep0 rowsep0" align="center">96</td><td class="colsep0 rowsep0" align="char" char="(">0.007 (12)</td><td class="colsep0 rowsep0" align="char" char="(">0.051 (6.4)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">>240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>106</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">0.010</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">>50 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">0.034 (3.6)</td><td class="colsep0 rowsep0" align="center">>48</td><td class="colsep0 rowsep0" align="center">7.5</td><td class="colsep0 rowsep0" align="center">158</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>123</b></td><td class="colsep0 rowsep0">drug</td><td class="colsep0 rowsep0" align="center">0.058</td><td class="colsep0 rowsep0" align="center">>98<a class="ref internalNav" href="#t8fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char="(">0.008 (>50)</td><td class="colsep0 rowsep0" align="char" char="(">0.21 (>50)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>15</b></td><td class="colsep0 rowsep0">prodrug</td><td class="colsep0 rowsep0" align="center">0.028</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="(">8.5 (16)</td><td class="colsep0 rowsep0" align="char" char="(">0.12 (>50)</td><td class="colsep0 rowsep0" align="center">>48</td><td class="colsep0 rowsep0" align="center">28</td><td class="colsep0 rowsep0" align="center">126</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Drug indicates the −OH-containing analogue; prodrug indicates the −OCH<sub>3</sub>-containing analogue.</p></div><div class="footnote" id="t8fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub>’s calculated from 12-point dose–response study, in triplicate, following 4 days in cell culture. 95% confidence intervals are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_001.csv" class="ext-link">Supporting Information</a>.</p></div><div class="footnote" id="t8fn3"><sup><sup>c</sup></sup><p class="last">Values in parentheses refer to EC<sub>50</sub>’s obtained when the cell-culture media was supplemented with 10 μM sodium oleate.</p></div><div class="footnote" id="t8fn4"><sup><sup>d</sup></sup><p class="last">H1155 cell line stably expressing Cyp4F11.</p></div><div class="footnote" id="t8fn5"><sup><sup>e</sup></sup><p class="last">3 μM.</p></div></div></div><div class="NLM_p">We used an isogenic-cell-culture system to precisely determine the relationship between compound metabolism, toxicity, and SCD inhibition. We engineered H1155 cells (which do not normally express CYP4F11) to stably express either a vector control (pLVX) or CYP4F11. To determine the impact of CYP4F11, we compared the stability and toxic effects of different analogues in these two cell lines. In addition, we tested both conditions in the presence and absence of oleate supplementation. Compounds rescued by oleate supplementation were considered inhibitors of SCD. Finally, as a control, we confirmed that there were no major differences in cell accumulation that could explain the differences in toxicity that we observed.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Results with analogue <b>106</b> are representative (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). This compound shows complete toxicity toward H2122 cells with an EC<sub>50</sub> of 10 nM. By contrast, it shows little toxicity toward H1155 cells expressing an empty vector (H1155 pLVX). However, <b>106</b> is toxic to H1155 cells ectopically expressing CYP4F11 with an EC<sub>50</sub> of 34 nM. In the presence of 10 μM oleate, the EC<sub>50</sub> is shifted 100-fold to 3.6 μM. The incomplete killing could be due to variable expression of CYP4F11, but the clear rescue by oleate confirms that the activity is on target. To confirm that the ectopically expressed CYP4F11 is active, we monitored the stability of compound <b>106</b> in the presence of H1155 cells that did and did not express CYP4F11. As expected, <b>106</b> was stable for over 48 h in the presence of H1155 control cells, but it was metabolized relatively rapidly in the presence of H1155 cells stably expressing CYP4F11. As further confirmation of our model, we observed the formation of the des-methyl form of <i>N</i>-acyl urea <b>106</b> (i.e., <b>122</b>) only in the presence of H1155 cells expressing CYP4F11 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_001.csv" class="ext-link">Figure S1</a>). Consistently, the drug form, phenol <b>122</b>, was potently toxic to H1155 irrespective of CYP4F11 status, and the dose–response curve was right-shifted at least 100-fold in the presence of oleate.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose–response curves for H2122 and H1155 cells. H1155 Cyp4F11 cells stably express CYP4F11, and H1155 pLVX cells contain the empty vector.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">All of the compounds with submicromolar potencies fit the model described for <b>106</b> and <b>122</b>. For example, the initial hit, <b>9</b>, is only toxic in the presence of CYP4F11, and that toxicity is rescued by oleate. Similar results are obtained with the optimized analogue, <b>15</b>. By contrast, the weak potency (10–40 μΜ) associated with <b>115</b>, <b>118</b>, and <b>119</b> may not be related to SCD inhibition; their activity is not affected by CYP4F11 expression in H1155 cells, and the weak toxicity is not rescued by oleate. The moderate activity of <b>116</b> (∼5 μM) is currently unresolved. It did not show inhibition of SCD, and its activity is not dependent on CYP4F11 expression. Nonetheless, its modest toxicity was rescued by oleate. It is possible that <b>116</b> and <b>88</b> target a different step in the UFA synthesis pathway.</div><div class="NLM_p">Taken together, the results shown in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a> indicate that in sensitive cell lines (e.g., H2122), CYP-mediated demethylation is not dominating the structure–activity relationship with regard to cytotoxicity. In other words, inactive compounds with the <i>p</i>-methoxyphenyl ethylamine groups are likely inactive because the −OH form is not an efficient inhibitor of SCD not because demethylation by CYP4F11 fails to occur. This observation holds true for changes to the linker length and substitution pattern (<b>115</b>–<b>118</b>) and the right-hand aryl ring as drawn (<b>114</b> and <b>119</b>). In the case of the benzyl amide, <b>115</b>, CYP-mediated demethylation appears retarded, but this appears irrelevant because the drug form (<b>80</b>) is nontoxic. Finally, the data in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a> confirm that potent SCD inhibition is required for potent cytotoxicity, as demonstrated by the correlation between SCD inhibition and EC<sub>50</sub> against H2122 cells.</div><div class="NLM_p last">All active SCD inhibitors from the oxalamide and <i>N</i>-acyl urea series contained a 4-substituted phenol subunit. Furthermore, prior work from our group revealed that these inhibitors formed covalent adducts with SCD. Although we do not understand the nature of the chemistry involved in forming these adducts, we have made some informative observations. First, these SCD inhibitors are not highly reactive. For example, <i>N</i>-acyl urea <b>122</b> shows excellent stability in the presence of murine liver S9 fractions (<i>t</i><sub>1/2</sub> > 4 h). Second, NADPH is required for both SCD enzymatic activity and for generating the adduct. These observations suggest that the catalytic activity of SCD may be required for covalent-adduct formation. Third, the oxalamides form covalent adducts with two other proteins besides SCD: heme-oxygenase 2 and CYP4F11. Cross-links to the CYP enzyme are only observed when it is overexpressed in H293T cells. Of note, all three of these enzymes are iron-containing oxygenases. We speculate that the phenol moiety of active SCD inhibitors could be oxidized to a phenolic radical, which could then react with amino acid side chains within the active site.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The oxalamide scaffold was synthesized through two amine additions to ethyl chlorooxoacetate (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A). In the first step, typically anilines were condensed with ethyl chlorooxoacetate. Nucleophilic addition to the resulting aminooxoacetate, <b>124</b>, at elevated temperatures then yielded the oxalamides. Usually, the desired oxalamide began to precipitate within five minutes. With this procedure, aminoheterocycles and anilines, as well as primary and secondary amines were introduced on the right-hand side as drawn. To provide comparisons between the methoxyphenyl and hydroxyphenyl derivatives (see <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>), the methyl groups of several derivatives were removed with BBr<sub>3</sub> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B). Alternatively, to modify the arylethylamines, a nitroaldol condensation reaction between aldehydes and nitroalkanes was used to generate nitroalkene <b>126</b>, which could be diverted down several paths (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>C). First, hydrogenation with palladium on carbon under acid conditions formed amine salt <b>127</b>. Second, nitroalkene <b>126</b> underwent conjugate addition with methylmagnesium bromide to yield nitroalkane <b>128</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Finally, the α-methyl amine, <b>131</b>, was synthesized through a similar procedure with nitroethane, followed by reduction with LiAlH<sub>4</sub> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>D).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Oxalamides</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To synthesize oxalamides for biological-target identification, we synthesized oxalamide <b>15</b>, which contains a benzophenone and propargyl ether to be used as a photo-cross-linking moiety and to undergo click-chemistry conjugation with an azide, respectively (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). <b>132</b>, a known<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> methoxybenzophenone, was hydrolyzed by refluxing concentrated hydrobromic acid in acetic acid and then subjected to etherification with propargyl bromide to install the alkyne. Subsequent nitro reduction followed by addition to ethyl chlorooxoacetate and the addition of 4-methoxyphenethylamine yielded oxalamide <b>15</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>15</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To evaluate replacements of the linking group between the anilide and the methoxyphenyl ring, several routes were devised (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). First, to remove a carbonyl oxygen from the oxalic acid linker, 4-methoxyphenethylamine was acylated with bromoacetyl bromide to form bromoacetamide <b>136</b>, which underwent nucleophilic substitution with either 4-chlorophenol or 4-chloroaniline (see <b>84</b> and <b>85</b>). Second, analogues lacking one carbonyl CO were assembled from carbamate <b>137</b> and 4-methoxyphenyl-alkyl amines of varying lengths (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>B). A third set of analogues consisting of simple amides with extended methylene linkers originated from the corresponding carboxylic acids (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>C). Similarly, EDC couplings provided amides <b>48</b>–<b>54</b>, derived from different heteroaryl carboxylic acids (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>D). Alternatively, compound <b>116</b>, which is a phenol version of amide <b>88</b>, was synthesized through an EDC–amide coupling with 4-chloroaniline and 3-(4-hydroxyphenyl)propionic acid (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>E). Lastly, substitution of 4-chlorobenzoyl chloride with different lengths of 4-methoxyphenyl alkyl amines yielded benzamides <b>91</b>–<b>93</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Varying the Linker between the Anilide and the 4-Methoxyphenyl Ring</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The oxalic acid diamide linker was replaced with an <i>N</i>-acyl urea as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Thus, addition of oxalyl chloride to an amide yielded isocyanate <b>138</b>, which underwent nucleophilic addition with phenethylamines to form a variety of <i>N</i>-acyl ureas (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>A).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><i>N</i>-acyl urea regioisomer <b>95</b> was prepared utilizing the same isocyanation and addition steps with 4-chloroaniline and 3-(4-methoxyphenyl)propionic acid (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>B). Next, several <i>N</i>-acyl ureas were further modified to provide additional inhibitors. For example, urea <b>99</b> formed the basis for installing different amides through sequential hydrolysis (<b>100</b>) and amide couplings (<b>101</b> and <b>102</b>). Additionally, <i>N</i>-acyl urea <b>103</b> underwent reduction to form alcohol <b>107</b>. Then, chlorination, azidation, and reduction yielded amine <b>108</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>D). Lastly, <i>N</i>-methylation of <i>N</i>-acyl urea <b>103</b> provided monomethylated and dimethylated ureas <b>112</b> and <b>113</b>, depending on the base utilized.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>N</i>-Acyl Ureas</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Oxalamide <b>9</b> was originally identified from an unbiased phenotypic screen for compounds that showed toxicity toward a subset of NSCLC cell lines. Subsequent optimization efforts showed that the tyramine chain is required for activity and that the <i>p</i>-OCH<sub>3</sub> is cleaved by CYP4F11 to reveal the active phenol. In turn, the phenol serves as an irreversible inhibitor of SCD, perhaps through the formation of reactive phenolic radicals. The ethylene linker of <b>9</b> could not be substituted, shortened, or lengthened, and the two amide groups appeared to be required. However, the oxalic acid diamide linker could be replaced with a more stable <i>N</i>-acyl urea. This change, in turn, allowed us to replace the aniline ring with a benzoic acid derivative. A variety of small substituents were accommodated on the right-hand (as drawn) aromatic ring. The most successful substitutions included modestly polar groups at the 4-position (ketone or ether) connected to aromatic rings. These inhibitors were cytotoxic to H2122 cells with EC<sub>50</sub> values <50 nM. The poor solubility of the oxalamides and <i>N</i>-acyl ureas compromises in vivo ADME properties, but the results described here provide the foundation for the discovery of more-bioavailable tumor-targeted inhibitors of SCD.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthetic Methods</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General</h4><div class="NLM_p last">All tested compounds had purities of >95% as judged by HPLC analysis (UV detection at 210 nM) except as noted. Specifically, several oxalamides contained tyramine dimer <b>57</b>, which is formed from 4-methoxyphenethylamine and ethyl chlorooxoacetate and is difficult to remove via purification methods. However, it is inactive against H2122 cells. The presence of this impurity is indicated below. Chemical shifts, δ, are in parts per million, and spectra are referenced using the residual solvent peak. The following abbreviations are used: singlet (s), doublet (d), triplet (t), quartet (q), double doublet (dd), quintet (quint), multiplet (m), and broad signal (br s). For signals with multiple coupling patterns, the coupling constants are listed in the same order as the pattern (e.g., for “dt, <i>J</i> = 2.0, 4.0”, 2.0 is the coupling constant for the doublet, and 4.0 is for the coupling constant for the triplet). Mass spectra (<i>m</i>/<i>z</i>) were recorded on an Agilent LC-MS 1100 or 1290 Infinity using ESI ionization or on an Agilent GC-MS 7820<i>A</i>/5975 using EI ionization. All chemicals were used as received unless otherwise noted.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure 1, for Synthesis of Oxalamides, As Exemplified by the Synthesis of <i>N</i><sup>1</sup>-(4-Methoxyphenethyl)-<i>N</i><sup>2</sup>-phenyloxalamide (<b>10</b>)</h4><div id="sec5_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Step 1</h5><div class="NLM_p last">A solution of ethyl chlorooxoacetate (0.15 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.86 M) was added dropwise slowly to a solution of 4-chloroaniline (0.15 mmol) and Et<sub>3</sub>N (0.3 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.1 M). The reaction was stirred at least 3 h at room temperature, typically overnight. Once complete, the reaction was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield ethyl 2-((4-chlorophenyl)amino)-2-oxoacetate as a white solid, which was used immediately without purification.</div></div><div id="sec5_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Step 2</h5><div class="NLM_p last">4-Methoxyphenethylamine (0.75 mmol) was added to a solution of the ethyl oxalate from <a class="ref internalNav" href="#sec5_1_2_1" aria-label="Step 1">Step 1</a> (0.15 mmol) in anhydrous EtOH (0.1 M). The solution was heated at 80 °C for 3–5 h. A precipitate formed immediately. After cooling to rt, the precipitate was filtered and washed with EtOH before drying under vacuum to give the final product as a white solid, 18.0 mg, 31% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.61 (br s, 1H), 9.01 (t, <i>J</i> = 5.7 Hz, 1H), 7.81 (d, <i>J</i> = 8.0 Hz, 2H), 7.38–7.32 (m, 2H), 7.16–7.11 (m, 3H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.42–3.37 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.8, 158.6, 157.7, 137.6, 130.9, 129.6, 128.7, 124.5, 120.3, 113.8, 55.0, 40.8, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 299.0 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i><sup>1</sup>-(4-Fluorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>11</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 63.7 mg of a white solid, 75% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (br s, 1H), 9.00 (t, <i>J</i> = 6.0 Hz, 1H), 7.87–7.81 (m, 2H), 7.22–7.16 (m, 2H), 7.16–7.11 (m, 2H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.7, 158.7 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 241.3 Hz), 158.5, 157.7, 134.1 (d, <i>J</i><sub>CF</sub> = 2.7 Hz), 130.9, 129.6, 122.2 (d, <i>J</i><sub>CF</sub> = 8.1 Hz), 115.3 (d, <i>J</i><sub>CF</sub> = 22.3 Hz), 113.8, 55.0, 40.8, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 315.2 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i><sup>1</sup>-(4-Cyanophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>12</b>)</h4><div class="NLM_p last">The title compound synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide a white solid, 14.6 mg, 30% isolated yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.06 (br s, 1H), 9.09 (t, <i>J</i> = 5.7 Hz, 1H), 8.03 (d, <i>J</i> = 8.6 Hz, 2H), 7.83 (d, <i>J</i> = 8.6 Hz, 2H), 7.13 (d, <i>J</i> = 8.4 Hz, 2H), 6.85 (d, <i>J</i> = 8.4 Hz, 2H), 3.71 (s, 3H), 3.44–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 159.2, 157.7, 141.9, 133.2, 130.9, 129.6, 120.5, 118.9, 113.8, 106.3, 55.0, 40.9, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 323.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i><sup>1</sup>-(4-Benzoylphenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>13</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide a white solid, 42.1 mg, 69% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99 (br s, 1H), 9.09 (t, <i>J</i> = 5.6 Hz, 1H), 8.02 (d, <i>J</i> = 8.0 Hz, 2H), 7.74 (dd, <i>J</i> = 17.9, 8.0 Hz, 4H), 7.70–7.64 (m, 1H), 7.56 (t, <i>J</i> = 7.5 Hz, 2H), 7.14 (d, <i>J</i> = 8.0 Hz, 2H), 6.86 (d, <i>J</i> = 8.0 Hz, 2H), 3.71 (s, 3H), 3.46–3.38 (m, 2H), 2.77 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 194.7, 159.5, 159.1, 157.7, 141.7, 137.3, 132.6, 132.5, 130.9, 130.8, 129.6, 129.5, 128.5, 119.9, 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 402.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i><sup>1</sup>-(4-(4-Methoxybenzoyl)phenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>14</b>)</h4><div id="sec5_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Step 1</h5><div class="NLM_p last">A solution of tin(II) chloride dihydrate (35 mmol) in concentrated HCl (1.1 M) was added dropwise over 20 min to a suspension of 4-methoxyphenyl(4-nitrophenyl)methanone<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<b>132</b>, 11.7 mmol) in 1,2-dimethoxyethane (1.1 M) and ethanol (1 M). The solution was stirred at room temperature for 1 h. Then, the mixture was poured into ice water (200 mL) and CH<sub>2</sub>Cl<sub>2</sub> (100 mL) with stirring. NaOH (15 g) in 50 mL of water was added slowly with stirring. The mixture was filtered to break the emulsion. The aqueous layer was back-extracted two times with CH<sub>2</sub>Cl<sub>2</sub>, and the organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was recrystallized in benzene/hexanes to yield (4-aminophenyl)(4-methoxyphenyl)methanone<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> as a light-orange solid, 1.43 g, 54% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.78–7.74 (m, 2H), 7.71–7.66 (m, 2H), 6.97–6.93 (m, 2H), 6.70–6.66 (m, 2H), 4.10 (br s, 2H), 3.88 (s, 3H). ESI-MS (<i>m</i>/<i>z</i>): 228.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Step 2</h5><div class="NLM_p last">Oxalamide <b>14</b> was synthesized using the amine from <a class="ref internalNav" href="#sec5_1_6_1" aria-label="Step 1">Step 1</a> following <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to yield the product as a white solid, 7 mg, 5% isolated yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95 (br s, 1H), 9.06 (t, <i>J</i> = 6.0 Hz, 1H), 8.02–7.98 (m, 2H), 7.77–7.69 (m, 4H), 7.17–7.12 (m, 2H), 7.12–7.07 (m, 2H), 6.88–6.82 (m, 2H), 3.86 (s, 3H), 3.72 (s, 3H), 3.45–3.38 (m, 2H), 2.78 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.4, 162.8, 159.5, 159.0, 157.7, 141.2, 133.4, 132.1, 130.9, 130.5, 129.62, 129.59, 119.7, 113.9, 113.8, 55.6, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 432.9 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i><sup>1</sup>-(4-Methoxyphenethyl)-<i>N</i><sup>2</sup>-(4-(4-(prop-2-yn-1-yloxy)benzoyl)phenyl)oxalamide (<b>15</b>)</h4><div id="sec5_1_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Step 1</h5><div class="NLM_p last">(4-Hydroxyphenyl)(4-nitrophenyl)methanone<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<b>133</b>, 1.1 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.5 mmol) were heated at reflux in acetone (0.2 M) for 30 min before propargyl bromide (80 wt % in toluene, 2.2 mmol) was added. After 2 h, the reaction was complete, as judged by TLC analysis, and the reaction mixture was cooled to rt and concentrated under reduced pressure. The residue was partitioned between water and EtOAc (5 mL). The layers were separated, and the aqueous fraction was extracted with EtOAc (2 × 5 mL). The combined organic extracts were washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give (4-nitrophenyl)(4-(prop-2-yn-1-yloxy)phenyl)methanone (<b>134</b>) as a yellow solid, 287.5 mg, 93% yield, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.39–8.35 (m, 2H), 7.95–7.90 (m, 2H), 7.82–7.77 (m, 2H), 7.19–7.15 (m, 2H), 4.95 (d, <i>J</i> = 2.4 Hz, 2H), 3.66 (t, <i>J</i> = 2.4 Hz, 1H). ESI-MS (<i>m</i>/<i>z</i>): 282.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Step 2</h5><div class="NLM_p last">A solution of tin(II) chloride dihydrate (22 mmol) in concentrated HCl (0.39 M) was added dropwise over 20 min to a solution of the nitroarene from <a class="ref internalNav" href="#sec5_1_7_1" aria-label="Step 1">Step 1</a> (7.3 mmol) in 1,2-dimethoxyethane (0.39 M) and EtOH (0.33 M). After being stirred overnight, the reaction mixture was poured into ice water, and CH<sub>2</sub>Cl<sub>2</sub> was added with stirring until the ice melted. The aqueous layer was neutralized with 7.5 M NaOH, and the solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The organic layer was dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure to yield (4-aminophenyl)(4-(prop-2-yn-1-yloxy)phenyl)methanone (<b>135</b>) as an orange oil, 654.4 mg, 35% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.65–7.61 (m, 2H), 7.52–7.49 (m, 2H), 7.11–7.07 (m, 2H), 6.62–6.59 (m, 2H), 4.90 (d, <i>J</i> = 2.4 Hz, 2H), 3.65 (t, <i>J</i> = 2.4 Hz, 1H). ESI-MS (<i>m</i>/<i>z</i>): 252.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Step 3</h5><div class="NLM_p last">The oxalamide <b>15</b> was synthesized using the amine from <a class="ref internalNav" href="#sec5_1_7_2" aria-label="Step 2">Step 2</a> following <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to yield the product as a cream-colored solid, 385.7 mg, 32% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.06 (t, <i>J</i> = 5.8 Hz, 1H), 8.03–7.98 (m, 2H), 7.78–7.70 (m, 4H), 7.17–7.12 (m, 4H), 6.88–6.83 (m, 2H), 4.93 (d, <i>J</i> = 2.2 Hz, 2H), 3.72 (s, 3H), 3.65 (t, <i>J</i> = 2.2 Hz, 1H), 3.45–3.38 (m, 2H), 2.78 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.4, 160.7, 159.5, 159.0, 157.8, 141.2, 133.3, 131.9, 130.9, 130.5, 130.3, 129.6, 119.7, 114.7, 113.8, 94.6, 78.8, 55.8, 55.0, 40.8, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 456.9 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>27</sub>H<sub>24</sub>N<sub>2</sub>O<sub>5</sub> (M + H)<sup>+</sup> 457.175 80, found 457.1750.</div></div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i><sup>1</sup>-(4-(4-Hydroxybenzoyl)phenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>16</b>)</h4><div id="sec5_1_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Step 1</h5><div class="NLM_p last">A solution of tin(II) chloride dihydrate (1.2 mmol) in concentrated HCl (0.39 M) was added dropwise over 20 min to a solution of (4-hydroxyphenyl)(4-nitrophenyl)methanone<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> (<b>133</b>, 0.41 mmol) in 1,2-dimethoxyethane (0.39 M) and EtOH (0.33 M). After being stirred overnight, the reaction mixture was poured into ice water, and CH<sub>2</sub>Cl<sub>2</sub> was added with stirring until the ice melted. The aqueous layer was neutralized with 7.5 M NaOH, and the solution was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield (4-aminophenyl)(4-hydroxyphenyl)methanone (<b>S1</b>) as a solid, 50.1 mg, 57% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.14 (br s, 1H), 7.57–7.51 (m, 2H), 7.51–7.45 (m, 2H), 6.87–6.82 (m, 2H), 6.62–6.57 (m, 2H). ESI-MS (<i>m</i>/<i>z</i>): 214.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Step 2</h5><div class="NLM_p last">The oxalamide <b>16</b> was synthesized using the amine from <a class="ref internalNav" href="#sec5_1_8_1" aria-label="Step 1">Step 1</a> following <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> with purification by flash chromatography over silica gel (0 to 100% EtOAc/hexanes) to give a cream-colored solid, 19.8 mg, 20% yield, contaminated with 23% dimer <b>57</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.96 (br s, 1H), 10.42 (br s, 1H), 9.09 (t, <i>J</i> = 6.0 Hz, 1H), 8.00–7.97 (m, 2H), 7.71–7.67 (m, 2H), 7.67–7.63 (m, 2H), 7.16–7.13 (m, 2H), 6.91–6.88 (m, 2H), 6.87–6.85 (m, 2H), 3.71 (s, 3H), 3.43–3.38 (m, 2H), 2.77 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 193.2, 161.8, 159.6, 159.0, 157.7, 140.9, 133.7, 132.4, 130.9, 130.3, 129.6, 128.1, 119.7, 115.2, 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 418.9 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i><sup>1</sup>-(4-Methoxyphenethyl)-<i>N</i><sup>2</sup>-(2-methoxyphenyl)oxalamide (<b>17</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 31.2 mg of a white solid, 35% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.77 (br s, 1H), 9.15 (t, <i>J</i> = 6.0 Hz, 1H), 8.17 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 7.19–7.08 (m, 4H), 7.02–6.96 (m, 1H), 6.88–6.83 (m, 2H), 3.89 (s, 3H), 3.71 (s, 3H), 3.42–3.35 (m, 2H), 2.76 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.5, 157.7, 157.3, 148.7, 130.8, 129.6, 125.7, 125.2, 120.6, 119.3, 113.8, 111.2, 56.0, 55.0, 41.0, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 328.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i><sup>1</sup>-(2-Fluorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>18</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 44.3 mg of a white solid, 52% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.18 (br s, 1H), 9.06 (t, <i>J</i> = 5.9 Hz, 1H), 7.70 (td, <i>J</i> = 7.9, 1.6 Hz, 1H), 7.34–7.19 (m, 3H), 7.17–7.11 (m, 2H), 6.88–6.83 (m, 2H), 3.72 (s, 3H), 3.43–3.35 (m, 2H), 2.76 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 158.5, 157.7, 154.8 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 247.1 Hz), 130.9, 129.6, 127.1 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 7.7 Hz), 125.2, 124.6 (d, <i>J</i><sub>CF</sub> = 3.7 Hz), 124.5 (d, <i>J</i><sub>CF</sub> = 4.4 Hz), 115.8 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 19.5 Hz), 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 317.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i><sup>1</sup>-(2-Bromophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>19</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> with purification by flash chromatography over silica gel (0 to 30% EtOAc/hexanes) to give a white solid, 34.4 mg, 30% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.12 (br s, 1H), 9.18 (t, <i>J</i> = 6.0 Hz, 1H), 7.98 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.72 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.44 (td, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.18 (td, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.16–7.12 (m, 2H), 6.88–6.84 (m, 2H), 3.71 (s, 3H), 3.42–3.36 (m, 2H), 2.77 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 158.1, 157.7, 134.8, 132.7, 130.8, 129.6, 128.5, 127.2, 123.6, 116.0, 113.8, 55.0, 41.1, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 376.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i><sup>1</sup>-(3-Chlorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>20</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 29.1 mg of a white solid, 33% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (br s, 1H), 9.03 (t, <i>J</i> = 5.9 Hz, 1H), 7.96 (t, <i>J</i> = 2.0 Hz, 1 Hz), 7.78 (dd, <i>J</i> = 8.2, 0.8 Hz, 1H), 7.38 (t, <i>J</i> = 8.1 Hz, 1H), 7.19 (dd, <i>J</i> = 8.1, 0.8 Hz, 1H), 7.16–7.11 (m, 2H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.5, 158.9, 157.7, 139.2, 133.0, 130.9, 130.4, 129.6, 124.2, 119.8, 118.8, 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 333.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i><sup>1</sup>-(3-Ethoxyphenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>21</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 40.5 mg, 83% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.53 (br s, 1H), 8.98 (t, <i>J</i> = 6.0 Hz, 1H), 7.46 (dd, <i>J</i> = 2.2, 2.2 Hz, 1H), 7.40 (ddd, <i>J</i> = 8.2, 2.2, 0.9 Hz, 1H), 7.22 (dd, <i>J</i> = 8.2, 8.2 Hz, 1H), 7.16–7.12 (m, 2H), 6.87–6.83 (m, 2H), 6.69 (ddd, <i>J</i> = 8.2, 2.2, 0.9 Hz, 1H), 3.99 (q, <i>J</i> = 7.0 Hz, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H), 1.32 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.8, 158.6, 158.5, 157.7, 138.7, 130.9, 129.6, 129.5, 113.8, 112.4, 110.4, 106.6, 62.9, 55.0, 40.8, 33.7, 14.6. ESI-MS (<i>m</i>/<i>z</i>): 343.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i><sup>1</sup>-(3-Cyanophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>22</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 20.2 mg, 23% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.00 (br s, 1H), 9.07 (t, <i>J</i> = 6.0 Hz, 1H), 8.25–8.23 (m, 1H), 8.13 (dt, <i>J</i> = 7.7, 1.9 Hz, 1H), 7.62–7.55 (m, 2H), 7.16–7.11 (m, 2H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.44–3.37 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 159.1, 157.7, 138.6, 130.9, 130.2, 129.6, 128.0, 125.0, 123.2, 118.6, 113.8, 111.5, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 324.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i><sup>1</sup>-(3-Chloro-5-fluorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>23</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 30.8 mg of a white solid, 33% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.07 (t, <i>J</i> = 5.9 Hz, 1 Hz), 7.85–7.82 (m, 1H), 7.73 (dt, <i>J</i> = 11.1, 2.1 Hz, 1H), 7.19 (dt, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.16–7.11 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 162.0 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 244.7 Hz), 159.2, 159.1, 157.7, 140.3 (d, <i>J</i><sub>CF</sub> = 12.8 Hz), 133.9 (d, <i>J</i><sub>CF</sub> = 12.8 Hz), 130.9, 129.6, 116.1 (d, <i>J</i><sub>CF</sub> = 3.1 Hz), 113.8, 111.7 (d, <i>J</i><sub>CF</sub> = 25.7 Hz), 106.0 (d, <i>J</i><sub>CF</sub> = 26.4 Hz), 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 351.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i><sup>1</sup>-(3-Chloro-5-(trifluoromethyl)phenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>24</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 53.9 mg of a white solid, 50% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.99 (br s, 1H), 9.08 (t, <i>J</i> = 6.0 Hz, 1H), 8.28–8.22 (m, 2H), 7.63–7.60 (m, 1H), 7.16–7.12 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 3.44–3.37 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 159.1, 157.7, 140.0, 134.2, 131.2, 130.9, 129.6, 124.5, 123.4, 120.7 (q, <i>J</i><sub>CF</sub> = 4.0 Hz), 115.3 (q, <i>J</i><sub>CF</sub> = 4.1 Hz), 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 399.1 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i><sup>1</sup>-(3,5-Dichlorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>25</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 71.6 mg of a light-brown solid, 73% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (br s, 1H), 9.05 (t, <i>J</i> = 5.9 Hz, 1H), 7.95 (app d, <i>J</i> = 1.9 Hz, 2H), 7.36 (app t, <i>J</i> = 1.9 Hz, 1H), 7.16–7.11 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.14, 159.13, 157.7, 140.1, 134.0, 130.9, 129.6, 123.7, 118.6, 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 365.1 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i><sup>1</sup>-(3-Fluoro-4-methylphenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>26</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 36.0 mg of a white solid, 41% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (br s, 1H), 9.01 (t, <i>J</i> = 6.0 Hz, 1H), 7.68 (dd, <i>J</i> = 12.2, 1.9 Hz, 1H), 7.56 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.24 (t, <i>J</i> = 8.6 Hz, 1H), 7.16–7.11 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H), 2.19 (s, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 160.1 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 241.1 Hz), 159.6, 158.7, 157.7, 137.0 (d, <i>J</i><sub>CF</sub> = 10.9 Hz), 131.4 (d, <i>J</i><sub>CF</sub> = 6.4 Hz), 130.9, 129.6, 119.9 (d, <i>J</i><sub>CF</sub> = 17.2 Hz), 116.0 (d, <i>J</i><sub>CF</sub> = 3.1 Hz), 113.8, 106.9 (d, <i>J</i><sub>CF</sub> = 27.2 Hz), 55.0, 40.8, 33.7, 13.8. ESI-MS (<i>m</i>/<i>z</i>): 329.1 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i><sup>1</sup>-(4-Chloro-3-fluorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>27</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 86.0 mg, 82% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (br s, 1H), 9.05 (t, <i>J</i> = 6.0 Hz, 1H), 7.93 (dd, <i>J</i> = 11.9, 2.4 Hz, 1H), 7.72 (ddd, <i>J</i> = 8.9, 2.4, 1.0 Hz, 1H), 7.57 (t, <i>J</i> = 8.7 Hz, 1H), 7.16–7.11 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 159.0, 157.7, 156.8 (<i>J</i> = 244.1 Hz), 138.3 (<i>J</i> = 10.1 Hz) 130.9, 130.6, 129.6, 117.3 (<i>J</i> = 3.5 Hz), 114.3 (<i>J</i> = 17.6 Hz), 113.8, 108.5 (<i>J</i> = 25.7 Hz), 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 350.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i><sup>1</sup>-(3-Chloro-4-fluorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>28</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 60.7 mg of a white solid, 64% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (br s, 1H), 9.03 (t, <i>J</i> = 5.9 Hz, 1H), 8.08 (dd, <i>J</i> = 6.9, 2.6 Hz, 1H), 7.85–7.79 (m, 1H), 7.42 (t, <i>J</i> = 9.1 Hz, 1H), 7.16–7.11 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.40 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.4, 158.8, 157.7, 153.8 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 243.6 Hz), 135.0 (d, <i>J</i><sub>CF</sub> = 3.1 Hz), 130.9, 129.6, 121.9, 120.8 (d, <i>J</i><sub>CF</sub> = 7.0 Hz), 119.1 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 18.4 Hz), 116.9 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 21.7 Hz), 113.8, 55.0, 40.8, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 351.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i><sup>1</sup>-(3-Chloro-4-methylphenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>29</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 50.5 mg, 87% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.73 (br s, 1H), 8.98 (t, <i>J</i> = 6.0 Hz, 1H), 7.95 (d, <i>J</i> = 1.7 Hz, 1H), 7.67 (dt, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 7.16–7.12 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 3.35–3.28 (m, 2H, under H<sub>2</sub>O peak), 2.75 (t, <i>J</i> = 7.3 Hz, 2H), 2.28 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 157.7, 136.8, 132.9, 131.2, 131.1, 130.9, 129.6, 120.3, 119.0, 113.8, 55.0, 40.8, 33.7, 19.0. ESI-MS (<i>m</i>/<i>z</i>): 347.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i><sup>1</sup>-(3,4-Dichlorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>30</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 93.3 mg, 69% yield contaminated with 5% dimer <b>57</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.96 (br s, 1H), 9.05 (t, <i>J</i> = 6.0 Hz, 1H), 8.16 (d, <i>J</i> = 2.5 Hz, 1H), 7.84 (dd, <i>J</i> = 8.9, 2.5 Hz, 1H), 7.62 (d, <i>J</i> = 8.9 Hz, 1H), 7.15–7.12 (m, 2H), 6.87–6.84 (m, 2H), 3.71 (s, 3H), 3.42–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.3, 159.0, 157.7, 137.9, 130.93, 130.87, 130.7, 129.6, 126.1, 121.6, 120.4, 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 368.8 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i><sup>1</sup>-(4-Chloro-3-nitrophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>31</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 83.0 mg of an orange solid, 82% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.12 (br s, 1H), 9.09 (t, <i>J</i> = 5.9 Hz, 1H), 8.62 (d, <i>J</i> = 2.2 Hz, 1H), 8.11 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.77 (d, <i>J</i> = 8.9 Hz, 1H), 7.16–7.10 (m, 2H), 6.88–6.82 (m, 2H), 3.71 (s, 3H), 3.44–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.2, 159.1, 157.7, 147.2, 137.7, 132.0, 130.9, 129.6, 125.4, 119.9, 116.8, 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 376.1 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i><sup>1</sup>-(4-Chloro-3-cyanophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>32</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 34.1 mg, 66% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.11 (br s, 1H), 9.08 (t, <i>J</i> = 6.0 Hz, 1H), 8.35 (d, <i>J</i> = 2.6 Hz, 1H), 8.16 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.75 (d, <i>J</i> = 9.0 Hz, 1H), 7.16–7.10 (m, 2H), 6.87–6.84 (m, 2H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.15, 159.12, 157.7, 137.4, 130.9, 130.6, 129.6, 130.1, 126.5, 125.2, 115.9, 113.8, 112.0, 55.0, 40.9, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 358.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i><sup>1</sup>-(4-Chloro-3-(trifluoromethyl)phenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>33</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 60.6 mg of a white solid in 56% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.06 (br s, 1H), 9.07 (t, <i>J</i> = 6.0 Hz, 1H), 8.43 (d, <i>J</i> = 2.5 Hz, 1H), 8.14 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 7.72 (d, <i>J</i> = 8.8 Hz, 1H), 7.16–7.11 (m, 2H), 6.87–6.82 (m, 2H), 3.71 (s, 3H), 3.44–3.37 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.2, 159.1, 157.7, 137.3, 132.1, 130.9, 129.6, 126.7 (q, <sup>2</sup><i>J</i><sub>CF</sub> = 30.6 Hz), 125.3 (q, <sup>4</sup><i>J</i><sub>CF</sub> = 1.9 Hz), 125.2, 122.7 (q, <sup>1</sup><i>J</i><sub>CF</sub> = 273.4 Hz), 119.3 (q, <sup>3</sup><i>J</i><sub>CF</sub>= 5.6 Hz), 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 399.1 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i><sup>1</sup>-(3-Methoxy-4-methylphenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>34</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 45.7 mg of a white solid, 50% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.49 (br s, 1H), 8.97 (t, <i>J</i> = 5.9 Hz, 1H), 7.50 (d, <i>J</i> = 1.7 Hz, 1H), 7.36 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.16–7.11 (m, 2H), 7.07 (d, <i>J</i> = 8.2 Hz, 1H), 6.88–6.83 (m, 2H), 3.74 (s, 3H), 3.71 (s, 3H), 3.43–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H), 2.10 (s, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.9, 158.3, 157.7, 157.1, 136.7, 130.9, 130.1, 129.6, 121.6, 113.8, 111.8, 103.1, 55.1, 55.0, 40.8, 33.7, 15.6. ESI-MS (<i>m</i>/<i>z</i>): 341.2 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i><sup>1</sup>-(4-Methoxy-3-methylphenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>35</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 60.4 mg of a white solid, 66% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (br s, 1H), 8.91 (t, <i>J</i> = 6.0 Hz, 1H), 7.62–7.55 (m, 2H), 7.16–7.11 (m, 2H), 6.89 (d, <i>J</i> = 8.8 Hz, 1H), 6.87–6.83 (m, 2H), 3.76 (s, 3H), 3.71 (s, 3H), 3.42–3.35 (m, 2H), 2.76 (t, <i>J</i> = 7.4 Hz, 2H), 2.12 (s, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 160.0, 158.0, 157.7, 154.2, 130.9, 130.2, 129.6, 125.5, 122.9, 119.1, 113.8, 110.2, 55.4, 55.0, 40.8, 33.7, 16.2. ESI-MS (<i>m</i>/<i>z</i>): 343.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i><sup>1</sup>-(4-Methoxyphenethyl)-<i>N</i><sup>2</sup>-(pyridin-4-yl)oxalamide (<b>36</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 44.6 mg, 49% yield, contaminated with 21% dimer <b>57</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.09 (t, <i>J</i> = 5.9 Hz, 1H), 8.49 (dd, <i>J</i> = 4.8 1.5 Hz, 2H), 7.82 (dd, <i>J</i> = 4.8, 1.5 Hz, 2H), 7.16–7.12 (m, 2H), 6.87–6.84 (m, 2H), 3.71 (s, 3H), 3.44–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.7, 159.2, 157.7, 150.4, 144.5, 130.9, 129.6, 114.2, 113.8, 55.0, 40.9, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 300.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i><sup>1</sup>-(4-Methoxyphenethyl)-<i>N</i><sup>2</sup>-(pyrazin-2-yl)oxalamide (<b>37</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> with purification by flash chromatography over silica gel (0 to 100% EtOAc/hexanes) to give a white solid, 26.0 mg, 29% yield, contaminated with 15% dimer <b>57</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.57 (br s, 1H), 9.24 (d, <i>J</i> = 1.2 Hz, 1H), 9.21 (t, <i>J</i> = 6.1 Hz, 1H), 8.73 (t, <i>J</i> = 6.0 Hz, 0.4H, dimer), 8.50–8.49 (m, 1H), 8.48 (d, <i>J</i> = 2.4 Hz, 1H), 7.16–7.13 (m, 2H), 7.11–7.08 (m, 0.8H, dimer), 6.88–6.85 (m, 2H), 6.84–6.82 (m, 0.5H, dimer), 3.71 (s, 3H), 3.71 (s, 1.3H, dimer), 3.42–3.37 (m, 2H), 3.33–3.28 (m, 0.9H, dimer), 2.76 (t, <i>J</i> = 7.5 Hz, 2H), 2.70 (t, <i>J</i> = 7.4 Hz, 0.8H, dimer). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.8, 158.9, 157.7, 147.1, 143.0, 141.1, 137.0, 130.8, 129.6, 113.8, 55.0, 41.0, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 301.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i><sup>1</sup>-(2-Fluoropyridin-3-yl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>38</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 102 mg, 99% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.28 (br s, 1H), 9.09 (t, <i>J</i> = 5.9 Hz, 1H), 8.16 (ddd, <i>J</i> = 10.0, 7.8, 1.8 Hz, 1H), 8.08 (dt, <i>J</i> = 4.9, 1.5 Hz, 1H), 7.40 (ddd, <i>J</i> = 7.8, 4.9, 1.2 Hz, 1H), 7.16–7.12 (m, 2H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.43–3.37 (m, 2H), 2.76 (t, <i>J</i> = 7.7 Hz, 2H). <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.01, 158.97, 157.8, 155.8 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 237.2 Hz), 143.7 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 14.3 Hz), 135.7 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 3.2 Hz), 130.9, 129.6, 122.3 (d, <sup>4</sup><i>J</i><sub>CF</sub> = 4.2 Hz), 120.0 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 27.4 Hz), 113.8, 55.0, 40.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 318.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i><sup>1</sup>-(4-Methoxyphenethyl)-<i>N</i><sup>2</sup>-(4-methylpyridin-3-yl)oxalamide (<b>39</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a pink solid, 68.3 mg, 73% yield, containing 22% dimer <b>57</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.25 (br s, 1H), 9.01 (t, <i>J</i> = 6.0 Hz, 1H), 8.48 (s, 1H), 8.31 (d, <i>J</i> = 4.9 Hz, 1H), 7.30 (d, <i>J</i> = 4.9 Hz, 1H), 7.17–7.12 (m, 2H), 6.88–6.84 (m, 2H), 3.72 (s, 3H), 3.43–3.37 (m, 2H), 2.77 (t, <i>J</i> = 7.8 Hz, 2H), 2.20 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.4, 159.1, 157.8, 147.0, 146.6, 142.2, 132.4, 130.9, 129.6, 125.4, 113.8, 55.0, 40.9, 33.7, 17.2. ESI-MS (<i>m</i>/<i>z</i>): 314.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i><sup>1</sup>-(5-Chloropyridin-3-yl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>40</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a cream-colored solid, 93.2 mg, 89% yield, contaminated with 26% dimer <b>57</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.09 (t, <i>J</i> = 6.0 Hz, 1H), 8.97 (d, <i>J</i> = 2.1 Hz, 1H), 8.40 (d, <i>J</i> = 2.2 Hz, 1H), 8.35 (t, <i>J</i> = 2.2 Hz, 1H), 7.16–7.12 (m, 2H), 6.87–6.85 (m, 2H), 3.71 (s, 3H), 3.44–3.37 (m, 2H), 2.77 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.4, 159.1, 157.7, 143.5, 140.3, 135.4, 130.9, 130.4, 129.6, 126.6, 113.8, 55.0, 43.7, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 333.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i><sup>1</sup>-(4-Methoxyphenethyl)-<i>N</i><sup>2</sup>-(5-methylpyridin-3-yl)oxalamide (<b>41</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a cream-colored solid, 79.8 mg, 87% yield, contaminated with 24% dimer <b>57</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.02 (t, <i>J</i> = 5.9 Hz, 1H), 8.78 (d, <i>J</i> = 2.3 Hz, 1H), 8.19–8.18 (m, 1H), 8.04–8.01 (m, 1H), 7.16–7.12 (m, 2H), 6.87–6.85 (m, 2H), 3.71 (s, 3H), 3.44–3.37 (m, 2H), 2.80–2.73 (m, 2H), 2.29 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.4, 159.1, 157.7, 145.7, 139.4, 134.0, 132.8, 130.9, 129.6, 127.7, 113.8, 55.0, 40.8, 33.7, 18.0. ESI-MS (<i>m</i>/<i>z</i>): 314.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i><sup>1</sup>-(6-Chloropyridin-3-yl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>42</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 103.4 mg, 96% yield, contaminated with 20% dimer <b>57</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.05 (br s, 1H), 9.07 (t, <i>J</i> = 6.0 Hz, 1H), 8.85 (dd, <i>J</i> = 2.8, 0.4 Hz, 1H), 8.26 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 7.52 (dd, <i>J</i> = 8.7, 0.4 Hz, 1H), 7.16–7.12 (m, 2H), 6.87–6.82 (m, 2H), 3.71 (s, 3H), 3.44–3.37 (m, 2H), 2.76 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.8, 159.2, 157.7, 144.8, 141.8, 134.1, 131.0, 130.9, 129.6, 124.2, 113.8, 55.0, 40.8, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 333.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i><sup>1</sup>-(4-Methoxyphenethyl)-<i>N</i><sup>2</sup>-(pyridin-2-yl)oxalamide (<b>43</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> with purification by flash chromatography over silica gel (0 to 100% EtOAc/hexanes) to give a yellow solid, 10.5 mg, 11% yield, contaminated with 16% dimer <b>57</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (t, <i>J</i> = 6.0 Hz, 1H), 8.39 (ddd, <i>J</i> = 4.9, 1.9, 0.8 Hz, 1H), 8.05 (d, <i>J</i> = 8.3 Hz, 1H), 7.89 (ddd, <i>J</i> = 8.3, 7.5, 1.9 Hz, 1H), 7.23 (ddd, <i>J</i> = 7.5, 4.9, 0.8 Hz, 1H), 7.16–7.12 (m, 2H), 6.87–6.84 (m, 2H), 3.71 (s, 3H), 3.42–3.37 (m, 2H), 2.76 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.2, 158.3, 157.7, 149.9, 148.5, 138.7, 130.8, 129.6, 120.8, 113.8, 113.7, 55.0, 41.0, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 300.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i><sup>1</sup>-(5-Chloropyridin-2-yl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>44</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> with purification by flash chromatography over silica gel (0 to 100% EtOAc/hexanes) to give an orange solid, 9.1 mg, 9% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (t, <i>J</i> = 6.0 Hz, 1H), 8.46 (dd, <i>J</i> = 2.6, 0.7 Hz, 1H), 8.06 (d, <i>J</i> = 8.8 Hz, 1H), 8.02 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 7.15–7.12 (m, 2H), 6.87–6.84 (m, 2H), 3.71 (s, 3H), 3.41–3.36 (m, 2H), 2.76 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.1, 158.5, 157.7, 148.7, 146.9, 138.3, 130.8, 129.6, 126.6, 115.0, 113.8, 55.0, 41.0, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 333.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i><sup>1</sup>-(5-Bromopyridin-2-yl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>45</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> with purification by flash chromatography over silica gel (0 to 100% EtOAc/hexanes) to give a white solid, 13.1 mg, 12% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.22 (br s, 1H), 9.20 (t, <i>J</i> = 6.0 Hz, 1H), 8.53 (dd, <i>J</i> = 2.5, 0.4 Hz, 1H), 8.13 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 8.01 (dd, <i>J</i> = 8.8, 0.4 Hz, 1H), 7.15–7.11 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 3.41–3.36 (m, 2H), 2.75 (t, <i>J</i> = 7.7 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.0, 158.5, 157.7, 149.1, 149.0, 141.1, 130.8, 129.6, 115.5, 115.1, 113.8, 55.0, 41.0, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 377.8 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i><sup>1</sup>-(6-Bromopyridin-2-yl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>46</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 37.2 mg, 33% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.23 (br s, 1H), 9.15 (t, <i>J</i> = 5.9 Hz, 1H), 8.02 (d, <i>J</i> = 8.1 Hz, 1H), 7.83 (t, <i>J</i> = 8.0 Hz, 1H), 7.46 (dd, <i>J</i> = 7.8, 0.4 Hz, 1H), 7.16–7.11 (m, 2H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.42–3.35 (m, 2H), 2.76 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.9, 158.7, 157.7, 150.2, 141.7, 139.1, 130.8, 129.6, 124.5, 113.8, 113.1, 55.0, 41.0, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 379.8 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i><sup>1</sup>-(6-Fluoropyridin-2-yl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>47</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 35.2 mg, 37% yield, contaminated with 16% dimer <b>57</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.16 (t, <i>J</i> = 5.9 Hz, 1H), 8.06 (dd, <i>J</i> = 8.1, 8.1 Hz, 1H), 7.94 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 7.16–7.12 (m, 2H), 6.99 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 6.88–6.84 (m, 2H), 3.71 (s, 3H), 3.42–3.35 (m, 2H), 2.76 (t, <i>J</i> = 7.7 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.4 (d, <sup>1</sup><i>J</i><sub>CF</sub> = 237.8 Hz), 159.0, 158.7, 157.7, 148.4 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 15.2 Hz), 144.3 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 7.9 Hz), 130.8, 129.6, 113.8, 111.2 (d, <sup>4</sup><i>J</i><sub>CF</sub> = 4.2 Hz), 105.4 (<sup>2</sup><i>J</i><sub>CF</sub> = 35.5 Hz), 55.0, 41.0, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 318.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> General Procedure 2, for the Synthesis of Amides with EDC or HOBt, As Exemplified by the Synthesis of <i>N</i>-(4-Methoxyphenethyl)quinoline-2-carboxamide (<b>48</b>)</h4><div class="NLM_p last">Quinaldic acid (0.7 mmol), 1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide HCl (EDC, 0.735 mmol), and 1-hydroxybenzotriazole hydrate (HOBT, 0.735 mmol) were dissolved in DMF (0.1 M), and the solution was stirred for 20 min before 4-methoxyphenethylamine (0.7 mmol) was added. The reaction mixture was stirred overnight. Water was added to the reaction mixture, and a precipitate formed. The precipitate was collected by filtration, washed with EtOAc, and dried to give the final product as a white solid, 139.7 mg, 66% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (t, <i>J</i> = 6.0 Hz, 1H), 8.56 (d, <i>J</i> = 8.5 Hz, 1H), 8.15 (d, <i>J</i> = 8.5 Hz, 1H), 8.12 (d, <i>J</i> = 8.4 Hz, 1H), 8.08 (d, <i>J</i> = 8.2 Hz, 1H), 7.87 (ddd, <i>J</i> = 8.6, 6.8, 1.4 Hz, 1H), 7.72 (ddd, <i>J</i> = 8.4, 6.8, 1.2 Hz, 1H), 7.21–7.17 (m, 2H), 6.89–6.84 (m, 2H), 3.71 (s, 3H), 3.60–3.53 (m, 2H), 2.85 (t, <i>J</i> = 7.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.8, 157.7, 150.2, 146.0, 137.9, 131.2, 130.5, 129.6, 129.1, 128.8, 128.1, 128.0, 118.6, 113.8, 55.0, 40.8, 34.3. ESI-MS (<i>m</i>/<i>z</i>): 307.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 307.144 10, found 307.1449.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i>-(4-Methoxyphenethyl)-4-oxo-3,4-dihydroquinazoline-2-carboxamide (<b>49</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_40" aria-label="General Procedure 2">General Procedure 2</a> with 4-oxo-3,4-dihydroquinazoline-2-carboxylic acid<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to yield a white solid, 6.4 mg, 9% isolated yield, after triturating in CH<sub>2</sub>Cl<sub>2</sub>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76 (t, <i>J</i> = 6.0 Hz, 1H), 7.95 (dd, <i>J</i> = 7.9, 1.1 Hz, 1H), 7.56 (d, <i>J</i> = 8.1 Hz, 1H), 7.50 (ddd, <i>J</i> = 8.3, 6.5, 1.4 Hz, 1H), 7.21 (ddd, <i>J</i> = 8.2, 6.6, 1.2 Hz, 1H), 7.19–7.15 (m, 2H), 6.88–6.85 (m, 2H), 3.72 (s, 3H), 3.49–3.42 (m, 2H), 2.78 (t, <i>J</i> = 7.6 Hz, 2H). ESI-MS (<i>m</i>/<i>z</i>): 324.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-(4-Methoxyphenethyl)quinoxaline-2-carboxamide (<b>50</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_40" aria-label="General Procedure 2">General Procedure 2</a> to give the final product as a peach-colored solid, 144.1 mg, 68% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.46 (br s, 1H), 9.10 (t, <i>J</i> = 5.9 Hz, 1H), 8.22–8.16 (m, 2H), 8.01–7.96 (m, 2H), 7.21–7.16 (m, 2H), 6.89–6.84 (m, 2H), 3.71 (s, 3H), 3.60–3.53 (m, 2H), 2.85 (t, <i>J</i> = 7.8 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.0, 157.7, 144.4, 143.7, 142.9, 139.8, 131.9, 131.3, 131.1, 129.6, 129.4, 129.1, 113.8, 55.0, 40.9, 34.2. ESI-MS (<i>m</i>/<i>z</i>): 308.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 8-Hydroxy-<i>N</i>-(4-methoxyphenethyl)quinoline-2-carboxamide (<b>51</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_40" aria-label="General Procedure 2">General Procedure 2</a> to give the final product as a red oil, 108.5 mg, 49% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.13 (br s, 1H), 9.74 (t, <i>J</i> = 5.9 Hz, 1H), 8.49 (d, <i>J</i> = 8.5 Hz, 1H), 8.13 (d, <i>J</i> = 8.5 Hz, 1H), 7.56 (t, <i>J</i> = 7.8 Hz, 1H), 7.47 (d, <i>J</i> = 8.2 Hz, 1H), 7.21–7.18 (m, 2H), 7.18–7.16 (m, 1H), 6.88–6.84 (m, 2H), 3.71 (s, 3H), 3.60–3.54 (m, 2H), 2.86 (t, <i>J</i> = 7.9 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.6, 157.7, 153.6, 147.5, 137.7, 136.4, 131.2, 129.6, 129.44, 129.35, 118.8, 117.5, 113.8, 111.5, 55.0, 40.8, 34.5. ESI-MS (<i>m</i>/<i>z</i>): 323.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-Mydroxy-<i>N</i>-(4-methoxyphenethyl)-2-naphthamide (<b>52</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_40" aria-label="General Procedure 2">General Procedure 2</a>, except no precipitate formed. Water and EtOAc were added to the reaction mixture, and the organic layer was washed with 1 M NaOH (3×), water (3×), 1 M HCl, water (3×), and brine. The organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the final product as a brown solid, 57.4 mg, 56% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.05 (t, <i>J</i> = 5.4 Hz, 1H), 8.26 (d, <i>J</i> = 8.3 Hz, 1H), 7.89–7.83 (m, 2H), 7.63 (ddd, <i>J</i> = 8.4, 6.9, 1.2 Hz, 1H), 7.55 (ddd, <i>J</i> = 8.5, 6.7, 1.2 Hz, 1H), 7.37 (d, <i>J</i> = 8.8 Hz, 1H), 7.21–7.16 (m, 2H), 6.89–6.85 (m, 2H), 3.71 (s, 3H), 3.57–3.50 (m, 2H), 3.34 (br s, 1H), 2.85 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.4, 159.6, 157.7, 135.8, 131.0, 129.6, 128.8, 127.4, 125.8, 124.7, 123.0, 122.5, 117.6, 113.8, 107.0, 55.0, 41.0, 33.9. ESI-MS (<i>m</i>/<i>z</i>): 322.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>N</i>-(4-Methoxyphenethyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carboxamide (<b>53</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_40" aria-label="General Procedure 2">General Procedure 2</a> to give the final product as a white solid, 132.7 mg, 65% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.20 (br s, 1H), 8.95 (t, <i>J</i> = 6.0 Hz, 1H), 7.74–7.67 (m, 1H), 7.56–7.48 (m, 1H), 7.34–7.23 (m, 2H), 7.19–7.14 (m, 2H), 6.87–6.82 (m, 2H), 3.71 (s, 3H), 3.55–3.48 (m, 2H), 2.82 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.6, 157.7, 145.7, 142.5, 134.4, 131.1, 129.6, 124.0, 122.5, 119.8, 113.8, 112.5, 55.0, 40.5, 34.1. ESI-MS (<i>m</i>/<i>z</i>): 296.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i>-(4-Methoxyphenethyl)benzo[<i>d</i>]oxazole-2-carboxamide (<b>54</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_40" aria-label="General Procedure 2">General Procedure 2</a>, except no precipitate formed. Water and EtOAc were added to the reaction mixture, and the organic layer was washed with 1 M NaOH (3×), water (3×), 1 M HCl, water (3×), and brine. The organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the final product as cream-colored solid, 6.3 mg, 7% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.33 (t, <i>J</i> = 5.7 Hz, 1H), 7.91–7.88 (m, 1H), 7.88–7.84 (m, 1H), 7.57 (ddd, <i>J</i> = 8.4, 7.3, 1.3 Hz, 1H), 7.50 (ddd, <i>J</i> = 8.4, 7.8, 1.2 Hz, 1H), 7.19–7.14 (m, 2H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.52–3.46 (m, 2H), 2.81 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.7, 155.7, 155.0, 150.1, 139.8, 130.9, 129.6, 127.4, 125.6, 121.0, 113.8, 111.8, 55.0, 40.9, 33.8. ESI-MS (<i>m</i>/<i>z</i>): 297.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-((4-Methoxyphenethyl)amino)-2-oxoacetic Acid (<b>55</b>)</h4><div class="NLM_p last">Lithium hydroxide (0.9 mmol) was added to a solution of ethyl (4-methoxyphenethyl)carbamate (0.3 mmol, formed according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a>) in 3:3:1 THF/MeOH/H<sub>2</sub>O (2 M). A white precipitate formed, and the reaction was finished in 2 h. HCl (1 M) was added until the reaction mixture became acidic. EtOAc was added, and the organic layer was washed with water and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to yield a white solid, 52.9 mg, 87% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.81 (t, <i>J</i> = 5.7 Hz, 1H), 7.13–7.08 (m, 2H), 6.87–6.82 (m, 2H), 3.71 (s, 3H), 3.34–3.27 (m, 2H), 2.70 (t, <i>J</i> = 7.7 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.2, 158.8, 157.7, 130.9, 129.6, 113.8, 55.0, 40.7, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 224.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> <i>N</i><sup>1</sup>-(4-Chlorobenzyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>56</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 12 mg, 23% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.33 (t, <i>J</i> = 6.4 Hz, 1H), 8.79 (t, <i>J</i> = 6.1 Hz, 1H), 7.40–7.36 (m, 2H), 7.30–7.24 (m, 2H), 7.13–7.09 (m, 2H), 6.86–6.82 (m, 2H), 4.32–4.27 (m, 2H), 3.71 (s, 3H), 3.34–3.30 (m, 2H), 2.71 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ160.2, 159.7, 157.7, 137.8, 131.5, 130.9, 129.5, 129.2, 128.2, 113.8, 55.0, 41.7, 40.6, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 346.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i><sup>1</sup>,<i>N</i><sup>2</sup>-Bis(4-methoxyphenethyl)oxalamide (<b>57</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 54.0 mg of a white solid in 56% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.70 (t, <i>J</i> = 6.1 Hz, 2H), 7.13–7.07 (m, 4H), 6.86–6.82 (m, 4H), 3.71 (s, 6H), 3.33–3.28 (m, 4H), 2.70 (t, <i>J</i> = 7.2 Hz, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.8, 157.7, 130.9, 129.5, 113.8, 55.0, 40.5, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 357.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i><sup>1</sup>-Cyclopropyl-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>58</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 147 mg, 99% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.75–8.68 (m, 2H), 7.13–7.08 (m, 2H), 6.86–6.82 (m, 2H), 3.71 (s, 3H), 3.35–3.28 (m, 2H), 2.78–2.67 (m, 3H), 0.65–0.59 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.2, 159.7, 157.7, 130.9, 129.5, 113.8, 55.0, 40.5, 33.7, 22.8, 5.4. ESI-MS (<i>m</i>/<i>z</i>): 263.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 263.139 02, found 263.1396.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>N</i><sup>1</sup>-Cyclobutyl-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>59</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 170 mg, 99% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.95 (d, <i>J</i> = 8.6 Hz, 1H), 8.72 (t, <i>J</i> = 6.0 Hz, 1H), 7.12–7.08 (m, 2H), 6.86–6.82 (m, 2H), 4.27–4.18 (m, 1H), 3.71 (s, 3H), 3.34–3.29 (m, 2H), 2.70 (t, <i>J</i> = 7.3 Hz, 2H), 2.13–2.06 (m, 4H), 1.64–1.56 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.9, 158.9, 157.7, 130.9, 129.5, 113.8, 55.0, 44.0, 40.5, 33.7, 29.5, 14.7. ESI-MS (<i>m</i>/<i>z</i>): 277.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>N</i><sup>1</sup>-Cyclopentyl-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>60</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 287 mg, 92% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.70 (t, <i>J</i> = 6.0 Hz, 1H), 8.55 (d, <i>J</i> = 8.2 Hz, 1H), 7.13–7.09 (m, 2H), 6.87–6.82 (m, 2H), 4.07–3.97 (m, 1H), 3.71 (s, 3H), 3.35–3.29 (m, 2H), 2.71 (t, <i>J</i> = 7.5 Hz, 2H), 1.84–1.72 (m, 2H), 1.71–1.58 (m, 2H), 1.55–1.44 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.0, 159.6, 157.7, 130.9, 129.5, 113.8, 55.0, 50.6, 40.5, 33.7, 31.7, 23.5. ESI-MS (<i>m</i>/<i>z</i>): 291.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>N</i><sup>1</sup>-Cyclohexyl-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>61</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 225 mg, 92% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.75–8.67 (m, 1H), 8.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.11 (d, <i>J</i> = 7.7 Hz, 2H), 6.84 (d, <i>J</i> = 7.7 Hz, 2H), 3.71 (s, 3H), 3.61–3.49 (m, 1H), 2.71 (t, <i>J</i> = 6.7 Hz, 2H), 1.74–1.61 (m, 4H), 1.60–1.51 (m, 2H), 1.40–1.16 (m, 4H), 1.15–1.01 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.0, 158.9, 157.7, 130.9, 129.5, 113.8, 55.0, 48.2, 40.6, 33.7, 31.8, 25.0, 24.8. ESI-MS (<i>m</i>/<i>z</i>): 305.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i><sup>1</sup>-Cycloheptyl<i>-N</i><sup>2</sup>-(4-methoxyphenethyl)oxalamide (<b>62</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 225 mg, 94% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (apps, 1H), 8.49 (d, <i>J</i> = 7.2 Hz, 1H), 7.11 (d, <i>J</i> = 6.4 Hz, 2H), 6.84 (d, <i>J</i> = 6.4 Hz, 2H), 3.78–3.65 (m, 4H), 3.32–3.26 (m, 2H), 2.75–2.66 (m, 2H), 1.77–1.29 (m, 12H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.1, 158.6, 157.7, 130.9, 129.5, 113.8, 55.0, 50.4, 40.6, 33.9, 33.7, 27.6, 23.8. ESI-MS (<i>m</i>/<i>z</i>): 319.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-(4-Methoxyphenethyl)-2-oxo-2-(pyrrolidin-1-yl)acetamide (<b>63</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> with purification by flash chromatography over silica gel (0 to 100% EtOAc/hexanes) to give a cream-colored solid, 161.5 mg, 97% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61 (t, <i>J</i> = 5.8 Hz, 1H), 7.15–7.09 (m, 2H), 6.87–6.82 (m, 2H), 3.71 (s, 3H), 3.55–3.50 (m, 2H), 3.35–3.28 (m, 4H), 2.69 (t, <i>J</i> = 7.5 Hz, 2H), 1.85–1.71 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.1, 160.9, 157.7, 131.0, 129.7, 113.7, 55.0, 47.3, 46.1, 40.0, 33.8, 25.9, 23.2. ESI-MS (<i>m</i>/<i>z</i>): 277.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-(4-Methoxyphenethyl)-2-oxo-2-(piperidin-1-yl)acetamide (<b>64</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a>. The crude residue was purified by flash chromatography (silica, 1:3 EtOAc/hex) to give a yellow oil, 103.8 mg, 99% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (t, <i>J</i> = 5.7 Hz, 1H), 7.15–7.11 (m, 2H), 6.86–6.82 (m, 2H), 3.71 (s, 3H), 3.40–3.36 (m, 2H), 3.33–3.30 (m, 2H), 3.16–3.12 (m, 2H), 2.68 (t, <i>J</i> = 7.1 Hz, 2H), 1.59–1.53 (m, 2H), 1.47–1.35 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.7, 158.6, 138.2, 136.6, 130.8, 130.6, 128.6, 128.3, 128.2, 122.0, 40.3, 33.8. ESI-MS (<i>m</i>/<i>z</i>): 291.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 2-(Indolin-1-yl)-<i>N</i>-(4-methoxyphenethyl)-2-oxoacetamide (<b>65</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 158 mg, 91% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.86 (t, <i>J</i> = 5.7 Hz, 1H), 8.04 (d, <i>J</i> = 8.0 Hz, 1H), 7.29 (d, <i>J</i> = 7.5 Hz, 1H), 7.24–7.18 (m, 1H), 7.18–7.13 (m, 2H), 7.12 7.05 (m, 1H), 6.89–6.84 (m, 2H), 4.08–4.01 (m, 2H), 3.72 (s, 3H), 3.43–3.36 (m, 2H), 3.09 (t, <i>J</i> = 8.4 Hz, 2H), 2.77–2.71 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.3, 161.3, 157.8, 142.0, 132.7, 130.9, 129.7, 127.1, 125.1, 124.6, 116.7, 113.7, 55.0, 48.4, 40.1, 33.8, 27.8. ESI-MS (<i>m</i>/<i>z</i>): 325.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 2-(Isoindolin-2-yl)-<i>N</i>-(4-methoxyphenethyl)-2-oxoacetamide (<b>66</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a cream-colored solid, 140 mg, 99% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (t, <i>J</i> = 5.9 Hz, 1H), 7.39–7.34 (m, 1H), 7.33–7.27 (m, 3H), 7.17–7.12 (m, 2H), 6.88–6.82 (m, 2H), 4.94 (s, 2H), 4.73 (s, 2H), 3.71 (s, 3H), 3.41–3.36 (m, 2H), 2.74 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.4, 160.8, 157.7, 137.1, 134.9, 131.0, 129.7, 127.5, 127.4, 122.9, 122.7, 113.7, 55.0, 53.3, 52.6, 40.1, 33.8. ESI-MS (<i>m</i>/<i>z</i>): 325.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 2-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)-<i>N</i>-(4-methoxyphenethyl)-2-oxoacetamide (<b>67</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a>. The crude residue was purified by flash chromatography (silica gel, 0 to 100% EtOAc in hexanes) to give the final product as a yellow oil, 103.6 mg, 77% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) (rotamers observed) δ 8.78–8.72 (m, 1H), 7.22–7.12 (m, 6H), 6.89–6.82 (m, 2H), 4.60 (s, 1H), 4.47 (s, 1H), 3.73–3.70 (m, 3H), 3.67 (t, <i>J</i> = 6.0 Hz, 1H), 3.49 (t, <i>J</i> = 6.0 Hz, 1H), 3.41–3.36 (m, 2H), 2.80 (t, <i>J</i> = 5.7 Hz, 1H), 2.75 (t, <i>J</i> = 5.7 Hz, 1H), 2.71 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) (rotamers observed) δ 163.9, 163.5, 163.4, 163.3, 157.8, 157.70, 157.68, 134.2, 134.0, 132.8, 132.4, 131.7, 129.7, 129.6, 128.7, 127.5, 127.0, 126.68, 126.67, 126.5, 126.3, 126.2, 126.1, 113.8, 113.7, 55.02, 54.97, 46.8, 43.0, 42.9, 33.8, 33.7, 28.8, 27.7, 27.5. ESI-MS (<i>m</i>/<i>z</i>): 339.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-phenethyloxalamide (<b>68</b>)</h4><div id="sec5_1_60_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> Step 1</h5><div class="NLM_p last">Nitromethane (5.5 mL, 99.75 mmol, 80 equiv) was added to a solution of benzaldehyde (0.12 mL, 1.25 mmol, 1 equiv) and ammonium acetate (62.1 mg, 0.75 mmol, 0.6 equiv) in toluene (9 mL, 0.1 M), and the reaction was heated to 100 °C for 22 h. After the solution cooled to room temperature, water was added, and the solution was extracted with EtOAc (3×). The organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 293.5 mg of <i>(E</i>)-(2-nitrovinyl)benzene as an orange solid in 99% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (d, <i>J</i> = 13.6 Hz, 1H), 8.13 (d, <i>J</i> = 13.6 Hz, 1H), 7.88–7.83 (m, 2H), 7.56–7.45 (m, 3H).</div></div><div id="sec5_1_60_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> Step 2</h5><div class="NLM_p last">Pd/C (10%, 329.7 mg, 3.1 mmol, 1.6 equiv) was added to a solution of the nitro alkene from <a class="ref internalNav" href="#sec5_1_60_1" aria-label="Step 1">Step 1</a> (289.6 mg, 1.9 mmol, 1 equiv) in anhydrous EtOH (30 mL, 0.067 M) and concentrated HCl (0.31 mL, 6.25 M) under nitrogen at 0 °C. The nitrogen was purged and replaced with a H<sub>2</sub> balloon. When the reaction was finished as determined by TLC analysis (3.5 h), the reaction was filtered through Celite and washed with EtOH, and the filtrate was concentrated under reduced pressure. Then, CH<sub>3</sub>CN was added, and a white precipitate formed, which was collected by filtration to yield 120.6 mg of 2-phenylethan-1-amine hydrochloride as a white solid in 51% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11 (br s, 2H), 7.35–7.31 (m, 2H), 7.28–7.23 (m, 3H), 3.03–2.98 (m, 2H), 2.91–2.86 (m, 2H).</div></div><div id="sec5_1_60_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> Step 3</h5><div class="NLM_p last">Oxalamide <b>68</b> was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> using the amine from <a class="ref internalNav" href="#sec5_1_60_2" aria-label="Step 2">Step 2</a> to give a white solid, 32.6 mg, 77% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (br s, 1H), 9.05 (t, <i>J</i> = 5.9 Hz, 1H), 7.88–7.83 (m, 2H), 7.43–7.38 (m, 2H), 7.32–7.28 (m, 2H), 7.24–7.18 (m, 3H), 3.47–3.40 (m, 2H), 2.83 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 139.1, 136.7, 128.6, 128.4, 128.2, 126.2, 122.0, 40.6, 34.6. ESI-MS (<i>m</i>/<i>z</i>): 302.9 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(3-methoxyphenethyl)oxalamide (<b>69</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 77.1 mg, 76% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.79 (br s, 1H), 9.03 (t, <i>J</i> = 6.0 Hz, 1H), 7.87–7.83 (m, 2H), 7.43–7.39 (m, 2H), 7.20 (t, <i>J</i> = 8.0 Hz, 1H), 6.81–6.75 (m, 3H), 3.73 (s, 3H), 3.48–3.40 (m, 2H), 2.81 (t, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 159.3, 158.7, 140.6, 136.7, 129.4, 128.6, 128.2, 121.9, 120.9, 114.2 111.7, 54.9, 40.4, 34.5. ESI-MS (<i>m</i>/<i>z</i>): 333.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(2-methoxyphenethyl)oxalamide (<b>70</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 37.9 mg, 72% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.79 (br s, 1H), 8.99 (t, <i>J</i> = 5.9 Hz, 1H), 7.87–7.83 (m, 2H), 7.43–7.39 (m, 2H), 7.20 (ddd, <i>J</i> = 7.8, 7.8, 1.7 Hz, 1H), 7.13 (dd, <i>J</i> = 7.4, 1.7 Hz, 1H), 6.96 (d, <i>J</i> = 8.0 Hz, 1H), 6.86 (ddd, <i>J</i> = 7.4, 7.4, 0.8 Hz, 1H), 3.78 (s, 3H), 3.44–3.37 (m, 2H), 2.81 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 157.3, 136.7, 130.0, 128.6, 127.7, 126.9, 121.9, 120.3, 110.7, 55.3, 39.9, 29.3. ESI-MS (<i>m</i>/<i>z</i>): 332.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> <i>N</i><sup>1</sup>-(4-Bromophenethyl)-<i>N</i><sup>2</sup>-(4-chlorophenyl)oxalamide (<b>71</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 42.2 mg, 74% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.79 (br s, 1H), 9.07 (t, <i>J</i> = 6.0 Hz, 1H), 7.87–7.83 (m, 2H), 7.50–7.45 (m, 2H), 7.43–7.39 (m, 2H), 7.21–7.17 (m, 2H), 3.46–3.40 (m, 2H), 2.81 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) 159.7, 158.7, 138.6, 136.7, 131.2, 131.0, 128.7, 128.3, 122.0, 119.3, 40.3, 33.9. ESI-MS (<i>m</i>/<i>z</i>): 380.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> <i>N</i><sup>1</sup>-(4-Chlorophenethyl)-<i>N</i><sup>2</sup>-(4-chlorophenyl)oxalamide (<b>72</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 36.7 mg, 72% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.79 (br s, 1H), 9.08 (t, <i>J</i> = 6.0 Hz, 1H), 7.87–7.83 (m, 2H), 7.43–7.39 (m, 2H), 7.36–7.32 (m, 2H), 7.26–7.23 (m, 2H), 3.46–3.40 (m, 2H), 2.82 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.6, 138.2, 136.6, 130.8, 130.6, 128.6, 128.3, 128.2, 121.9, 40.3, 33.8. ESI-MS (<i>m</i>/<i>z</i>): 336.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(4-fluorophenethyl)oxalamide (<b>73</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 8.6 mg, 20% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) 10.79 (br s, 1H), 9.07 (t, <i>J</i> = 6.1 Hz, 1H), 7.87–7.83 (m, 2H), 7.43–7.39 (m, 2H), 7.27–7.23 (m, 2H), 7.14–7.09 (m, 2H), 3.45–3.39 (m, 2H), 2.82 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 158.4, 136.6, 135.3, 130.4 (d, <sup>3</sup><i>J</i><sub>CF</sub> = 7.7 Hz), 128.6, 128.2, 121.9, 115.0 (d, <sup>2</sup><i>J</i><sub>CF</sub> = 21.0 Hz), 40.6, 33.6. ESI-MS (<i>m</i>/<i>z</i>): 320.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(4-ethoxyphenethyl)oxalamide (<b>74</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 43.1 mg, 77% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (br s, 1H), 9.01 (t, <i>J</i> = 5.9 Hz, 1H), 7.88–7.82 (m, 2H), 7.43–7.38 (m, 2H), 7.14–7.09 (m, 2H), 6.86–6.81 (m, 2H), 3.97 (q, <i>J</i> = 7.0 Hz, 2H), 3.43–3.35 (m, 2H), 2.75 (t, <i>J</i> = 7.2 Hz, 2H), 1.30 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 157.0, 136.7, 130.8, 129.6, 128.6, 128.2, 121.9, 114.3, 62.9, 40.8, 33.7, 14.7. ESI-MS (<i>m</i>/<i>z</i>): 346.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(4-methylphenethyl)oxalamide (<b>75</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 27.4 mg, 53% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.80 (br s, 1H), 9.04 (t, <i>J</i> = 6.0 Hz, 1H), 7.88–7.83 (m, 2H), 7.43–7.39 (m, 2H), 7.12–7.08 (m, 4H), 3.43–3.38 (m, 2H), 2.78 (t, <i>J</i> = 7.3 Hz, 2H), 2.25 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 136.7, 135.9, 135.1, 128.9, 128.6, 128.5, 128.2, 121.9, 40.7, 34.1, 20.7. ESI-MS (<i>m</i>/<i>z</i>): 316.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(3,4-dimethoxyphenethyl)oxalamide (<b>76</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 38.0 mg, 67% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (br s, 1H), 9.00 (t, <i>J</i> = 6.0 Hz, 1H), 7.87–7.82 (m, 2H), 7.43–7.38 (m, 2H), 6.85 (d, <i>J</i> = 8.1 Hz, 1H), 6.81 (s, 1H), 6.72 (d, <i>J</i> = 8.1, 1H), 3.72 (s, 3H), 3.70 (s, 3H), 3.45–3.38 (m, 2H), 2.76 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 148.6, 147.3, 136.7, 131.5, 128.6, 128.2, 122.0, 120.4, 112.4, 111.8, 55.5, 55.3, 40.7, 34.1. ESI-MS (<i>m</i>/<i>z</i>): 362.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(4-hydroxyphenethyl)oxalamide (<b>77</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give a white solid, 35.2 mg, 68% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.79 (br s, 1H), 9.20 (br s, 1H), 9.01 (t, <i>J</i> = 6.0 Hz, 1H), 7.88–7.83 (m, 2H), 7.44–7.39 (m, 2H), 7.02–6.98 (m, 2H), 6.69–6.65 (m, 2H), 3.39–3.35 (m, 2H), 2.70 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 155.7, 136.7, 129.5, 129.0, 128.6, 128.2, 121.9, 115.1, 40.9, 33.8. ESI-MS (<i>m</i>/<i>z</i>): 317.0 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(3-hydroxyphenethyl)oxalamide (<b>78</b>)</h4><div class="NLM_p last">A solution of analogue <b>69</b> (49.7 mg, 0.15 mmol, 1 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (0.75 mL, 0.2 M) under nitrogen was cooled to −78 °C for 20 min before 1.5 mL of a 1.0 M solution of BBr<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL, 1 mmol, 10 equiv) was added dropwise at −78 °C. The reaction was stirred at −78 °C until the reaction was complete as judged by TLC analysis (4–5 h). Then, the reaction was warmed to room temperature, poured into ice water, and extracted into EtOAc (3×). The organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by flash chromatography over silica gel (0.5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to provide 12.7 mg of a white solid in 27% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.79 (br s, 1H), 9.29 (br s, 1H), 9.03 (t, <i>J</i> = 5.9 Hz, 1H), 7.88–7.83 (m, 2H), 7.43–7.38 (m, 2H), 7.07 (t, <i>J</i> = 7.7 Hz, 1H), 6.65–6.57 (m, 3H), 3.43–3.36 (m, 2H), 2.73 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.7, 157.4, 140.4, 136.7, 129.3, 128.6, 128.2, 122.0, 119.2, 115.5, 113.2, 40.6, 34.6. ESI-MS (<i>m</i>/<i>z</i>): 317.0 [M – H]<sup>−</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 319.084 40, found 319.0855.</div></div><div id="sec5_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(2-hydroxyphenethyl)oxalamide (<b>79</b>)</h4><div class="NLM_p last">The title compound was prepared using the synthetic procedures described for the preparation of analogue <b>78</b> using analogue <b>70</b> (66.3 mg, 0.2 mmol, 1 equiv). The residue was purified by flash chromatography over silica gel (0 to 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) and triturated with hexanes to provide 19.8 mg of a white solid in 31% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (br s, 1H), 9.44 (br s, 1H), 8.97 (t, <i>J</i> = 5.3 Hz, 1H), 7.88–7.82 (m, 2H), 7.43–7.38 (m, 2H), 7.08–6.97 (m, 2H), 6.81–6.76 (m, 1H), 6.74–6.68 (m, 1H), 3.45–3.37 (m, 2H), 2.81–2.74 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.6, 158.8, 155.3, 136.7, 130.2, 128.6, 128.2, 127.4, 125.2, 121.9, 118.9, 114.9, 39.4, 29.3. ESI-MS (<i>m</i>/<i>z</i>): 319.1 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 319.084 40, found 319.0853.</div></div><div id="sec5_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(4-methoxybenzyl)oxalamide (<b>80</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to give the final product as a white solid, 32.3 mg, 68% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) 10.83 (br s, 1H), 9.50 (t, <i>J</i> = 6.4 Hz, 1H), 7.87–7.83 (m, 2H), 7.43–7.39 (m, 2H), 7.25–7.22 (m, 2H), 6.90–6.86 (m, 2H), 4.31 (d, <i>J</i> = 6.4 Hz, 2H), 3.72 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.8, 158.8, 158.3, 136.7, 130.6, 128.9, 128.6, 128.2, 122.0, 113.7, 55.1, 42.1. ESI-MS (<i>m</i>/<i>z</i>): 317.0 [M – H]<sup>−</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>3</sub> (M + Na)<sup>+</sup> 341.066 34, found 341.0667.</div></div><div id="sec5_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(2-(4-methoxyphenyl)propyl)oxalamide (<b>81</b>)</h4><div id="sec5_1_73_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i105" class="anchor-spacer"></div><h5 class="article-section__title" id="_i105"> Step 1</h5><div class="NLM_p last"><i>(E</i>)-1-Methoxy-4-(2-nitrovinyl)benzene was synthesized following <a class="ref internalNav" href="#sec5_1_60_1" aria-label="Step 1">Step 1</a> of the procedure to synthesize <b>68</b> with <i>p</i>-anisaldehyde (0.15 mL, 1.25 mmol, 1 equiv) to yield 213.5 mg of <i>(E</i>)-1-methoxy-4-(2-nitrovinyl)benzene as an orange solid in 96% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.17–8.07 (m, 2H), 7.86–7.81 (m, 2H), 7.07–7.02 (m, 2H), 3.83 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.6, 139.4, 135.8, 132.1, 122.7, 114.8, 55.6. LC-MS (<i>m</i>/<i>z</i>): 180.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_73_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i106" class="anchor-spacer"></div><h5 class="article-section__title" id="_i106"> Step 2</h5><div class="NLM_p last">According to a procedure by Bartoli,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> CeCl<sub>3</sub>·7H<sub>2</sub>O was dried by heating to 140 °C under vacuum with stirring overnight. Then, a slurry of CeCl<sub>3</sub> (492.7 mg, 2 mmol, 2 equiv) in anhydrous THF (16 mL, 0.0625 M) was cooled to −78 °C under nitrogen for 20 min before a 2.9 M solution of methylmagnesium bromide in Et<sub>2</sub>O (0.69 mL, 2 mmol, 2 equiv) was added. The reaction was stirred at −78 °C for 1.5 h before it was warmed to −40 °C. Then, the nitro alkene from <a class="ref internalNav" href="#sec5_1_73_1" aria-label="Step 1">Step 1</a> (179.3 mg, 1 mmol, 1 equiv) in anhydrous THF (2.5 mL, 0.4 M) was added slowly to the reaction mixture. The reaction was finished in 10 min as determined by TLC, and the reaction was quenched with acetic acid (0.6 mL, 10 equiv). The solution was stirred for 5 min, and the solution turned bright yellow. The reaction was diluted with water, extracted into hexanes (3×), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The solution was azeotroped with toluene to remove acetic acid. The residue was purified by flash chromatography over silica gel (0 to 10% EtOAc in hexanes) to yield 139.3 mg of 1-methoxy-4-(1-nitropropan-2-yl)benzene as a yellow oil in 71% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.17–7.12 (m, 2H), 6.90–6.85 (m, 2H), 4.54–4.42 (m, 2H), 3.79 (s, 3H), 3.64–3.54 (m, 1H), 1.36 (d, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.0, 133.0, 128.1, 114.5, 82.3, 55.4, 38.1, 19.0. GC-MS <i>m</i>/<i>z</i> = 195.1.</div></div><div id="sec5_1_73_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i107" class="anchor-spacer"></div><h5 class="article-section__title" id="_i107"> Step 3</h5><div class="NLM_p last">Pd/C (10%, 295.4 mg) was added to a solution of the nitro alkane from <a class="ref internalNav" href="#sec5_1_73_2" aria-label="Step 2">Step 2</a> (179.2 mg, 0.9 mmol, 1 equiv) in EtOAc (9 mL, 0.1 M). The reaction solution was purged with N<sub>2</sub> before the addition of H<sub>2</sub> at 50 psi. After 2 h, additional 10% Pd/C (293.7 mg) was added. When the reaction was complete according to TLC analysis (2 h), the solution was filtered through Celite and washed with EtOAc. The filtrate was concentrated under reduced pressure to yield 104.1 mg of 2-(4-methoxyphenyl)propan-1-amine as a cream-colored solid in 69% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.15–7.10 (m, 2H), 6.89–6.84 (m, 2H), 3.79 (s, 3H), 2.86–2.75 (m, 2H), 2.73–2.67 (m, 1H), 1.22 (d, <i>J</i> = 6.9 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) 158.2, 137.1, 128.4, 114.1, 55.4, 49.8, 42.8, 19.6. GC-MS <i>m</i>/<i>z</i> = 165.1.</div></div><div id="sec5_1_73_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i108" class="anchor-spacer"></div><h5 class="article-section__title" id="_i108"> Step 4</h5><div class="NLM_p last">Oxalamide <b>81</b> was synthesized with the amine salt from <a class="ref internalNav" href="#sec5_1_73_3" aria-label="Step 3">Step 3</a> (104.1 mg, 0.63 mmol) according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 20.2 mg of a white solid in 20% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) 10.78 (br s, 1H), 8.90 (t, <i>J</i> = 6.1 Hz, 1H), 7.87–7.81 (m, 2H), 7.43–7.38 (m, 2H), 7.18–7.13 (m, 2H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.39–3.25 (m, 2H, under water), 3.06–2.95 (m, 1H), 1.16 (d, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) 159.6, 158.7, 157.8, 136.7, 136.3, 128.7, 128.3, 128.1, 122.0, 113.8, 55.0, 46.2, 37.9, 19.5. LC-MS (<i>m</i>/<i>z</i>): 347.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(1-(4-methoxyphenyl)propan-2-yl)oxalamide (<b>82</b>)</h4><div id="sec5_1_74_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i110" class="anchor-spacer"></div><h5 class="article-section__title" id="_i110"> Step 1</h5><div class="NLM_p last">(<i>E</i>)-1-Methoxy-4-(2-nitroprop-1-en-1-yl)benzene was synthesized according to <a class="ref internalNav" href="#sec5_1_60_1" aria-label="Step 1">Step 1</a> of the procedure to synthesize <b>68</b> with nitroethane (7.2 mL, 99.75 mmol, 80 equiv). The crude mixture was purified by flash chromatography over silica gel (0 to 30% EtOAc in hexanes) to yield 465.0 mg of (<i>E</i>)-1-methoxy-4-(2-nitroprop-1-en-1-yl)benzene (<b>130</b>) as a yellow solid in 99% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08 (s, 1H), 7.63–7.58 (m, 2H), 7.10–7.05 (m, 2H), 3.82 (s, 3H), 2.42 (s, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 160.9, 145.5, 133.3, 132.6, 124.3, 114.5, 55.4, 14.0. ESI-MS (<i>m</i>/<i>z</i>): 194.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_74_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i111" class="anchor-spacer"></div><h5 class="article-section__title" id="_i111"> Step 2</h5><div class="NLM_p last">Following a procedure by Munoz,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> a solution of the nitro alkene from <a class="ref internalNav" href="#sec5_1_74_1" aria-label="Step 1">Step 1</a> (287.1 mg, 1.5 mmol, 1 equiv) in anhydrous Et<sub>2</sub>O (15 mL, 0.1 M) was added dropwise to a solution of LiAlH<sub>4</sub> in anhydrous Et<sub>2</sub>O (15 mL, 0.1 M) under a nitrogen atmosphere. The solution was heated at reflux until complete as judged by TLC analysis (3 h). Then, the solution was cooled to 0 °C and quenched slowly with 0.2 mL of water, 0.2 mL of 15% NaOH(aq), and 0.7 mL of water. The solution was stirred for 15 min. MgSO<sub>4</sub> was added, and the solution was stirred for 15 min. Then, the solution was filtered to remove salts and concentrated under reduced pressure to yield 201.3 mg of 2-(4-methoxyphenyl)propan-1-amine (<b>131</b>) as a clear oil in 82% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.10–7.05 (m, 2H), 6.86–6.81 (m, 2H), 3.71 (s, 3H), 2.97–2.88 (m, 1H), 2.44 (dd, <i>J</i> = 6.7, 1.6 Hz, 2H), 0.92 (d, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 157.5, 132.0, 130.1, 113.6, 54.9, 48.4, 45.4, 23.2. ESI-MS (<i>m</i>/<i>z</i>): 166.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_74_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i112" class="anchor-spacer"></div><h5 class="article-section__title" id="_i112"> Step 3</h5><div class="NLM_p last">Oxalamide <b>82</b> was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> using the amine from <a class="ref internalNav" href="#sec5_1_74_2" aria-label="Step 2">Step 2</a> (41.3 mg, 2.5 mmol, 3 equiv) to provide 92.5 mg of a white solid in 25% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (br s, 1H), 8.87 (d, <i>J</i> = 8.9 Hz, 1H), 7.86–7.81 (m, 2H), 7.43–7.38 (m, 2H), 7.14–7.09 (m, 2H), 6.85–6.80 (m, 2H), 4.10–4.00 (m, 1H), 3.69 (s, 3H), 2.82 (dd, <i>J</i> = 13.5, 8.2 Hz, 1H), 2.67 (dd, <i>J</i> = 13.5, 6.2 Hz, 1H), 1.14 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.1, 158.9, 157.8, 136.7, 131.0, 130.2, 128.8, 128.5, 122.2, 133.8, 55.1, 47.5, 40.5, 20.1. ESI-MS (<i>m</i>/<i>z</i>): 347.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(4-methoxyphenethyl)-<i>N</i><sup>2</sup>-methyloxalamide (<b>83</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a>. Upon cooling the reaction mixture to rt, a precipitate formed and was filtered. The filtrate was concentrated, and the residue was purified by flash chromatography (silica gel, 0 to 100% EtOAc in hexanes) to give the final product as a cream-colored solid, 4.4 mg, 11% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) (rotamers) δ 10.87 (br s, 1H), 10.71 (br s, 1H), 7.72–7.65 (m, 4H), 7.43–7.38 (m, 4H), 7.22–7.17 (m, 2H), 7.08–7.03 (m, 2H), 6.90–6.85 (m, 2H), 6.80–6.76 (m, 2H), 3.72 (s, 2H), 3.65 (s, 3H), 3.61–3.55 (m, 2H), 3.55–3.48 (m, 2H), 2.99 (s, 2H), 2.92 (s, 3H), 2.88–2.75 (m, 4H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) (rotamers) δ 163.6, 163.4, 162.1, 161.9, 157.8, 136.91, 136.87, 129.7, 129.6, 128.8, 128.7, 121.4, 113.94, 113.90, 55.0, 54.9, 51.4, 48.3, 35.5, 33.5, 32.4, 31.6. ESI-MS (<i>m</i>/<i>z</i>): 346.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 2-(4-Chlorophenoxy)-<i>N</i>-(4-methoxyphenethyl)acetamide (<b>84</b>)</h4><div id="sec5_1_76_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i115" class="anchor-spacer"></div><h5 class="article-section__title" id="_i115"> Step 1</h5><div class="NLM_p last">A solution of 4-methoxyphenethylamine (0.73 mL, 5 mmol, 1 equiv) and Et<sub>3</sub>N (0.69 mL, 5 mmol, 1 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (10 mL, 0.5 M) was stirred at 0 °C for 30 min. Then, bromoacetyl bromide (0.52 mL, 6 mmol, 1.2 equiv) was added dropwise over 20 min. The solution was warmed to room temperature and stirred overnight. Then, the solution was filtered to remove the HBr salts, and the filtrate was washed with water (5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 1.21 g of 2-bromo-<i>N</i>-(4-methoxyphenethyl)acetamide (<b>136</b>) as a brown solid in 88% yield. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.14–7.10 (m, 2H), 6.88–6.84 (m, 2H), 6.52 (br s, 1H), 3.86 (s, 2H), 3.80 (s, 3H), 3.53–3.48 (m, 2H), 2.78 (t, <i>J</i> = 7.0 Hz, 2H). ESI-MS (<i>m</i>/<i>z</i>): 273.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_76_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i116" class="anchor-spacer"></div><h5 class="article-section__title" id="_i116"> Step 2</h5><div class="NLM_p last">4-Chlorophenol (1.5 mmol) was added to the bromoacetamide from <a class="ref internalNav" href="#sec5_1_76_1" aria-label="Step 1">Step 1</a> (1.5 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.5 mmol) in acetonitrile (0.5 M). The mixture was headed at reflux overnight until the reaction was complete as judged by TLC analysis. After cooling to rt, the reaction mixture was filtered to remove salts, and the filtrate was concentrated. H<sub>2</sub>O and diethyl ether (1:1, v/v; 4 mL) were added to the residue with stirring, and a precipitate formed. The precipitate was collected by filtration, rinsed with diethyl ether, and dried to give analogue <b>84</b> as a cream-colored solid, 83.1 mg, 17% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (t, <i>J</i> = 5.7 Hz, 1H), 7.36–7.32 (m, 2H), 7.11–7.07 (m, 2H), 6.96–6.92 (m, 2H), 6.85–6.81 (m, 2H), 4.45 (s, 2H), 3.71 (s, 3H), 3.33–3.27 (m, 2H), 2.67 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.2, 157.7, 156.6, 131.1, 129.6, 129.2, 124.8, 116.5, 113.7, 67.2, 55.0, 39.9, 34.2. ESI-MS (<i>m</i>/<i>z</i>): 319.9 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 2-((4-Chlorophenyl)amino)-<i>N</i>-(4-methoxyphenethyl)acetamide (<b>85</b>)</h4><div class="NLM_p last">The title compound was synthesized analogously to compound <b>84</b>. The crude precipitate was purified by flash chromatography (silica gel, 0–100% EtOAc in hexanes) to give an orange solid, 244.7 mg, 50% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (t, <i>J</i> = 5.8 Hz, 1H), 7.11–7.08 (m, 2H), 7.07–7.04 (m, 2H), 6.82–6.79 (m, 2H), 6.51–6.47 (m, 2H), 6.16 (t, <i>J</i> = 5.8 Hz, 1H), 3.71 (s, 3H), 3.57 (d, <i>J</i> = 5.8 Hz, 2H), 3.28–3.23 (m, 2H), 2.62 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO- <i>d</i><sub>6</sub>) δ 169.7, 157.6, 147.3, 131.2, 129.6, 128.5, 119.6, 113.7, 113.6, 55.0, 46.8, 40.3, 34.3. ESI-MS (<i>m</i>/<i>z</i>): 318.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 1-(4-Chlorophenyl)-3-(4-methoxyphenethyl)urea (<b>86</b>)</h4><div id="sec5_1_78_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i119" class="anchor-spacer"></div><h5 class="article-section__title" id="_i119"> Step 1</h5><div class="NLM_p last">4-Nitrophenyl chloroformate (1.11 mmol) was added to a mixture of 4-chloroaniline (1 mmol), saturated NaHCO<sub>3</sub> (1.3 mmol), <i>t</i>-butyl methyl ether (0.71 M), and H<sub>2</sub>O (0.35 M). After being stirred at rt for 1 h, the reaction was washed with 1 M HCl (3 × 5 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 4-nitrophenyl (4-chlorophenyl)carbamate (<b>137</b>) as a cream-colored solid, 213.2 mg, 82% yield. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.32–8.28 (m, 2H), 7.43–7.37 (m, 4H), 7.36–7.32 (m, 2H), 7.01 (br s, 1H). ESI-MS (<i>m</i>/<i>z</i>): 293.8 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_78_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i120" class="anchor-spacer"></div><h5 class="article-section__title" id="_i120"> Step 2</h5><div class="NLM_p last">4-Methoxyphenethylamine (0.3 mmol) was added to a solution of Et<sub>3</sub>N (0.3 mmol) and the carbamate from <a class="ref internalNav" href="#sec5_1_78_1" aria-label="Step 1">Step 1</a> (0.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.125 M), and the yellow reaction mixture was stirred at room temperature for 1 h. The precipitate was collected by filtration and rinsed with water to remove the yellow color, which give urea <b>86</b> as a white solid, 55.7 mg, 61% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.62 (br s, 1H), 7.42–7.38 (m, 2H), 7.26–7.23 (m, 2H), 7.16–7.13 (m, 2H), 6.89–6.85 (m, 2H), 6.11 (t, <i>J</i> = 5.6 Hz, 1H), 3.72 (s, 3H), 3.31–3.25 (m, 2H), 2.67 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.7, 155.0, 139.6, 131.3, 129.6, 128.5, 124.4, 119.0, 113.8, 55.0, 40.8, 34.9. ESI-MS (<i>m</i>/<i>z</i>): 304.9 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 1-(4-Chlorophenyl)-3-(3-(4-methoxyphenyl)propyl)urea (<b>87</b>)</h4><div class="NLM_p last">The title compound was synthesized analogously to compound <b>86</b> from the known 3-(4-methoxyphenyl)propan-1-amine (prepared in three steps from 3-(4-methoxyphenyl)-1-propanol).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The crude residue was purified by flash chromatography (silica gel, 0–100% EtOAc in hexanes) to give the product as a white solid, 27.6 mg, 66% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.56 (br s, 1H), 7.44–7.39 (m, 2H), 7.27–7.22 (m, 2H), 7.14–7.10 (m, 2H), 6.86–6.82 (m, 2H), 6.22 (t, <i>J</i> = 5.6 Hz, 1H), 3.71 (s, 3H), 3.10–3.03 (m, 2H), 2.56–2.51 (m, 2H), 1.68 (quint, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.4, 155.0, 139.6, 133.5, 129.2, 128.4, 124.3, 119.0, 113.7, 55.0, 38.6, 31.7, 31.6. ESI-MS (<i>m</i>/<i>z</i>): 318.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> <i>N</i>-(4-Chlorophenyl)-3-(4-methoxyphenyl)propanamide (<b>88</b>)</h4><div class="NLM_p last">Oxalyl chloride (0.5 mmol) and DMF (1 drop) were added to a solution of 3-(4-methoxyphenyl)propanoic acid (2.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.1 M). The reaction was stirred at room temperature for 1.5 h, and the solvent was removed under a flow of N<sub>2</sub> over 1 h. The acid chloride was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (0.1 M), and Et<sub>3</sub>N (2 equiv) and 4-chloroaniline (0.19 mmol) were added. The reaction mixture was stirred overnight at rt. It was concentrated under reduced pressure, and the residue was purified by flash chromatography (silica gel, 0 to 30% EtOAc in hexanes) to give the product as a white solid, 12.9 mg, 23% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (br s, 1H), 7.63–7.58 (m, 2H), 7.36–7.31 (m, 2H), 7.17–7.13 (m, 2H), 6.86–6.82 (m, 2H), 3.70 (s, 3H), 2.84 (t, <i>J</i> = 7.3 Hz, 2H), 2.58 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.6, 157.5, 138.2, 132.9, 129.2, 128.6, 126.5, 120.5, 113.7, 55.0, 38.3, 29.9. ESI-MS (<i>m</i>/<i>z</i>): 290.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> <i>N</i>-(4-Chlorophenyl)-4-(4-methoxyphenyl)butanamide (<b>89</b>)</h4><div class="NLM_p last">The title compound was synthesized analogously to amide <b>88</b>. After the reaction was finished, the reaction was concentrated under reduced pressure, and then water (3 mL) and EtOAc (5 mL) were added. The residue was extracted with EtOAc (3 × 5 mL), washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the product as a white solid, 125.9 mg, 83% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.00 (br s, 1H), 7.64–7.59 (m, 2H), 7.35–7.31 (m, 2H), 7.14–7.09 (m, 2H), 6.87–6.82 (m, 2H), 3.71 (s, 3H), 2.55 (t, <i>J</i> = 7.5 Hz, 2H), 2.29 (t, <i>J</i> = 7.5 Hz, 2H), 1.84 (quint, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.2, 157.4, 138.3, 133.4, 129.3, 128.5, 126.4, 120.5, 113.7, 55.0, 35.7, 33.7, 26.9. ESI-MS (<i>m</i>/<i>z</i>): 304.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> <i>N</i>-(4-Chlorophenyl)-5-(4-methoxyphenyl)pentanamide (<b>90</b>)</h4><div class="NLM_p last">The title compound was synthesized analogously to amide <b>88</b>. The crude reaction mixture was purified by flash chromatography (silica gel, 0 to 100% EtOAc in hexanes) to give the product as a cream-colored solid, 1.9 mg, 1% yield after. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (br s, 1H), 7.62–7.59 (m, 2H), 7.35–7.31 (m, 2H), 7.11–7.08 (m, 2H), 6.84–6.81 (m, 2H), 3.70 (s, 3H), 2.55–2.51 (m, 2H), 2.33–2.93 (m, 2H), 1.60–1.52 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.3, 157.3, 138.3, 133.9, 129.2, 128.6, 126.4, 120.5, 113.7, 55.0, 36.3, 34.0, 30.9, 24.6. ESI-MS (<i>m</i>/<i>z</i>): 318.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 4-Chloro-<i>N</i>-(4-methoxyphenethyl)benzamide (<b>91</b>)</h4><div class="NLM_p last">4-Methoxyphenethylamine (0.3 mmol) was added to a solution of 4-chlorobenzoyl chloride (0.3 mmol) and Et<sub>3</sub>N (0.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.1 M). After TLC indicated the complete consumption of the starting materials (2 d), the reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with saturated NaHCO<sub>3</sub>. The organic layer was dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated under reduced pressure, and purified by flash chromatography (silica gel, 0 to 100% EtOAc in hexanes) to give the final product as a white solid, 18.6 mg, 21% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.62 (t, <i>J</i> = 5.6 Hz, 1H), 7.85–7.81 (m, 2H), 7.55–7.51 (m, 2H), 7.17–7.12 (m, 2H), 6.88–6.83 (m, 2H), 3.71 (s, 3H), 3.46–3.39 (m, 2H), 2.77 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.0, 157.7, 135.9, 133.3, 131.3, 129.6, 129.1, 128.4, 113.8, 55.0, 41.2, 34.2. ESI-MS (<i>m</i>/<i>z</i>): 290.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> 4-Chloro-<i>N</i>-(3-(4-methoxyphenyl)propyl)benzamide (<b>92</b>)</h4><div class="NLM_p last">The title compound was synthesized analogously to amide <b>91</b> to give the final product as a white solid, 51.2 mg, 54% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (t, <i>J</i> = 5.5 Hz, 1H), 7.88–7.83 (m, 2H), 7.55–7.51 (m, 2H), 7.15–7.11 (m, 2H), 6.86–6.82 (m, 2H), 3.71 (s, 3H), 3.29–3.22 (m, 2H), 2.56 (t, <i>J</i> = 7.5 Hz, 2H), 1.78 (quint, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.1, 157.4, 135.8, 133.5, 133.4, 129.2, 129.1, 128.3, 113.7, 55.0, 38.9, 31.7, 31.0. ESI-MS (<i>m</i>/<i>z</i>): 304.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 4-Chloro-<i>N</i>-(4-(4-methoxyphenyl)butyl)benzamide (<b>93</b>)</h4><div id="sec5_1_85_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i128" class="anchor-spacer"></div><h5 class="article-section__title" id="_i128"> Step 1</h5><div class="NLM_p last">Oxalyl chloride (5 equiv, 5.2 mmol) was added to a solution of 4-(4-methoxyphenyl)butyric acid (1 equiv, 1 mmol) in THF (0.1 M), and then a catalytic amount of DMF was added to initiate the reaction. After 1 h, the volatile components were removed under a positive N<sub>2</sub> flow over 1 h. Ammonium hydroxide (1 mL) was added to the residue in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) at 0 °C, and a white precipitate formed. The reaction mixture was stirred for 20 min at rt. Then, the precipitate was collected by filtration, rinsed with water, and dried under vacuum to give 4-(4-methoxyphenyl)butanamide as a white solid, which was used without purification. ESI-MS (<i>m</i>/<i>z</i>): 194.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_85_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i129" class="anchor-spacer"></div><h5 class="article-section__title" id="_i129"> Step 2</h5><div class="NLM_p last">A solution of the amide from <a class="ref internalNav" href="#sec5_1_85_1" aria-label="Step 1">Step 1</a> (1 equiv, 1.04 mmol) in anhydrous THF (1 M) was added to a suspension of LiAlH<sub>4</sub> (5 equiv, 4.2 mmol) in anhydrous THF (5 M) under N<sub>2</sub>. The reaction was heated at reflux for 6.5 h. Then, the reaction was cooled to 0 °C and quenched slowly with 0.167 mL of H<sub>2</sub>O, 0.17 mL of 1 M NaOH, and 0.5 mL of 1 M NaOH, consecutively, and then stirred for 1 h. The mixture was filtered through Celite, and the filtrate was diluted with water and extracted with EtOAc. The organic extracts were washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give 4-(4-methoxyphenyl)butan-1-amine as a yellow oil in 36% yield (67.9 mg). ESI-MS (<i>m</i>/<i>z</i>): 180.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_85_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i130" class="anchor-spacer"></div><h5 class="article-section__title" id="_i130"> Step 3</h5><div class="NLM_p last">The amine from <a class="ref internalNav" href="#sec5_1_85_2" aria-label="Step 2">Step 2</a> was coupled with 4-chlorobenzoyl chloride as described for compound <b>91</b> to give amide <b>93</b> as a white solid in 14% yield (16.7 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.53 (t, <i>J</i> = 5.5 Hz, 1H), 7.86–7.82 (m, 2H), 7.54–7.50 (m, 2H), 7.12–7.08 (m, 2H), 6.85–6.80 (m, 2H), 3.70 (s, 3H), 3.29–3.23 (m, 2H), 2.56–2.51 (m, 2H), 1.61–1.45 (m, 4H). 4-Chlorobenzoyl chloride: δ 7.96–7.92 (m, 0.7H), 7.59–7.55 (m, 0.7H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.0, 157.3, 135.8, 134.0, 133.4, 129.2, 129.1, 128.3, 113.7, 55.0, 33.9, 28.73, 28.67. 4-Chlorobenzoyl chloride: δ 131.2 and 128.8. ESI-MS (<i>m</i>/<i>z</i>): 318.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> General Procedure 3, for the Synthesis of <i>N</i>-Acyl Ureas, As Exemplified by the Synthesis of 4-Chloro-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>94</b>)</h4><div class="NLM_p last">Oxalyl chloride (4.3 mmol) was added to a solution of 4-chlorobenzamide (0.85 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.1 M) and heated at 50 °C to form an intermediate isocyanate (<b>138</b>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> After 5 h, the volatile solvents were removed under a flow of N<sub>2</sub>. 4-Methoxyphenethylamine (1 mmol) was added to a solution of the residue in acetonitrile (0.1 M), and a white precipitate formed immediately. The reaction mixture was stirred until completion as indicated by TLC analysis (12–48 h). The reaction mixture was concentrated under reduced pressure, and the residue was suspended in water (10 mL) and EtOAc (15 mL). The white precipitate was collected by filtration and dried under vacuum to give the final product as a white solid, 234.4 mg, 82% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (br s, 1H), 8.66 (t, <i>J</i> = 5.6 Hz, 1H), 7.97–7.93 (m, 2H), 7.58–7.53 (m, 2H), 7.19–7.14 (m, 2H), 6.89–6.84 (m, 2H), 3.72 (s, 3H), 3.46–3.40 (m, 2H), 2.75 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.3, 157.7, 153.8, 137.4, 131.8, 131.0, 130.1, 129.6, 128.5, 113.8, 55.0, 40.9, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 332.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> <i>N</i>-((4-Chlorophenyl)carbamoyl)-3-(4-methoxyphenyl)propanamide (<b>95</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> after purification by flash chromatography over silica gel (0 to 100% EtOAc in hexanes) to give a white solid, 18.7 mg, 36% yield (18.7 mg). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.77 (br s, 1H), 10.60 (br s, 1H), 7.58–7.54 (m, 2H), 7.39–7.35 (m, 2H), 7.16–7.12 (m, 2H), 6.87–6.83 (m, 2H), 3.71 (s, 3H), 2.81 (t, <i>J</i> = 7.4 Hz, 2H), 2.66 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 175.0, 157.6, 150.8, 136.6, 132.3, 129.2, 128.8, 127.3, 121.3, 113.8, 55.0, 37.7, 29.1. ESI-MS (<i>m</i>/<i>z</i>): 332.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 4-Bromo-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>96</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> to give the final product as a white solid, 279.4 mg, 70% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.76 (br s, 1H), 8.62 (t, <i>J</i> = 5.6 Hz, 1H), 7.88–7.85 (m, 2H), 7.73–7.69 (m, 2H), 7.18–7.15 (m, 2H), 6.88–6.85 (m, 2H), 3.72 (s, 3H), 3.45–3.40 (m, 2H), 2.75 (t, <i>J</i> = 7.4 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.4, 157.7, 153.3, 131.8, 131.5, 131.0, 130.2, 129.6, 126.7, 113.8, 55.0, 40.9, 34.3. ESI-MS (<i>m</i>/<i>z</i>): 377.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> <i>N</i>-((4-Methoxyphenethyl)carbamoyl)-[1,1′-biphenyl]-4-carboxamide (<b>97</b>)</h4><div class="NLM_p last">A solution of 4-bromo-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>96</b>, 0.15 mmol, 1 equiv), phenylboronic acid (0.3 mmol, 1 equiv), Pd(dppf)Cl<sub>2</sub> (0.015 mmol), cesium fluoride (0.39 mmol, 2.6 equiv), isopropanol (0.1 M), and Et<sub>3</sub>N (0.225 mmol, 1.5 equiv) was heated at 100 °C for 5 h. After the solution cooled to rt, water was added to the reaction solution, and it was extracted into EtOAc. The organic layer was washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated before purification by flash chromatography (silica gel, 0 to 100% EtOAc in hexanes) to give the desired product as a white solid, 20.3 mg, 36% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (br s, 1H), 8.72 (t, <i>J</i> = 5.8 Hz, 1H), 8.07–8.03 (m, 2H), 7.82–7.79 (m, 2H), 7.77–7.73 (m, 2H), 7.53–7.48 (m, 2H), 7.45–7.41 (m, 1H), 7.20–7.17 (m, 2H), 6.89–6.85 (m, 2H), 3.72 (s, 3H), 3.48–3.42 (m, 2H), 2.77 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.8, 157.8, 153.5, 144.2, 138.8, 131.3, 131.0, 129.7, 129.1, 128.9, 128.4, 127.0, 126.7, 113.9, 55.0, 40.9, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 375.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> 4-Methoxy-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>98</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> to give the final product as a white solid, 63.9 mg, 29% yield, contaminated with 41% dimer <b>57</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50 (br s, 1H), 8.74 (t, <i>J</i> = 5.6 Hz, 1H), 7.99–7.94 (m, 2H), 7.19–7.14 (m, 2H), 7.13–7.08 (m, 2H), 6.89–6.86 (m, 2H), 3.82 (s, 3H), 3.72 (s, 3H), 3.46–3.40 (m, 2H), 3.32–3.28 2.75 (t, <i>J</i> = 7.1 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.4, 162.8, 159.8, 153.7, 131.0, 130.3, 129.6, 124.5, 113.81, 113.75, 55.5, 55.0, 40.8, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 329.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> Methyl 4-(((4-Methoxyphenethyl)carbamoyl)carbamoyl)benzoate (<b>99</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> to give the final product as a white solid, 707.8 mg, 35% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.83 (br s, 1H), 8.60 (t, <i>J</i> = 5.4 Hz, 1H), 8.04–8.02 (m, 4H), 7.19–7.14 (m, 2H), 6.89–6.84 (m, 2H), 3.88 (s, 3H), 3.72 (s, 3H), 3.48–3.41 (m, 2H), 2.76 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.5, 165.5, 157.7, 153.2, 136.7, 132.9, 131.0, 129.6, 129.1, 128.6, 113.8, 55.0, 52.5, 40.9, 34.3. ESI-MS (<i>m</i>/<i>z</i>): 357.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> 4-(((4-Methoxyphenethyl)carbamoyl)carbamoyl)benzoic Acid (<b>100</b>)</h4><div class="NLM_p last">Methyl 4-(((4-methoxyphenethyl)carbamoyl)carbamoyl)benzoate (<b>99</b>, 2 mmol, 1 equiv), LiOH (6 mmol, 3 equiv), THF, H<sub>2</sub>O, and MeOH (3:1:3 ratio, 0.3 M) were combined in a vial. Additional LiOH (6 mmol) was added after 1 h. After 1 h, 1 M HCl was added until the reaction mixture became acidic. A precipitate was collected by filtration, rinsed with water, and dried under vacuum to give the acid as a white solid, 561.0 mg, 82% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.74 (br s, 1H), 8.65 (br s, 1H), 7.99–7.88 (m, 4H), 7.19–7.15 (m, 2H), 6.89–6.85 (m, 2H), 3.72 (s, 3H), 3.47–3.41 (m, 2H), 2.76 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.7, 166.7, 157.8, 153.3, 136.0, 131.0, 129.6, 129.4, 129.2, 128.3, 113.8, 55.0, 40.9, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 342.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> <i>N</i>-((4-Methoxyphenethyl)carbamoyl)-4-(morpholine-4-carbonyl)benzamide (<b>101</b>)</h4><div class="NLM_p last">Carboxylic acid <b>100</b> (0.88 mmol, 1 equiv), EDC (0.92 mmol, 1.05 equiv), and HOBT (0.92 mmol, 1.05 equiv) were dissolved in DMF (0.1 M) and stirred for 20 min before the addition of morpholine (0.88 mmol, 1 equiv). The reaction mixture was stirred overnight. Water and EtOAc were added to the reaction mixture, and the organic layer was washed with 1 M NaOH (3×), water (3×), 1 M HCl, water (3×), and brine. Then, the organic layer was dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the final product as a white solid, 3.8 mg, 12% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.84 (br s, 1H), 8.65 (t, <i>J</i> = 5.6 Hz, 1H), 7.97–7.92 (m, 2H), 7.54–7.49 (m, 2H), 7.19–7.13 (m, 2H), 6.89–6.84 (m, 2H), 3.85–3.62 (m, 9H), 3.62–3.55 (m, 2H), 3.38 (br s, 2H), 2.86 (t, <i>J</i> = 7.2 Hz, 2H). ESI-MS (<i>m</i>/<i>z</i>): 412.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> <i>N</i>-((4-Methoxyphenethyl)carbamoyl)-4-(piperidine-1-carbonyl)benzamide (<b>102</b>)</h4><div class="NLM_p last">The title compound was synthesized analogously to amide <b>101</b> to give the final product as a white solid, 15.7 mg, 38% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.75 (br s, 1H), 8.65 (t, <i>J</i> = 5.7 Hz, 1H), 8.00–7.95 (m, 2H), 7.48–7.43 (m, 2H), 7.20–7.15 (m, 2H), 6.89–6.85 (m, 2H), 3.72 (s, 3H), 3.59 (br s, 2H), 3.48–3.41 (m, 2H), 3.22 (br s, 2H), 2.76 (t, <i>J</i> = 7.3 Hz, 2H), 1.65–1.51 (m, 4H), 1.45 (br s, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.8, 167.7, 157.7, 153.4, 140.5, 133.1, 131.0, 129.6, 128.3, 126.5, 113.8, 55.0, 47.9, 40.9, 34.4, 25.9, 24.0. ESI-MS (<i>m</i>/<i>z</i>): 410.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> 4-Benzoyl-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>103</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> to give the final product as a white solid, 17.7 mg, 18% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (br s, 1H), 8.64 (t, <i>J</i> = 5.6 Hz, 1H), 8.11–8.06 (m, 2H), 7.83–7.78 (m, 2H), 7.78–7.74 (m, 2H), 7.74–7.69 (m, 1H), 7.62–7.56 (m, 2H), 7.20–7.15 (m, 2H), 6.90–6.85 (m, 2H), 3.73 (s, 3H), 3.49–3.42 (m, 2H), 2.77 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 195.3, 167.6, 159.8, 157.7, 153.3, 140.4, 136.4, 135.8, 133.2, 130.9, 129.7, 129.5, 128.7, 128.4, 113.8, 55.0, 40.5, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 403.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> <i>N</i>-((4-Methoxyphenethyl)carbamoyl)-4-phenoxybenzamide (<b>104</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> to give the final product as a white solid, 23.8 mg, 24% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (br s, 1H), 8.69 (t, <i>J</i> = 5.7 Hz, 1H), 8.02–7.97 (m, 2H), 7.49–7.43 (m, 2H), 7.28–7.22 (m, 1H), 7.19–7.14 (m, 2H), 7.14–7.10 (m, 2H), 7.03–6.99 (m, 2H), 6.89–6.84 (m, 2H), 3.72 (s, 3H), 3.47–3.40 (m, 2H), 2.75 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.2, 160.9, 157.7, 155.0, 153.5, 131.0, 130.6, 130.3, 129.6, 126.8, 124.8, 120.0, 117.0, 113.8, 55.0, 40.8, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 391.0 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>22</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> 391.165 23, found 391.1653.</div></div><div id="sec5_1_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i142" class="anchor-spacer"></div><h4 class="article-section__title" id="_i142"> 4-(Benzyloxy)-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>105</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> to give the final product as a white solid, 35.3 mg, 36% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50 (br s, 1H), 8.73 (t, <i>J</i> = 5.7 Hz, 1H), 7.98–7.93 (m, 2H), 7.48–7.43 (m, 2H), 7.43–7.37 (m, 2H), 7.37–7.31 (m, 1H), 7.19–7.14 (m, 2H), 7.12–7.07 (m, 2H), 6.89–6.84 (m, 2H), 5.19 (s, 2H), 3.72 (s, 3H), 3.47–3.40 (m, 2H), 2.75 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.4, 161.9, 157.7, 153.7, 136.5, 131.0, 130.3, 129.6, 128.5, 128.0, 127.8, 124.7, 114.5, 113.8, 69.5, 55.0, 40.8, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 405.1 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> 405.180 88, found 405.1815.</div></div><div id="sec5_1_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i143" class="anchor-spacer"></div><h4 class="article-section__title" id="_i143"> <i>N</i>-((4-Methoxyphenethyl)carbamoyl)-4-(phenoxymethyl)benzamide (<b>106</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> to give the final product as a white solid, 26.5 mg, 36% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.65 (br s, 1H), 8.68 (t, <i>J</i> = 5.7 Hz, 1H), 7.98–7.93 (m, 2H), 7.58–7.53 (m, 2H), 7.33–7.26 (m, 2H), 7.20–7.14 (m, 2H), 7.04–6.99 (m, 2H), 6.98–6.92 (m, 1H), 6.89–6.84 (m, 2H), 5.19 (s, 2H), 3.72 (s, 3H), 3.48–3.41 (m, 2H), 2.76 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.9, 158.1, 157.7, 153.5, 142.1, 131.9, 131.0, 129.62, 129.56, 128.3, 127.2, 120.9, 114.8, 113.8, 68.3, 55.0, 40.9, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 405.1 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>24</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> 405.180 88, found 405.1811.</div></div><div id="sec5_1_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i144" class="anchor-spacer"></div><h4 class="article-section__title" id="_i144"> 4-(Hydroxy(phenyl)methyl)-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>107</b>)</h4><div class="NLM_p last">Ti(<sup><i>i</i></sup>PrO)<sub>4</sub> (2 equiv, 1 mmol) was added dropwise over 5 min to a cloudy solution of 4-benzoyl-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>106</b>, 1 equiv, 0.5 mmol) in 1,4-dioxane (1 M) under N<sub>2</sub>. Then, NaBH<sub>4</sub> (1.5 equiv, 0.75 mmol) was added; lastly, MeOH (0.64 M) was added, and the reaction solution bubbled and turned clear. The reaction mixture was stirred at rt for 2 h until the reaction was complete as judged by TLC analysis. NH<sub>4</sub>OH and then water were added to the reaction solution. The reaction mixture was extracted into EtOAc, and the organic extracts were washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the alcohol product as a white solid in 35% yield (73.3 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (br s, 1H), 8.68 (t, <i>J</i> = 5.7 Hz, 1H), 7.90–7.86 (m, 2H), 7.51–7.46 (m, 2H), 7.40–7.36 (m, 2H), 7.33–7.27 (m, 2H), 7.24–7.18 (m, 1H), 7.18–7.13 (m, 2H), 6.88–6.83 (m, 2H), 6.06 (d, <i>J</i> = 4.0 Hz, 1H), 5.76 (d, <i>J</i> = 4.0 Hz, 1H), 3.71 (s, 3H), 3.46–3.39 (m, 2H), 2.74 (t, <i>J</i> = 7.1 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.0, 157.7, 153.5, 150.5, 145.1, 131.0, 130.9, 129.6, 128.2, 128.1, 127.0, 126.3, 126.1, 113.8, 73.8, 55.0, 40.8, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 405.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i145" class="anchor-spacer"></div><h4 class="article-section__title" id="_i145"> 4-(Amino(phenyl)methyl)-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>108</b>)</h4><div id="sec5_1_100_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i146" class="anchor-spacer"></div><h5 class="article-section__title" id="_i146"> Step 1</h5><div class="NLM_p last">Thionyl chloride (5 equiv, 0.58 mmol) was added to a solution of 4-(hydroxy(phenyl)methyl)-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>107</b>, 1 equiv, 0.12 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.1 M). After 1.5 h, another 5 equiv of thionyl chloride were added. When the reaction was complete as judged by TLC analysis (3 more hours), the reaction mixture was concentrated and dried under vacuum to give 4-(chloro(phenyl)methyl)-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide in 40.7 mg, 83% yield, which was used directly in the next step. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.69 (br s, 1H), 8.64 (t, <i>J</i> = 5.7 Hz, 1H), 7.96–7.92 (m, 2H), 7.61–7.56 (m, 2H), 7.50–7.46 (m, 2H), 7.42–7.37 (m, 2H), 7.35–7.30 (m, 1H), 7.19–7.14 (m, 2H), 6.88–6.84 (m, 2H), 6.60 (s, 1H), 3.72 (s, 3H), 3.46–3.40 (m, 2H), 2.75 (t, <i>J</i> = 7.3 Hz, 2H). ESI-MS (<i>m</i>/<i>z</i>): 422.9 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_100_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i147" class="anchor-spacer"></div><h5 class="article-section__title" id="_i147"> Step 2</h5><div class="NLM_p last">Sodium azide (2 equiv, 0.19 mmol) was added to a solution of the chloride from <a class="ref internalNav" href="#sec5_1_100_1" aria-label="Step 1">Step 1</a> (1 equiv, 0.09 mmol) in DMF (0.1 M) and stirred overnight at rt. Then, water was added to the reaction, and a precipitate formed. The precipitate was collected by filtration, rinsed with water, and dried under vacuum to give 4-(azido(phenyl)methyl)-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide in 74% yield (30.6 mg). ESI-MS (<i>m</i>/<i>z</i>): 430.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_100_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i148" class="anchor-spacer"></div><h5 class="article-section__title" id="_i148"> Step 3</h5><div class="NLM_p last">Solid 10% Pd/C (1.8 equiv, 0.13 mmol) was added to a solution of the azide from <a class="ref internalNav" href="#sec5_1_100_2" aria-label="Step 2">Step 2</a> (1 equiv, 0.07 mmol) in anhydrous MeOH (0.1 M). After purging with N<sub>2</sub>, the suspension was stirred under H<sub>2</sub> at 50 psi for 2.5 h. Then, the solution was filtered through Celite to remove Pd/C, and the filtrate was concentrated. The residue was purified by flash chromatography (silica gel, 0 to 20% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give amine <b>108</b> as a white solid in 37% yield (10.7 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (br s, 1H), 8.69 (t, <i>J</i> = 5.6 Hz, 1H), 7.89–7.85 (m, 2H), 7.54–7.49 (m, 2H), 7.42–7.37 (m, 2H), 7.31–7.25 (m, 2H), 7.20–7.17 (m, 1H), 7.17–7.14 (m, 2H), 6.88–6.84 (m, 2H), 5.14 (s, 1H), 3.71 (s, 3H), 3.46–3.39 (m, 2H), 2.74 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.9, 157.7, 153.5, 151.9, 146.2, 131.0, 130.5, 129.6, 128.2, 128.1, 126.8, 126.7, 126.6, 113.8, 59.0, 55.0, 40.8, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 402.0 [M – H]<sup>−</sup>.</div></div></div><div id="sec5_1_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i149" class="anchor-spacer"></div><h4 class="article-section__title" id="_i149"> 3-Bromo-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>109</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a> to give the final product as a white solid, 144.2 mg, 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.77 (br s, 1H), 8.58 (t, <i>J</i> = 5.6 Hz, 1H), 8.11 (t, <i>J</i> = 1.8 Hz, 1H), 7.92 (ddd, <i>J</i> = 7.8, 1.6, 0.9 Hz, 1H), 7.81 (ddd, <i>J</i> = 8.0, 1.9, 0.9 Hz, 1H), 7.46 (t, <i>J</i> = 7.9 Hz, 1H), 7.19–7.14 (m, 2H), 6.89–6.84 (m, 2H), 3.72 (s, 3H), 3.47–3.40 (m, 2H), 2.75 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.8, 157.7, 153.2, 135.3, 134.8, 131.0, 130.8, 130.7, 129.6, 127.2, 121.7, 113.8, 55.0, 40.9, 34.3. ESI-MS (<i>m</i>/<i>z</i>): 377.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i150" class="anchor-spacer"></div><h4 class="article-section__title" id="_i150"> <i>N</i>-((4-Methoxyphenethyl)carbamoyl)-[1,1′-biphenyl]-3-carboxamide (<b>110</b>)</h4><div class="NLM_p last">The title compound was synthesized from bromide <b>109</b> analogously to the synthesis of <b>97</b> to provide the product as a white solid, 3.0 mg, 5% yield. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (br s, 1H), 8.73 (t, <i>J</i> = 5.7 Hz, 1H), 8.26 (t, <i>J</i> = 1.6 Hz, 1H), 7.93–7.89 (m, 2H), 7.82–7.79 (m, 2H), 7.60 (t, <i>J</i> = 7.8 Hz, 1H), 7.52–7.48 (m, 2H), 7.43–7.39 (m, 1H), 7.20–7.17 (m, 2H), 6.89–6.85 (m, 2H), 3.72 (s, 3H), 3.49–3.43 (m, 2H), 2.77 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 168.1, 157.7, 153.5, 140.3, 139.2, 133.2, 131.0, 130.8, 129.6, 129.2, 129.0, 127.9, 127.3, 127.0, 126.2, 113.8, 55.0, 40.9, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 375.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i151" class="anchor-spacer"></div><h4 class="article-section__title" id="_i151"> 4-Benzoyl-<i>N</i>-((4-methoxyphenethyl)(methyl)carbamoyl)benzamide (<b>111</b>)</h4><div id="sec5_1_103_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i152" class="anchor-spacer"></div><h5 class="article-section__title" id="_i152"> Step 1</h5><div class="NLM_p last">Ethyl chloroformate (1 equiv, 0.5 mmol) was added to a solution of 4-methoxyphenethylamine (1 equiv, 0.5 mmol) and pyridine (2 equiv, 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 M) at 0 °C. The solution warmed to rt. When the reaction was complete as judged by TLC analysis, the reaction was filtered to remove the solid. The filtrate was washed with 1 M HCl and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give ethyl (4-methoxyphenethyl)carbamate as a cream-colored solid, which was used without further purification, 147.4 mg, 99% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.12–7.07 (m, 2H), 6.86–6.82 (m, 2H), 3.95 (q, <i>J</i> = 7.1 Hz, 2H), 3.71 (s, 3H), 3.17–3.10 (m, 2H), 2.65–2.59 (m, 2H), 1.13 (t, <i>J</i> = 7.0 Hz, 3H). ESI-MS (<i>m</i>/<i>z</i>): 224.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_103_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i153" class="anchor-spacer"></div><h5 class="article-section__title" id="_i153"> Step 2</h5><div class="NLM_p last">A solution of the carbamate from <a class="ref internalNav" href="#sec5_1_103_1" aria-label="Step 1">Step 1</a> (1 equiv, 0.5 mmol) in anhydrous THF (1.3 M) was added dropwise to a solution of LiAlH<sub>4</sub> (6 equiv, 3 mmol) in anhydrous THF (0.4 M) at 0 °C under a nitrogen atmosphere. The reaction mixture warmed to rt after 45 min. After 4 h, the solution was heated to 50 °C overnight. Then, the reaction mixture was cooled to 0 °C and quenched by the slow addition of 0.1 mL of water, 0.1 mL of 1 M NaOH, and 0.3 mL of water. The reaction mixture was stirred for 1 h before an additional 0.5 mL of 1 M NaOH was added. The solid material was removed by filtration through Celite, and the filtrate was concentrated under reduced pressure. The residue was purified by flash chromatography (silica gel, 0 to 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to give 2-(4-methoxyphenyl)-<i>N</i>-methylethan-1-amine as a cream-colored solid in 27% yield (29.6 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.15–7.10 (m, 2H), 6.86–6.82 (m, 2H), 3.79 (s, 3H), 2.87–2.81 (m, 2H), 2.81–2.75 (m, 2H), 2.00 (br s, 3H). ESI-MS (<i>m</i>/<i>z</i>): 166.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_103_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i154" class="anchor-spacer"></div><h5 class="article-section__title" id="_i154"> Step 3</h5><div class="NLM_p last">The amine from <a class="ref internalNav" href="#sec5_1_103_2" aria-label="Step 2">Step 2</a> was used to prepare <i>N</i>-acyl urea <b>111</b> according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a>. The crude reaction mixture was purified by flash chromatography (silica gel, 0 to 100% EtOAc in hexanes) to give the final product as a solid, 1.7 mg, 3% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.99–7.85 (m, 2H), 7.83–7.78 (m, 2H), 7.78–7.75 (m, 2H), 7.74–7.69 (m, 1H), 7.62–7.57 (m, 2H), 7.20–7.13 (m, 2H), 6.89–6.83 (m, 2H), 3.71 (s, 3H), 3.53–3.47 (m, 2H), 2.93 (s, 3H), 2.79 (t, <i>J</i> = 7.7 Hz, 2H). ESI-MS (<i>m</i>/<i>z</i>): 417.1 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_1_104" class="NLM_sec NLM_sec_level_3"><div id="ac_i155" class="anchor-spacer"></div><h4 class="article-section__title" id="_i155"> 4-Benzoyl-<i>N</i>-((4-methoxyphenethyl)carbamoyl)-<i>N</i>-methylbenzamide (<b>112</b>)</h4><div class="NLM_p last">Methyl iodide (0.37 mmol) was added to a solution of 4-benzoyl-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>103</b>, 0.07 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.22 mmol) in DMF (0.2 M). When the reaction was complete as judged by TLC analysis (3 h), EtOAc was added, and the organic layer was washed with water and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give a white solid, 23.3 mg, 73% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (t, <i>J</i> = 5.4 Hz, 1H), 7.78–7.72 (m, 4H), 7.72–7.67 (m, 1H), 7.64–7.59 (m, 2H), 7.59–7.53 (m, 2H), 7.13–7.08 (m, 2H), 6.87–6.82 (m, 2H), 3.69 (s, 3H), 3.32–3.25 (m, 2H), 3.12 (s, 3H), 2.61 (t, <i>J</i> = 7.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 195.2, 171.2, 157.7, 155.3, 139.9, 138.4, 136.6, 133.0, 130.9, 129.7, 129.6, 129.4, 128.7, 127.0, 113.8, 55.0, 41.9, 33.9, 33.7. ESI-MS (<i>m</i>/<i>z</i>): 417.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_105" class="NLM_sec NLM_sec_level_3"><div id="ac_i156" class="anchor-spacer"></div><h4 class="article-section__title" id="_i156"> 4-Benzoyl-<i>N</i>-((4-methoxyphenethyl)(methyl)carbamoyl)-<i>N</i>-methylbenzamide (<b>113</b>)</h4><div class="NLM_p last">Methyl iodide (0.37 mmol) was added to a solution of 4-benzoyl-<i>N</i>-((4-methoxyphenethyl)carbamoyl)benzamide (<b>103</b>, 0.07 mmol) and NaH (60% in mineral oil, 0.15 mmol) in DMF (0.2 M). When the reaction was complete as judged by TLC analysis (3 h), EtOAc was added, and the organic layer was washed with water and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (silica gel, 0 to 100% EtOAc in hexanes) to give a colorless oil, 11.0 mg, 35% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.82–7.78 (m, 2H), 7.78–7.74 (m, 2H), 7.74–7.63 (m, 2H), 7.63–7.57 (m, 1H), 7.50–7.43 (m, 2H), 7.06–7.01 (m, 2H), 6.86–6.80 (m, 2H), 3.77 (s, 3H), 3.43–3.29 (m, 2H), 3.21 (s, 3H), 2.77 (s, 3H), 2.65 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 196.0, 158.6, 158.0, 139.9, 138.8, 137.1, 133.0, 130.21, 130.17, 130.0, 129.8, 128.6, 128.5, 127.6, 114.3, 55.4, 51.2, 33.4, 32.1, 29.8. ESI-MS (<i>m</i>/<i>z</i>): 431.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_106" class="NLM_sec NLM_sec_level_3"><div id="ac_i157" class="anchor-spacer"></div><h4 class="article-section__title" id="_i157"> <i>N</i><sup>1</sup>-Cyclopropyl-<i>N</i><sup>2</sup>-(4-hydroxyphenethyl)oxalamide (<b>114</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_2" aria-label="General Procedure 1">General Procedure 1</a> to provide 143.3 mg of a white solid in 96% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (s, 1H), 8.77–8.65 (m, 2H), 6.98 (d, <i>J</i> = 8.0 Hz, 2H), 6.66 (d, <i>J</i> = 8.0 Hz, 2H), 3.32–3.24 (m, 2H), 2.79–2.70 (m, 1H), 2.65 (t, <i>J</i> = 7.2 Hz, 2H), 0.68–0.55 (m, 4H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.3, 159.7, 155.7, 129.5, 129.1, 115.1, 40.6, 33.9, 22.8, 5.4. ESI-MS (<i>m</i>/<i>z</i>): 249.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_107" class="NLM_sec NLM_sec_level_3"><div id="ac_i158" class="anchor-spacer"></div><h4 class="article-section__title" id="_i158"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(4-hydroxybenzyl)oxalamide (<b>115</b>)</h4><div class="NLM_p last">The title compound was prepared using the synthetic procedures described for the preparation of phenol <b>78</b> using methyl ether <b>80</b> (78.3 mg, 0.25 mmol, 1 equiv). The residue was purified by flash chromatography over silica gel (0 to 100% EtOAc in hexanes) to provide 33.0 mg of a white solid in 44% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (s, 1H), 9.41 (t, <i>J</i> = 6.3 Hz, 1H), 7.85–7.80 (m, 2H), 7.43–7.38 (m, 2H), 7.13–7.08 (m, 2H), 6.72–6.67 (m, 2H), 4.26 (d, <i>J</i> = 6.3 Hz, 2H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 159.8, 159.0, 156.5, 136.7, 129.1, 129.0, 128.8, 128.4, 122.2, 115.2, 42.3. ESI-MS (<i>m</i>/<i>z</i>): 303.0 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_108" class="NLM_sec NLM_sec_level_3"><div id="ac_i159" class="anchor-spacer"></div><h4 class="article-section__title" id="_i159"> <i>N</i>-(4-Chlorophenyl)-3-(4-hydroxyphenyl)propanamide (<b>116</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_40" aria-label="General Procedure 2">General Procedure 2</a>, using 3-(4-hydroxyphenyl)propionic acid (50.0 mg, 0.3 mmol) and 4-chloroaniline (38.2 mg, 0.3 mmol). When water was added, a precipitate formed upon cooling to 0 °C. The precipitate was filtered and washed with cold water to yield 9.7 mg of a white solid in 12% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.01 (br s, 1H), 9.16 (br s, 1H), 7.62–7.57 (m, 2H), 7.36–7.31 (m, 2H), 7.04–6.99 (m, 2H), 6.68–6.63 (m, 2H), 2.81–2.75 (m, 2H), 2.58–2.52 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.7, 155.5, 138.2, 131.1, 129.1, 128.6, 126.5, 120.5, 115.1, 38.5, 30.0. ESI-MS (<i>m</i>/<i>z</i>): 276.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_109" class="NLM_sec NLM_sec_level_3"><div id="ac_i160" class="anchor-spacer"></div><h4 class="article-section__title" id="_i160"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(2-(4-hydroxyphenyl)propyl)oxalamide (<b>117</b>)</h4><div class="NLM_p last">The title compound was prepared using the synthetic procedures described for the preparation of phenol <b>78</b> using methyl ether <b>81</b> (11.8 mg, 0.34 mmol). The residue was purified by flash chromatography over silica gel (0% to 100% EtOAc) to yield 5.8 mg of a white solid in 51% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) 10.77 (br s, 1H), 9.19 (br s, 1H), 8.86 (t, <i>J</i> = 6.0 Hz, 1H), 7.87–7.82 (m, 2H), 7.42–7.38 (m, 2H), 7.05–7.00 (m, 2H), 6.70–6.66 (m, 2H), 3.32–3.21 (m, 2H), 3.00–2.90 (m, 1H), 1.16–1.11 (d, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) 159.6, 158.7, 155.7, 136.7, 134.4, 128.6, 128.2, 127.9, 121.9, 115.1, 46.3, 37.8, 19.5. ESI-MS (<i>m</i>/<i>z</i>): 333.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_110" class="NLM_sec NLM_sec_level_3"><div id="ac_i161" class="anchor-spacer"></div><h4 class="article-section__title" id="_i161"> <i>N</i><sup>1</sup>-(4-Chlorophenyl)-<i>N</i><sup>2</sup>-(1-(4-hydroxyphenyl)propan-2-yl)oxalamide (<b>118</b>)</h4><div class="NLM_p last">The title compound was prepared using the synthetic procedures described for the preparation of phenol <b>78</b> using methyl ether <b>82</b> (42.2 mg, 0.12 mmol). The crude product was purified by flash chromatography over silica gel (0 to 20% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) to provide 9.3 mg of a white solid in 23% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.72 (br s, 1H), 9.16 (br s, 1H), 8.83 (d, <i>J</i> = 8.9 Hz, 1H), 7.86–7.81 (m, 2H), 7.42–7.38 (m, 2H), 7.01–6.96 (m, 2H), 6.66–6.62 (m, 2H), 4.07–3.95 (m, 1H), 2.76 (dd, <i>J</i> = 13.6, 8.0 Hz, 1H), 2.61 (dd, <i>J</i> = 13.6, 6.4 Hz, 1H), 1.12 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 158.9, 158.8, 155.6, 136.7, 129.9, 129.0, 128.6, 128.2, 121.9, 115.0, 47.3, 40.4, 19.9. ESI-MS (<i>m</i>/<i>z</i>): 331.0 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_111" class="NLM_sec NLM_sec_level_3"><div id="ac_i162" class="anchor-spacer"></div><h4 class="article-section__title" id="_i162"> <i>N</i>-(4-Hydroxyphenethyl)quinoline-2-carboxamide (<b>119</b>)</h4><div class="NLM_p last">The title compound was prepared according to <a class="ref internalNav" href="#sec5_1_40" aria-label="General Procedure 2">General Procedure 2</a> using quinaldic acid (56.0 mg, 0.3 mmol) and tyramine (41.1 mg, 0.3 mmol) to yield 34.6 mg of a white solid in 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (br s, 1H), 8.94 (t, <i>J</i> = 6.1 Hz, 1H), 8.56 (d, <i>J</i> = 8.5 Hz, 1H), 8.15 (d, <i>J</i> = 8.5 Hz, 1H), 8.13–8.06 (m, 2H), 7.90–7.84 (m, 1H), 7.75–7.69 (m, 1H), 7.09–7.04 (m, 2H), 6.72–6.67 (m, 2H), 3.58–3.49 (m, 2H), 2.83–2.76 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.8, 155.7, 150.2, 146.0, 137.9, 130.5, 129.5, 129.4, 129.1, 128.8, 128.1, 128.0, 118.6, 115.2, 40.9, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 293.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_112" class="NLM_sec NLM_sec_level_3"><div id="ac_i163" class="anchor-spacer"></div><h4 class="article-section__title" id="_i163"> <i>N</i>-((4-Hydroxyphenethyl)carbamoyl)-4-(2-methylbenzoyl)benzamide (<b>120</b>)</h4><div id="sec5_1_112_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i164" class="anchor-spacer"></div><h5 class="article-section__title" id="_i164"> Step 1</h5><div class="NLM_p last">A 1.9 M solution of <i>o</i>-tolylmagnesium bromide in THF (2.4 mmol, 1.2 equiv) was added dropwise to a solution of 4-formylbenzonitrile (2 mmol, 1 equiv) in anhydrous THF (0.1 M) at −78 °C. After 2 h at −78 °C, the solution was warmed to room temperature, and the solution was stirred at room temperature overnight. Then, the solution was washed with NH<sub>4</sub>Cl(aq) and extracted into EtOAc (3×). The organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude residue was purified by flash chromatography over silica gel (1:1 EtOAc/hexanes) to yield 425.8 mg of 4-(hydroxy(<i>o</i>-tolyl)methyl)benzonitrile as a yellow oil in 95% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.79–7.75 (m, 2H), 7.50–7.46 (m, 2H), 7.37–7.34 (m, 1H), 7.22–7.11 (m, 3H), 6.05 (d, <i>J</i> = 4.4 Hz, 1H), 5.92 (d, <i>J</i> = 4.4 Hz, 1H), 2.22 (s, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 150.1, 142.1, 135.0, 132.1, 130.3, 127.7, 127.2, 126.9, 125.9, 118.9, 109.5, 71.0, 19.1.</div></div><div id="sec5_1_112_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i165" class="anchor-spacer"></div><h5 class="article-section__title" id="_i165"> Step 2</h5><div class="NLM_p last">The nitrile from <a class="ref internalNav" href="#sec5_1_112_1" aria-label="Step 1">Step 1</a> (425.8 mg, 1.9 mmol, 1 equiv) and KOH (2.6 g, 34 mmol, 18 equiv) were dissolved in anhydrous <i>t</i>-butanol (6.4 mL, 0.3 M), and the solution was heated at 60 °C for 4 h. The solution was then cooled, and water was added. The solution was extracted into EtOAc (3×), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 340.5 mg of 4-(hydroxy(<i>o</i>-tolyl)methyl)benzamide in 80% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.90 (br s, 1H), 7.81–7.77 (m, 2H), 7.43–7.39 (m, 1H), 7.37–7.32 (m, 2H), 7.30 (br s, 1H), 7.22–7.09 (m, 3H), 5.88 (s, 2H), 2.21 (s, 3H).</div></div><div id="sec5_1_112_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i166" class="anchor-spacer"></div><h5 class="article-section__title" id="_i166"> Step 3</h5><div class="NLM_p last">Pyridinium chlorochromate (PCC, 4.6 mmol, 3 equiv) was added to a solution of the alcohol from <a class="ref internalNav" href="#sec5_1_112_2" aria-label="Step 2">Step 2</a> (1.5 mmol, 1 equiv) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (15 mL, 0.1 M), and the reaction was stirred at room temperature. After 1.5 h, more PCC (3 equiv) was added, and the reaction was finished in 1.5 h as determined by TLC. The reaction was filtered through Celite and washed with CH<sub>2</sub>Cl<sub>2</sub>, and the filtrate was concentrated under reduced pressure. The residue was purified by flash chromatography over silica gel (3:4 EtOAc/hexanes) to yield 51.8 mg of 4-(2-methylbenzoyl)benzamide as a white solid in 14% yield. ESI-MS (<i>m</i>/<i>z</i>): 240.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_112_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i167" class="anchor-spacer"></div><h5 class="article-section__title" id="_i167"> Step 4</h5><div class="NLM_p last"><i>N</i>-((4-Hydroxyphenethyl)carbamoyl)-4-(2-methylbenzoyl)benzamide (<b>120</b>) was prepared according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a>. To form the <i>N</i>-acyl urea, tyramine (55.4 mg, 0.39 mmol) was dissolved in acetonitrile (1 mL, 0.1 M) by heating to 80 °C, and then a solution of the isocyanate in CH<sub>3</sub>CN (1 mL, 0.1 M) was added. The reaction mixture was stirred overnight at 80 °C before being concentrated. The residue was extracted with water (3 mL) and EtOAc (3 × 3 mL), and the organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography over silica gel (0 to 40% EtOAc in hexanes) to provide 33.4 mg of a yellow oil in 43% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.84–7.79 (m, 2H), 7.77–7.72 (m, 2H), 7.45–7.39 (m, 1H), 7.34–7.27 (m, 3H), 7.11–7.07 (m, 2H), 6.83–6.78 (m, 2H), 6.22 (t, <i>J</i> = 5.6 Hz, 1H), 3.73–3.66 (m, 2H), 2.87 (t, <i>J</i> = 6.8 Hz, 2H), 2.33 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 198.0, 166.8, 154.9, 140.2, 138.6, 138.0, 137.2, 131.4, 130.9, 130.7, 130.43, 130.41, 130.0, 128.9, 127.1, 125.5, 115.8, 41.6, 34.8, 20.3. ESI-MS (<i>m</i>/<i>z</i>): 403.0 [M – H]<sup>+</sup>.</div></div></div><div id="sec5_1_113" class="NLM_sec NLM_sec_level_3"><div id="ac_i168" class="anchor-spacer"></div><h4 class="article-section__title" id="_i168"> <i>N</i>-((4-Methoxyphenethyl)carbamoyl)-4-(2-methylbenzoyl)benzamide (<b>121</b>)</h4><div class="NLM_p last">The title compound was synthesized analogously to <i>N</i>-acyl urea <b>120</b> to yield 30.9 mg of a white solid in 34% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.62 (t, <i>J</i> = 5.6 Hz, 1H), 8.08–8.03 (m, 2H), 7.79–7.74 (m, 2H), 7.52–7.47 (m, 1H), 7.39 (d, <i>J</i> = 7.7 Hz, 1H), 7.35–7.30 (m, 2H), 7.20–7.14 (m, 2H), 6.89–6.84 (m, 2H), 3.72 (s, 3H), 3.48–3.41 (m, 2H), 2.76 (t, <i>J</i> = 7.3 Hz, 2H), 2.25 (s, 3H). <sup>13</sup>C NMR (100 Hz, DMSO-<i>d</i><sub>6</sub>) δ 197.5, 167.8, 157.9, 153.5, 140.3, 137.7, 136.8, 136.4, 131.3, 131.13, 131.07, 129.8, 129.7, 128.8, 128.7, 125.8, 114.0, 55.2, 41.1, 34.5, 19.8. ESI-MS (<i>m</i>/<i>z</i>): 415.1 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_114" class="NLM_sec NLM_sec_level_3"><div id="ac_i169" class="anchor-spacer"></div><h4 class="article-section__title" id="_i169"> <i>N</i>-((4-Hydroxyphenethyl)carbamoyl)-4-(phenoxymethyl)benzamide (<b>122</b>)</h4><div class="NLM_p last">The title compound was synthesized according to <a class="ref internalNav" href="#sec5_1_86" aria-label="General Procedure 3">General Procedure 3</a>, except the addition of tyramine was carried out at 80 °C. The final product was isolated by filtration as a white solid, 111.9 mg, 65% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.66 (br s, 1H), 9.23 (br s, 1H), 8.67 (t, <i>J</i> = 5.6 Hz, 1H), 7.96 (d, <i>J</i> = 8.2 Hz, 2H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.33–7.26 (m, 2H), 7.06–6.99 (m, 4H), 6.97–6.92 (m, 1H), 6.72–6.67 (m, 2H), 5.19 (s, 2H), 3.45–3.38 (m, 2H), 2.70 (t, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.9, 158.1, 155.7, 153.5, 142.1, 131.9, 129.6, 129.5, 129.1, 128.3, 127.2, 120.9, 115.2, 114.8, 68.3, 41.0, 34.4. ESI-MS (<i>m</i>/<i>z</i>): 391.1 [M + H]<sup>+</sup>. HRMS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>22</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> 391.165 23, found 391.1655.</div></div><div id="sec5_1_115" class="NLM_sec NLM_sec_level_3"><div id="ac_i170" class="anchor-spacer"></div><h4 class="article-section__title" id="_i170"> <i>N</i><sup>1</sup>-(4-Hydroxyphenethyl)-<i>N</i><sup>2</sup>-(4-(4-(prop-2-yn-1-yloxy)benzoyl)phenyl)oxalamide (<b>123</b>)</h4><div id="sec5_1_115_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i171" class="anchor-spacer"></div><h5 class="article-section__title" id="_i171"> Step 1</h5><div class="NLM_p last">To a solution of (4-aminophenyl)(4-(prop-2-yn-1-yloxy)phenyl)methanone (<b>135</b>, 654 mg, 2.60 mmol, 1 equiv) and triethylamine (0.72 mL, 5.2 mmol, 2 equiv) dissolved in anhydrous methylene chloride (26 mL) was slowly added a solution of ethyl chlorooxoacetate (0.29 mL, 2.60 mmol, 1 equiv) in anhydrous methylene chloride (2.9 mL). The reaction was stirred for 16 h at room temperature and then washed with saturated aqueous sodium bicarbonate. The organic layer was dried over sodium sulfate and concentrated under vacuum to yield the intermediate ethyl 2-oxo-2-((4-(4-(prop-2-yn-1-yloxy) benzoyl)phenyl)amino)acetate, which was used immediately in the next step without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 9.09 (s, 1H), 7.85–7.74 (m, 7H), 7.07–7.03 (m, 2H), 4.78 (d, <i>J</i> = 2.4 Hz, 2H), 4.41 (dq, <i>J</i> = 21.1, 7.2 Hz, 4H), 2.57 (t, <i>J</i> = 2.4 Hz, 1H), 1.42 (dt, <i>J</i> = 17.9, 7.1 Hz, 6H).</div></div><div id="sec5_1_115_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i172" class="anchor-spacer"></div><h5 class="article-section__title" id="_i172"> Step 2</h5><div class="NLM_p last">The ethyl ester from <a class="ref internalNav" href="#sec5_1_115_1" aria-label="Step 1">Step 1</a> (93 mg, 0.3 mmol) was dissolved in THF (1 mL) and treated with aqueous 1 M lithium hydroxide (1 mL). The resulting mixture was stirred for 16 h at room temperature. The volatiles were removed by passing a stream of dry nitrogen over the mixture, and the resulting residue was dissolved in water (1 mL) and acidified with 1 M HCl, whereupon a precipitate formed. The precipitate was filtered and dried by aspiration to give 2-oxo-2-((4-(4-(prop-2-yn-1-yloxy)benzoyl)phenyl)amino)acetic acid as a tan powder, 48 mg, 55% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 10.97 (s, 1H), 7.94 (d, <i>J</i> = 8.4 Hz, 1H), 7.78–7.68 (m, 2H), 7.66–7.57 (m, 2H), 7.53–7.45 (m, 2H), 7.16–7.03 (m, 3H), 6.64–6.54 (m, 2H), 4.90 (dd, <i>J</i> = 12.3, 2.4 Hz, 3H), 3.63 (dt, <i>J</i> = 6.9, 2.3 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 193.77, 192.74, 162.34, 161.05, 160.03, 153.87, 141.90, 133.53, 132.80, 132.75, 132.34, 131.70, 131.54, 131.00, 130.74, 124.58, 119.97, 115.09, 114.75, 112.94, 79.35, 79.22, 79.18, 79.07, 56.16, 56.04, 40.58, 40.37, 40.22, 40.16, 39.95, 39.74, 39.54, 39.33; ESI-MS (<i>m</i>/<i>z</i>): 322.0 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_116" class="NLM_sec NLM_sec_level_4"><div id="ac_i173" class="anchor-spacer"></div><h5 class="article-section__title" id="_i173"> Step 3</h5><div class="NLM_p last">The acid from <a class="ref internalNav" href="#sec5_1_115_2" aria-label="Step 2">Step 2</a> (26 mg, 0.08 mmol) was combined with HATU (37 mg, 0.1 mmol) and tyramine (12 mg, 0.09 mmol) and dissolved in DMF (300 μL) and triethylamine (33 μL, 0.24 mmol). The resulting mixture was stirred for 16 h at room temperature and diluted with water, and the resulting precipitate was filtered, triturated with ether/methanol, and purified by flash chromatography over silica gel to give <i>N</i>-acyl urea <b>123</b>, 3.2 mg, 9% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.96 (s, 1H), 9.19 (s, 1H), 9.05 (t, <i>J</i> = 6.0 Hz, 1H), 8.03–7.98 (m, 2H), 7.78–7.70 (m, 2H), 7.16–7.11 (m, 2H), 7.04–6.99 (m, 2H), 6.70–6.66 (m, 2H), 4.93 (d, <i>J</i> = 2.2 Hz, 2H), 3.66 (t, <i>J</i> = 2.2 Hz, 1H), 3.42–3.35 (m, 2H), 2.72 (t, <i>J</i> = 7.5 Hz, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.06, 159.94, 159.49, 156.14, 141.70, 133.63, 132.35, 130.94, 130.72, 129.92, 129.49, 120.17, 115.59, 115.10, 103.70, 79.22, 79.18, 56.16, 41.42, 40.57, 40.36, 40.15, 39.94, 39.73, 39.53, 39.32, 34.23. ESI-MS (<i>m</i>/<i>z</i>): 441.1 [M – H]<sup>−</sup>.</div></div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i174" class="anchor-spacer"></div><h3 class="article-section__title" id="_i174"> Cell Culture and Toxicity Testing</h3><div class="NLM_p last">All NSCLC cell lines were obtained from the Minna and Gazdar laboratories at UT Southwestern Medical Center. They were screened for mycoplasma by PCR and authenticated by short-tandem-repeat (STR) analysis through the McDermott Core at UT Southwestern. All NSCLC cell lines were cultured in RPMI 1640 (Sigma) supplemented with 5% FBS (Sigma) and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma). For the dose–response analyses, cells were plated in 96-well plates at 15% confluence in 100 μL of the above medium and allowed to adhere overnight. On the next day, this medium was removed, and new medium containing 1 of 10 concentrations of the compound was added, starting from 50 μM and decreasing in 3-fold serial dilutions in DMSO. The final concentration of DMSO in each well was 0.5%. Each dose of compound was tested in duplicate, and the values displayed represent the averages of these duplicates.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i175" class="anchor-spacer"></div><h3 class="article-section__title" id="_i175"> In Vitro SCD Assay</h3><div class="NLM_p last">Mouse liver were collected from female CD1 mice sacrificed by inhalation overdoses of CO<sub>2</sub> followed by cervical dislocation. Livers were diced and incubated on ice for 30 min in a buffer containing 50 mM HEPES (pH 8.0), 2 mM MgCl<sub>2</sub>, and 10 mM KCl supplemented with the SIGMAFAST protease-inhibitor cocktail (Sigma). The liver was then homogenized with 10 strokes in a dounce homogenizer. The resulting homogenate was centrifuged at 12 000<i>g</i> to remove the heavy membrane fraction, and the supernatant was used for reactions. Either DMSO or a compound was added to a 100 μL reaction containing 250 μg of protein, 2 mM NADPH (Sigma, from a 100 mM stock solution solubilized in 10 mM NaOH), and 50 nM Stearoyl [9,10-3H] CoA (American Radiolabeled Chemical, from a 2 μM stock solution in a 1:1 EtOH/0.1 M sodium acetate solution). Reactions were incubated for 2 h at 37 °C and then transferred to a 40% charcoal solution in water (JT Baker) and incubated for another 20 min. The charcoal–reaction mixture was filtered through a Spin-X-Centrifuge filter (#8160), and the filtrate was transferred to scintillation vials containing 10 mL of scintillation fluid (RPI). Counts per minute were measured by a Beckman LS 6000IC scintillation counter.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i176" class="anchor-spacer"></div><h3 class="article-section__title" id="_i176"> Cellular and S9-Stability Assay</h3><div class="NLM_p last">Methylated-prodrug and demethylated-drug compound levels for metabolic stability and cell-accumulation studies were monitored by LC-MS/MS using an AB Sciex 4000 Qtrap mass spectrometer coupled to a Shimadzu Prominence LC. Analytes were detected with the mass spectrometer in positive multiple-reaction-monitoring (MRM) mode by following the precursor to the fragment-ion transitions indicated here: <b>58</b>: 263.152/135.163, <b>114</b>: 249.162/121.000, <b>80</b>: 317.03/125.9, <b>115</b>: 303.001/125.970, <b>48</b>: 307.147/135.098, <b>119</b>: 293.130/121.109, <b>160</b>: 405.162/228.123, <b>122</b>: 391.140/228.121, <b>15</b>: 457.099/135.046, and <b>123</b>: 443.169/146.040. An Agilent C18 XDB column (5 μm, 50 × 4.6 mm) was used for chromatography for all compounds with the following conditions: Buffer A was dH<sub>2</sub>0 with 0.1% formic acid, and Buffer B was methanol with 0.1% formic acid. The gradient was 0–1.0 min, 3% B; 1.0–1.5 min, gradient to 100% B; 1.5–3.0 min, 100% B; 3.0–3.1 min, gradient to 3% B; and 3.1–4.0 min, 3% B. Tolbutamide (Sigma) was used as an internal standard (IS, transition of 269.1/169.9 for negative mode and 271.2/91.2 for positive mode). Ammonium acetate was added at 2–5 mM as necessary to buffers to prevent the formation of sodium adducts. Cell culture and S9 studies were conducted as described in ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>. Methylated prodrug was incubated with H1155 cells expressing Cyp4F11 or the vector only at a concentration of 500 nM.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i177" class="anchor-spacer"></div><h3 class="article-section__title" id="_i177"> Compound Accumulation in H1155 Cells</h3><div class="NLM_p">H1155 cells were seeded in 6 cm dishes at 500 000 cells per well. After 18 h, the media was replaced with fresh media, and cells were treated with a 500 nM concentration of a compound. After 4 h of incubation with a compound, cells were washed three times with ice-cold PBS, harvested using trypsin, and counted on ice. Each sample was then centrifuged, resuspended at a million cells per milliliter, and snap frozen. All samples were stored at −80 °C until analyses were performed.</div><div class="NLM_p last">Treated or untreated cell lysate (250 μL) was aliquoted into Eppendorf tubes. Blank lysates were spiked with varying concentrations of each compound to create a standard curve. Each sample was mixed with 0.5 mL of methanol, vortexed for 15 s, incubated for 10 min at RT, and then centrifuged twice at 16 100<i>g</i>. The supernatant was dried, resuspended in 175 μL of a 1:1 mixture of dH<sub>2</sub>0/methanol containing 0.1% formic acid and 100 ng/mL tolbutamide, and analyzed by LC-MS/MS as described above. The length and width of trypsinized H1155 cells was measured by light microscopy, and an estimate of the intracellular volume was calculated as <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_m001.gif" alt="" id="_i178" /></img></span>. The total compound in lysate was then divided by the total intracellular volume represented by the cells in that lysate to estimate the final intracellular compound concentration.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i179"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00052" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00052" class="ext-link">10.1021/acs.jmedchem.8b00052</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra for synthetic compounds, 95% confidence intervals for EC<sub>50</sub> values, and time-course studies for conversion from drug to prodrug forms (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Molecular-formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_001.csv">jm8b00052_si_001.csv (10.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_002.pdf">jm8b00052_si_002.pdf (10.88 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00052" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepak Nijhawan</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, 
    Department of Internal Medicine, 
    , , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cda9a8a8bdaca6e3a3a4a7a5acbaaca38db8b9bea2b8b9a5baa8beb9a8bfa3e3a8a9b8"><span class="__cf_email__" data-cfemail="5f3b3a3a2f3e3471313635373e283e311f2a2b2c302a2b37283a2c2b3a2d31713a3b2a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph M. Ready</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1305-9581" title="Orcid link">http://orcid.org/0000-0003-1305-9581</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#cda7a2bea8bda5e3bfa8aca9b48db8b9bea2b8b9a5baa8beb9a8bfa3e3a8a9b8"><span class="__cf_email__" data-cfemail="c9a3a6baacb9a1e7bbaca8adb089bcbdbaa6bcbda1beacbabdacbba7e7acadbc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah
E. Winterton</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuela Capota</span> - <span class="hlFld-Affiliation affiliation">Department of Internal Medicine, , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoyu Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Chen</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prema L. Mallipeddi</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noelle S. Williams</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce A. Posner</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, , UT Southwestern
Medical Center, 5323
Harry Hines Blvd., Dallas, Texas 75390-9038, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i180">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Funding was provided by CPRIT (RP110708-P3), NIH (R01 CA216863, R01 CA217333), and the Welch Foundation (I-1612). This research was also supported by a Harold C. Simmons Cancer Center Startup Award, a Disease Oriented Clinical Scholar (DOCS) award, a Damon Runyon Clinical Investigator award (CI-68-13), and a grant from the Welch Foundation (I-1879) to D.N. Pano Theodoropoulos is acknowledged for helpful discussions, and Meghan Campbell and Vo Lam are acknowledged for synthetic work.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Ac</td><td class="NLM_def"><p class="first last">acetate;</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">adsorption, distribution, metabolism, excretion</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">Dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide HCl</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole hydrate</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PCC</td><td class="NLM_def"><p class="first last">pyridinium chlorochromate</p></td></tr><tr><td class="NLM_term">SCD</td><td class="NLM_def"><p class="first last">stearoyl-CoA desaturase</p></td></tr><tr><td class="NLM_term">SDS-PAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate–polyacrylamide-gel electrophoresis</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">UFA</td><td class="NLM_def"><p class="first last">unsaturated fatty acid</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i182">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">Hypoxia, lipids, and cancer: Surviving the harsh tumor microenvironment</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2014.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.tcb.2014.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=24985940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWis7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=472-478&author=D.+Ackermanauthor=M.+C.+Simon&title=Hypoxia%2C+lipids%2C+and+cancer%3A+Surviving+the+harsh+tumor+microenvironment&doi=10.1016%2Fj.tcb.2014.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment</span></div><div class="casAuthors">Ackerman, Daniel; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">472-478</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Solid tumors typically develop hostile microenvironments characterized by irregular vascularization and poor oxygen (O2) and nutrient supply.  Whereas normal cells modulate anabolic and catabolic pathways in response to changes in nutrient availability, cancer cells exhibit unregulated growth even under nutrient scarcity.  Recent studies have demonstrated that constitutive activation of growth-promoting pathways results in dependence on unsatd. fatty acids for survival under O2 deprivation.  In cancer cells, this dependence represents a crit. metabolic vulnerability that could be exploited therapeutically.  Here we review how this dependence on unsatd. lipids is affected by the microenvironmental conditions faced by cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFWrZ3BgqjUrVg90H21EOLACvtfcHk0liP2ws50IEQBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWis7bO&md5=af539e0fc502e760a99b3417c2919a6d</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2014.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2014.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DAckerman%26aufirst%3DD.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DHypoxia%252C%2520lipids%252C%2520and%2520cancer%253A%2520Surviving%2520the%2520harsh%2520tumor%2520microenvironment%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2014%26volume%3D24%26spage%3D472%26epage%3D478%26doi%3D10.1016%2Fj.tcb.2014.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Listenberger, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cases, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farese, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ory, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, J. E.</span></span> <span> </span><span class="NLM_article-title">Triglyceride accumulation protects against fatty acid-induced lipotoxicity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">3077</span>– <span class="NLM_lpage">3082</span>, <span class="refDoi"> DOI: 10.1073/pnas.0630588100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1073%2Fpnas.0630588100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=12629214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVCnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=3077-3082&author=L.+L.+Listenbergerauthor=X.+Hanauthor=S.+E.+Lewisauthor=S.+Casesauthor=R.+V.+Fareseauthor=D.+S.+Oryauthor=J.+E.+Schaffer&title=Triglyceride+accumulation+protects+against+fatty+acid-induced+lipotoxicity&doi=10.1073%2Fpnas.0630588100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Triglyceride accumulation protects against fatty acid-induced lipotoxicity</span></div><div class="casAuthors">Listenberger, Laura L.; Han, Xianlin; Lewis, Sarah E.; Cases, Sylvaine; Farese, Robert V., Jr.; Ory, Daniel S.; Schaffer, Jean E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3077-3082</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Excess lipid accumulation in non-adipose tissues is assocd. with insulin resistance, pancreatic β-cell apoptosis and heart failure.  Here, we demonstrate in cultured cells that the relative toxicity of two common dietary long chain fatty acids is related to channeling of these lipids to distinct cellular metabolic fates.  Oleic acid supplementation leads to triglyceride accumulation and is well tolerated, whereas excess palmitic acid is poorly incorporated into triglyceride and causes apoptosis.  Unsatd. fatty acids rescue palmitate-induced apoptosis by channeling palmitate into triglyceride pools and away from pathways leading to apoptosis.  Moreover, in the setting of impaired triglyceride synthesis, oleate induces lipotoxicity.  Our findings support a model of cellular lipid metab. in which unsatd. fatty acids serve a protective function against lipotoxicity though promotion of triglyceride accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpVjeAQxiRBbVg90H21EOLACvtfcHk0lj6yJ5T5PeG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVCnsLs%253D&md5=eb9429653cd3fee65308c5811ccb617e</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0630588100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0630588100%26sid%3Dliteratum%253Aachs%26aulast%3DListenberger%26aufirst%3DL.%2BL.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DLewis%26aufirst%3DS.%2BE.%26aulast%3DCases%26aufirst%3DS.%26aulast%3DFarese%26aufirst%3DR.%2BV.%26aulast%3DOry%26aufirst%3DD.%2BS.%26aulast%3DSchaffer%26aufirst%3DJ.%2BE.%26atitle%3DTriglyceride%2520accumulation%2520protects%2520against%2520fatty%2520acid-induced%2520lipotoxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D3077%26epage%3D3082%26doi%3D10.1073%2Fpnas.0630588100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paton, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntambi, J. M.</span></span> <span> </span><span class="NLM_article-title">Biochemical and physiological function of stearoyl-coA desaturase</span>. <i>Am. J. Physiol. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">E28</span>– <span class="NLM_lpage">E37</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.90897.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1152%2Fajpendo.90897.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=19066317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVKjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=E28-E37&author=C.+M.+Patonauthor=J.+M.+Ntambi&title=Biochemical+and+physiological+function+of+stearoyl-coA+desaturase&doi=10.1152%2Fajpendo.90897.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and physiological function of stearoyl-CoA desaturase</span></div><div class="casAuthors">Paton, Chad M.; Ntambi, James M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1, Pt. 1</span>),
    <span class="NLM_cas:pages">E28-E37</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  A key and highly regulated enzyme that is required for the biosynthesis of monounsatd. fatty acids is stearoyl-CoA desaturase (SCD), which catalyzes the Δ9-cis desatn. of a range of fatty acyl-CoA substrates.  The preferred substrates are palmitoyl- and stearoyl-CoA, which are converted into palmitoleoyl- and oleoyl-CoA resp.  Oleate is the most abundant monounsatd. fatty acid in dietary fat and is therefore readily available.  Studies of mice that have a naturally occurring mutation in the SCD-1 gene isoform as well as a mouse model with a targeted disruption of the SCD gene (SCD-1-/-) have revealed the role of de novo synthesized oleate and thus the physiol. importance of SCD-1 expression.  SCD-1 deficiency results in reduced body adiposity, increased insulin sensitivity, and resistance to diet-induced obesity.  The expression of several genes of lipid oxidn. are up-regulated, whereas lipid synthesis genes are down-regulated.  SCD-1 was also found to be a component of the novel metabolic response to the hormone, leptin.  Therefore, SCD-1 appears to be an important metabolic control point, and inhibition of its expression could be of benefit for the treatment of obesity, diabetes, and other metabolic diseases.  Here, the authors summarize the recent and timely advances concerning the important role of SCD in the biochem. and physiol. of lipid metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBLqSZKQsyjrVg90H21EOLACvtfcHk0lj6yJ5T5PeG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVKjtro%253D&md5=a717a295113e91c3aa17fd628b67b53a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.90897.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.90897.2008%26sid%3Dliteratum%253Aachs%26aulast%3DPaton%26aufirst%3DC.%2BM.%26aulast%3DNtambi%26aufirst%3DJ.%2BM.%26atitle%3DBiochemical%2520and%2520physiological%2520function%2520of%2520stearoyl-coA%2520desaturase%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D297%26spage%3DE28%26epage%3DE37%26doi%3D10.1152%2Fajpendo.90897.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parimoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prouty, S. M.</span></span> <span> </span><span class="NLM_article-title">Human stearoyl-CoA desaturase: Alternative transcripts generated from a single gene by usage of tandem polyadenylation sites</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1042/bj3400255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1042%2Fbj3400255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10229681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADyaK1MXjs12ks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1999&pages=255-264&author=L.+Zhangauthor=L.+Geauthor=S.+Parimooauthor=K.+Stennauthor=S.+M.+Prouty&title=Human+stearoyl-CoA+desaturase%3A+Alternative+transcripts+generated+from+a+single+gene+by+usage+of+tandem+polyadenylation+sites&doi=10.1042%2Fbj3400255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites</span></div><div class="casAuthors">Zhang, Lin; Ge, Lan; Parimoo, Satish; Stenn, Kurt; Prouty, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">255-264</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A crit. step in the synthesis of unsatd. fatty acids is catalyzed by stearoyl-CoA desaturase (Scd).  To det. the regulation of human Scd, we characterized the gene and its transcripts.  Screening a human keratinocyte cDNA library and anal. of 3'-RACE (rapid amplification of cDNA ends) products from various tissues yielded a 5.2 kb cDNA encoding a 359 amino acid protein with a calcd. mol. mass of 41.5 kDa.  Anal. of 3'-RACE products suggested that alternative usage of polyadenylation sites generates two transcripts of 3.9 and 5.2 kb, a result consistent with Northern anal.  Southern anal. demonstrated the existence of two SCD loci in the human genome.  Chromosomal mapping localized one locus to chromosome 10, and the second locus to chromosome 17.  Characterization of genomic clones isolated from chromosome-specific libraries revealed that only the locus on chromosome 10 contained introns.  Sequence anal. of the intron-less locus displayed multiple nucleotide insertions and deletions, as well as in-frame stop codons.  Reverse transcriptase-PCR anal. performed with primers specific to the intron-less locus failed to produce a PCR product from brain, liver and skin RNA, indicating that the locus on chromosome 17 is most likely a transcriptionally inactive, fully processed pseudogene.  These results suggest strongly that there is one structural SCD gene in the human genome, and that it generates two transcripts by use of alternative polyadenylation sites.  Although the primary sequence and intron-exon structure of SCD is phylogenetically conserved, divergence between rodent and human is seen in the no. of SCD genes and in the generation of alternative transcripts, suggesting a species-specific component of SCD regulation and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzP4Q_IyqhYbVg90H21EOLACvtfcHk0lj-Vk1zdlmWBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs12ks7g%253D&md5=938b723707d751e84c544e60f3e4f08a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2Fbj3400255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3400255%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DParimoo%26aufirst%3DS.%26aulast%3DStenn%26aufirst%3DK.%26aulast%3DProuty%26aufirst%3DS.%2BM.%26atitle%3DHuman%2520stearoyl-CoA%2520desaturase%253A%2520Alternative%2520transcripts%2520generated%2520from%2520a%2520single%2520gene%2520by%2520usage%2520of%2520tandem%2520polyadenylation%2520sites%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D340%26spage%3D255%26epage%3D264%26doi%3D10.1042%2Fbj3400255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schug, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dankworth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smethurst, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer-Dene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGarry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanks, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboagye, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchlow, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakelam, M. J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments</span>. <i>Cancer Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1186/s40170-016-0146-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1186%2Fs40170-016-0146-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=1-18&author=B.+Peckauthor=Z.+T.+Schugauthor=Q.+Zhangauthor=B.+Dankworthauthor=D.+T.+Jonesauthor=E.+Smethurstauthor=R.+Patelauthor=S.+Masonauthor=M.+Jiangauthor=R.+Saundersauthor=M.+Howellauthor=R.+Mitterauthor=B.+Spencer-Deneauthor=G.+Stampauthor=L.+McGarryauthor=D.+Jamesauthor=E.+Shanksauthor=E.+O.+Aboagyeauthor=S.+E.+Critchlowauthor=H.+Y.+Leungauthor=A.+L.+Harrisauthor=M.+J.+O.+Wakelamauthor=E.+Gottliebauthor=A.+Schulze&title=Inhibition+of+fatty+acid+desaturation+is+detrimental+to+cancer+cell+survival+in+metabolically+compromised+environments&doi=10.1186%2Fs40170-016-0146-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2Fs40170-016-0146-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40170-016-0146-8%26sid%3Dliteratum%253Aachs%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DSchug%26aufirst%3DZ.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DDankworth%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DD.%2BT.%26aulast%3DSmethurst%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DMason%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DSaunders%26aufirst%3DR.%26aulast%3DHowell%26aufirst%3DM.%26aulast%3DMitter%26aufirst%3DR.%26aulast%3DSpencer-Dene%26aufirst%3DB.%26aulast%3DStamp%26aufirst%3DG.%26aulast%3DMcGarry%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DShanks%26aufirst%3DE.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DLeung%26aufirst%3DH.%2BY.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DWakelam%26aufirst%3DM.%2BJ.%2BO.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DSchulze%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520fatty%2520acid%2520desaturation%2520is%2520detrimental%2520to%2520cancer%2520cell%2520survival%2520in%2520metabolically%2520compromised%2520environments%26jtitle%3DCancer%2520Metab.%26date%3D2016%26volume%3D4%26spage%3D1%26epage%3D18%26doi%3D10.1186%2Fs40170-016-0146-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Navas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollipara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedrosa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugarolas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span> <span> </span><span class="NLM_article-title">Unsaturated fatty acids stimulate tumor growth through stabilization of β-catenin</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.celrep.2015.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=26456834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=495-503&author=H.+Kimauthor=C.+Rodriguez-Navasauthor=R.+K.+Kolliparaauthor=P.+Kapurauthor=I.+Pedrosaauthor=J.+Brugarolasauthor=R.+Kittlerauthor=J.+Ye&title=Unsaturated+fatty+acids+stimulate+tumor+growth+through+stabilization+of+%CE%B2-catenin&doi=10.1016%2Fj.celrep.2015.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Unsaturated Fatty Acids Stimulate Tumor Growth through Stabilization of β-Catenin</span></div><div class="casAuthors">Kim, Hyeonwoo; Rodriguez-Navas, Carlos; Kollipara, Rahul K.; Kapur, Payal; Pedrosa, Ivan; Brugarolas, James; Kittler, Ralf; Ye, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-503</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Some cancer cells exhibit elevated levels of free fatty acids (FAs) as well as high levels of β-catenin, a transcriptional co-activator that promotes their growth.  Here, we link these two phenomena by showing that unsatd. FAs inhibit degrdn. of β-catenin.  Unsatd. FAs bind to the UAS domain of Fas-assocd. factor 1 (FAF1), a protein known to bind β-catenin, accelerating its degrdn.  FA binding disrupts the FAF1/β-catenin complex, preventing proteasomal degrdn. of ubiquitinated β-catenin.  This mechanism for stabilization of β-catenin differs from that of Wnt signaling, which blocks ubiquitination of β-catenin.  In clear cell renal cell carcinoma (ccRCC) cells, unsatd. FAs stimulated cell proliferation through stabilization of β-catenin.  In tissues from biopsies of human ccRCC, elevated levels of unsatd. FAs correlated with increased levels of β-catenin.  Thus, targeting FAF1 may be an effective approach to treat cancers that exhibit elevated FAs and β-catenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkdpftiPLvWrVg90H21EOLACvtfcHk0lj-Vk1zdlmWBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjE&md5=011813811573e946f25a65ab65373020</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DRodriguez-Navas%26aufirst%3DC.%26aulast%3DKollipara%26aufirst%3DR.%2BK.%26aulast%3DKapur%26aufirst%3DP.%26aulast%3DPedrosa%26aufirst%3DI.%26aulast%3DBrugarolas%26aufirst%3DJ.%26aulast%3DKittler%26aufirst%3DR.%26aulast%3DYe%26aufirst%3DJ.%26atitle%3DUnsaturated%2520fatty%2520acids%2520stimulate%2520tumor%2520growth%2520through%2520stabilization%2520of%2520%25CE%25B2-catenin%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D13%26spage%3D495%26epage%3D503%26doi%3D10.1016%2Fj.celrep.2015.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dales, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M. D.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5039</span>– <span class="NLM_lpage">5056</span>, <span class="refDoi"> DOI: 10.1021/jm401516c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401516c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5039-5056&author=Z.+Zhangauthor=N.+A.+Dalesauthor=M.+D.+Winther&title=Opportunities+and+challenges+in+developing+stearoyl-coenzyme+A+desaturase-1+inhibitors+as+novel+therapeutics+for+human+disease&doi=10.1021%2Fjm401516c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease</span></div><div class="casAuthors">Zhang, Zaihui; Dales, Natalie A.; Winther, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5039-5056</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review provides an overview of stearoyl-CoA desaturase-1 (SCD1) as a novel therapeutic target for metabolic disorders and other indications.  Target validation is reviewed, and limitations due to incomplete knowledge of the relevant biol. systems are described.  Assay development, particularly for high throughput screening, and characterization of SCD1 inhibition are summarized.  The progress and evolution in medicinal chem. are discussed, specifically focusing on key attributes of the most advanced SCD1 inhibitors described in the primary literature and in patent applications.  This work culminated in numerous companies identifying potent selective inhibitors, some of which progressed to early clin. development.  The status of current SCD1 drug discovery programs is reviewed.  Challenges are discussed, and potential new directions are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkpUEA9vY2yLVg90H21EOLACvtfcHk0lgwzXDrwd9Z-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrbM&md5=8c32a3269be75d9f758b8bf4dde30f74</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm401516c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401516c%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DDales%26aufirst%3DN.%2BA.%26aulast%3DWinther%26aufirst%3DM.%2BD.%26atitle%3DOpportunities%2520and%2520challenges%2520in%2520developing%2520stearoyl-coenzyme%2520A%2520desaturase-1%2520inhibitors%2520as%2520novel%2520therapeutics%2520for%2520human%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5039%26epage%3D5056%26doi%3D10.1021%2Fjm401516c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serby, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepankiewicz, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, L. T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhar, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janis, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surowy, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of piperidine-aryl urea-based stearoyl-coa desaturase 1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4298</span>– <span class="NLM_lpage">4302</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.06.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.bmcl.2008.06.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=18632269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVeqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4298-4302&author=Z.+Xinauthor=H.+Zhaoauthor=M.+D.+Serbyauthor=B.+Liuauthor=M.+Liuauthor=B.+G.+Szczepankiewiczauthor=L.+T.+J.+Nelsonauthor=H.+T.+Smithauthor=T.+S.+Suharauthor=R.+S.+Janisauthor=N.+Caoauthor=H.+S.+Campauthor=C.+A.+Collinsauthor=H.+L.+Shamauthor=T.+K.+Surowyauthor=G.+Liu&title=Discovery+of+piperidine-aryl+urea-based+stearoyl-coa+desaturase+1+inhibitors&doi=10.1016%2Fj.bmcl.2008.06.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors</span></div><div class="casAuthors">Xin, Zhili; Zhao, Hongyu; Serby, Michael D.; Liu, Bo; Liu, Mei; Szczepankiewicz, Bruce G.; Nelson, Lissa T. J.; Smith, Harriet T.; Suhar, Tom S.; Janis, Rich S.; Cao, Ning; Camp, Heidi S.; Collins, Christine A.; Sham, Hing L.; Surowy, Teresa K.; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4298-4302</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of structurally novel stearoyl-Co-A desaturase 1 (SCD1) inhibitors has been identified via mol. scaffold manipulation.  Preliminary structure-activity relationship (SAR) studies led to the discovery of potent, and orally bioavailable piperidine-aryl urea-based SCD1 inhibitors.  4-(2-Chlorophenoxy)-N-[3-(Me carbamoyl)phenyl]piperidine-1-carboxamide (I) exhibited robust in vivo activity with dose-dependent desatn. index lowering effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4JuK5CeLSQrVg90H21EOLACvtfcHk0lgwzXDrwd9Z-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVeqtLk%253D&md5=0c64d7005bd418fd73563cc66ea515ba</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.088%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DSerby%26aufirst%3DM.%2BD.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSzczepankiewicz%26aufirst%3DB.%2BG.%26aulast%3DNelson%26aufirst%3DL.%2BT.%2BJ.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DSuhar%26aufirst%3DT.%2BS.%26aulast%3DJanis%26aufirst%3DR.%2BS.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DCamp%26aufirst%3DH.%2BS.%26aulast%3DCollins%26aufirst%3DC.%2BA.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSurowy%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520piperidine-aryl%2520urea-based%2520stearoyl-coa%2520desaturase%25201%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4298%26epage%3D4302%26doi%3D10.1016%2Fj.bmcl.2008.06.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roongta, U. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabalan, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryseck, R.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madireddi, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupnow, B. A.</span></span> <span> </span><span class="NLM_article-title">Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1551</span>– <span class="NLM_lpage">1561</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-11-0126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1158%2F1541-7786.MCR-11-0126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=21954435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOhtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1551-1561&author=U.+V.+Roongtaauthor=J.+G.+Pabalanauthor=X.+Wangauthor=R.-P.+Ryseckauthor=J.+Fargnoliauthor=B.+J.+Henleyauthor=W.-P.+Yangauthor=J.+Zhuauthor=M.+T.+Madireddiauthor=R.+M.+Lawrenceauthor=T.+W.+Wongauthor=B.+A.+Rupnow&title=Cancer+cell+dependence+on+unsaturated+fatty+acids+implicates+stearoyl-CoA+desaturase+as+a+target+for+cancer+therapy&doi=10.1158%2F1541-7786.MCR-11-0126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy</span></div><div class="casAuthors">Roongta, Urvashi V.; Pabalan, Jonathan G.; Wang, Xinyu; Ryseck, Rolf-Peter; Fargnoli, Joseph; Henley, Benjamin J.; Yang, Wen-Pin; Zhu, Jun; Madireddi, Malavi T.; Lawrence, R. Michael; Wong, Tai W.; Rupnow, Brent A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1551-1561</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Emerging literature suggests that metabolic pathways play an important role in the maintenance and progression of human cancers.  In particular, recent studies have implicated lipid biosynthesis and desatn. as a requirement for tumor cell survival.  In the studies reported here, we aimed to understand whether tumor cells require the activity of either human isoform of stearoyl-CoA-desaturase (SCD1 or SCD5) for survival.  Inhibition of SCD1 by siRNA or a small mol. antagonist results in strong induction of apoptosis and growth inhibition, when tumor cells are cultured in reduced (2%) serum conditions, but has little impact on cells cultured in 10% serum.  Depletion of SCD5 had minimal effects on cell growth or apoptosis.  Consistent with the obsd. dependence on SCD1, but not SCD5, levels of SCD1 protein increased in response to decreasing serum levels.  Both induction of SCD1 protein and sensitivity to growth inhibition by SCD1 inhibition could be reversed by supplementing growth media with unsatd. fatty acids, the product of the enzymic reaction catalyzed by SCD1.  Transcription profiling of cells treated with an SCD inhibitor revealed strong induction of markers of endoplasmic reticulum stress.  Underscoring its importance in cancer, SCD1 protein was found to be highly expressed in a large percentage of human cancer specimens.  SCD inhibition resulted in tumor growth delay in a human gastric cancer xenograft model.  Altogether, these results suggest that desatd. fatty acids are required for tumor cell survival and that SCD may represent a viable target for the development of novel agents for cancer therapy.  Mol Cancer Res; 9(11); 1551-61.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZd82MtZXeCLVg90H21EOLACvtfcHk0lgwzXDrwd9Z-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOhtb%252FF&md5=4fff414d184620da7188ea95c1670994</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-11-0126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-11-0126%26sid%3Dliteratum%253Aachs%26aulast%3DRoongta%26aufirst%3DU.%2BV.%26aulast%3DPabalan%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRyseck%26aufirst%3DR.-P.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DB.%2BJ.%26aulast%3DYang%26aufirst%3DW.-P.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMadireddi%26aufirst%3DM.%2BT.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DWong%26aufirst%3DT.%2BW.%26aulast%3DRupnow%26aufirst%3DB.%2BA.%26atitle%3DCancer%2520cell%2520dependence%2520on%2520unsaturated%2520fatty%2520acids%2520implicates%2520stearoyl-CoA%2520desaturase%2520as%2520a%2520target%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2011%26volume%3D9%26spage%3D1551%26epage%3D1561%26doi%3D10.1158%2F1541-7786.MCR-11-0126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Roemeling, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlow, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tun, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copland, J. A.</span></span> <span> </span><span class="NLM_article-title">Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2368</span>– <span class="NLM_lpage">2380</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1158%2F1078-0432.CCR-12-3249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=23633458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2368-2380&author=C.+A.+von%0ARoemelingauthor=L.+A.+Marlowauthor=J.+J.+Weiauthor=S.+J.+Cooperauthor=T.+R.+Caulfieldauthor=K.+Wuauthor=W.+W.+Tanauthor=H.+W.+Tunauthor=J.+A.+Copland&title=Stearoyl-CoA+desaturase+1+is+a+novel+molecular+therapeutic+target+for+clear+cell+renal+cell+carcinoma&doi=10.1158%2F1078-0432.CCR-12-3249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma</span></div><div class="casAuthors">von Roemeling, Christina A.; Marlow, Laura A.; Wei, Johnny J.; Cooper, Simon J.; Caulfield, Thomas R.; Wu, Kevin; Tan, Winston W.; Tun, Han W.; Copland, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2368-2380</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We set out to identify Stearoyl-CoA desaturase 1 (SCD1) as a novel mol. target in clear cell renal cell carcinoma (ccRCC) and examine its role in tumor cell growth and viability in vitro and in vivo independently as well as in combination with current U.S.  Food and Drug Administration (FDA)-approved regimens.  Exptl. Design: Patient normal and ccRCC tissue samples and cell lines were examd. for SCD1 expression.  Genetic knockdown models and targeted inhibition of SCD1 through use of a small mol. inhibitor, A939572, were analyzed for growth, apoptosis, and alterations in gene expression using gene array anal.  Therapeutic models of synergy were evaluated utilizing pharmacol. inhibition of SCD1 with the tyrosine kinase inhibitors (TKI) sunitinib and pazopanib, and the mTOR inhibitor temsirolimus.  Results: Our studies identify increased SCD1 expression in all stages of ccRCC.  Both genetic knockdown and pharmacol. inhibition of SCD1 decreased tumor cell proliferation and induced apoptosis in vitro and in vivo.  Upon gene array, quant. real-time PCR, and protein anal. of A939572-treated or SCD1 lentiviral knockdown samples, induction of endoplasmic reticulum stress response signaling was obsd., providing mechanistic insight for SCD1 activity in ccRCC.  Furthermore, combinatorial application of A939572 with temsirolimus synergistically inhibited tumor growth in vitro and in vivo.  Conclusions: Increased SCD1 expression supports ccRCC viability and therefore we propose it as a novel mol. target for therapy either independently or in combination with an mTOR inhibitor for patients whose disease cannot be remedied with surgical intervention, such as in cases of advanced or metastatic disease.  Clin Cancer Res; 19(9); 2368-80. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI19frRdyidrVg90H21EOLACvtfcHk0ljI3V6SxxYA9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrurg%253D&md5=557136bec3d76db58046752da651617e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3249%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BRoemeling%26aufirst%3DC.%2BA.%26aulast%3DMarlow%26aufirst%3DL.%2BA.%26aulast%3DWei%26aufirst%3DJ.%2BJ.%26aulast%3DCooper%26aufirst%3DS.%2BJ.%26aulast%3DCaulfield%26aufirst%3DT.%2BR.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DTan%26aufirst%3DW.%2BW.%26aulast%3DTun%26aufirst%3DH.%2BW.%26aulast%3DCopland%26aufirst%3DJ.%2BA.%26atitle%3DStearoyl-CoA%2520desaturase%25201%2520is%2520a%2520novel%2520molecular%2520therapeutic%2520target%2520for%2520clear%2520cell%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D2368%26epage%3D2380%26doi%3D10.1158%2F1078-0432.CCR-12-3249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serby, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kym, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhar, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janis, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauser, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cepa, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, D. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surowy, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, H. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3086</span>– <span class="NLM_lpage">3100</span>, <span class="refDoi"> DOI: 10.1021/jm070219p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070219p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVelsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3086-3100&author=G.+Liuauthor=J.+K.+Lynchauthor=J.+Freemanauthor=B.+Liuauthor=Z.+Xinauthor=H.+Zhaoauthor=M.+D.+Serbyauthor=P.+R.+Kymauthor=T.+S.+Suharauthor=H.+T.+Smithauthor=N.+Caoauthor=R.+Yangauthor=R.+S.+Janisauthor=J.+A.+Krauserauthor=S.+P.+Cepaauthor=D.+W.+A.+Benoauthor=H.+L.+Shamauthor=C.+A.+Collinsauthor=T.+K.+Surowyauthor=H.+S.+Camp&title=Discovery+of+potent%2C+selective%2C+orally+bioavailable+stearoyl-CoA+desaturase+1+inhibitors&doi=10.1021%2Fjm070219p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors</span></div><div class="casAuthors">Liu, Gang; Lynch, John K.; Freeman, Jennifer; Liu, Bo; Xin, Zhili; Zhao, Hongyu; Serby, Michael D.; Kym, Philip R.; Suhar, Tom S.; Smith, Harriet T.; Cao, Ning; Yang, Ruojing; Janis, Rich S.; Krauser, Joel A.; Cepa, Steven P.; Beno, David W. A.; Sham, Hing L.; Collins, Christine A.; Surowy, Teresa K.; Camp, Heidi S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3086-3100</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stearoyl-CoA desaturase 1 (SCD1) catalyzes the committed step in the biosynthesis of monounsatd. fatty acids from satd., long-chain fatty acids.  Studies with SCD1 knockout mice have established that these animals are lean and protected from leptin deficiency-induced and diet-induced obesity, with greater whole body insulin sensitivity than wild-type animals.  In this work, we have discovered a series of potent, selective, orally bioavailable SCD1 inhibitors based on a known pyridazine carboxamide template.  The representative lead inhibitor 28c also demonstrates excellent cellular activity in blocking the conversion of satd. long-chain fatty acid-CoAs (LCFA-CoAs) to monounsatd. LCFA-CoAs in HepG2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC81HS5TOS87Vg90H21EOLACvtfcHk0ljI3V6SxxYA9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVelsL8%253D&md5=12caa56ed9261e2de77ddfe9b7e2dddc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm070219p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070219p%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLynch%26aufirst%3DJ.%2BK.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DSerby%26aufirst%3DM.%2BD.%26aulast%3DKym%26aufirst%3DP.%2BR.%26aulast%3DSuhar%26aufirst%3DT.%2BS.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DJanis%26aufirst%3DR.%2BS.%26aulast%3DKrauser%26aufirst%3DJ.%2BA.%26aulast%3DCepa%26aufirst%3DS.%2BP.%26aulast%3DBeno%26aufirst%3DD.%2BW.%2BA.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DCollins%26aufirst%3DC.%2BA.%26aulast%3DSurowy%26aufirst%3DT.%2BK.%26aulast%3DCamp%26aufirst%3DH.%2BS.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520stearoyl-CoA%2520desaturase%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3086%26epage%3D3100%26doi%3D10.1021%2Fjm070219p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremgen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biemann, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komarnitsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jancsics, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumbholz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, K.</span></span> <span> </span><span class="NLM_article-title">SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e33823</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0033823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1371%2Fjournal.pone.0033823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=22457791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Churo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=P.+Masonauthor=B.+Liangauthor=L.+Liauthor=T.+Fremgenauthor=E.+Murphyauthor=A.+Quinnauthor=S.+L.+Maddenauthor=H.-P.+Biemannauthor=B.+Wangauthor=A.+Cohenauthor=S.+Komarnitskyauthor=K.+Jancsicsauthor=B.+Hirthauthor=C.+G.+F.+Cooperauthor=E.+Leeauthor=S.+Wilsonauthor=R.+Krumbholzauthor=S.+Schmidauthor=Y.+Xiangauthor=M.+Bookerauthor=J.+Lillieauthor=K.+Carter&title=SCD1+inhibition+causes+cancer+cell+death+by+depleting+mono-unsaturated+fatty+acids&doi=10.1371%2Fjournal.pone.0033823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids</span></div><div class="casAuthors">Mason, Paul; Liang, Beirong; Li, Lingyun; Fremgen, Trisha; Murphy, Erin; Quinn, Angela; Madden, Stephen L.; Biemann, Hans-Peter; Wang, Bing; Cohen, Aharon; Komarnitsky, Svetlana; Jancsics, Kate; Hirth, Brad; Cooper, Christopher G. F.; Lee, Edward; Wilson, Sean; Krumbholz, Roy; Schmid, Steven; Xiang, Yibin; Booker, Michael; Lillie, James; Carter, Kara</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e33823</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Increased metab. is a requirement for tumor cell proliferation.  To understand the dependence of tumor cells on fatty acid metab., we evaluated various nodes of the fatty acid synthesis pathway.  Using RNAi we have demonstrated that depletion of fatty-acid synthesis pathway enzymes SCD1, FASN, or ACC1 in HCT116 colon cancer cells results in cytotoxicity that is reversible by addn. of exogenous fatty acids.  This conditional phenotype is most pronounced when SCD1 is depleted.  We used this fatty-acid rescue strategy to characterize several small-mol. inhibitors of fatty acid synthesis, including identification of TOFA as a potent SCD1 inhibitor, representing a previously undescribed activity for this compd.  Ref. FASN and ACC inhibitors show cytotoxicity that is less pronounced than that of TOFA, and fatty-acid rescue profiles consistent with their proposed enzyme targets.  Two ref. SCD1 inhibitors show low-nanomolar cytotoxicity that is offset by at least 2 orders of magnitude by exogenous oleate.  One of these inhibitors slows growth of HCT116 xenograft tumors.  These data outline an effective strategy for interrogation of on-mechanism potency and pathway-node-specificity of fatty acid synthesis inhibitors, establish an unambiguous link between fatty acid synthesis and cancer cell survival, and point toward SCD1 as a key target in this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUv6I0T_UMcbVg90H21EOLACvtfcHk0lh3nPeURmyRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Churo%253D&md5=748deff029043c4201b201cc0a142623</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0033823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0033823%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DP.%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DFremgen%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DQuinn%26aufirst%3DA.%26aulast%3DMadden%26aufirst%3DS.%2BL.%26aulast%3DBiemann%26aufirst%3DH.-P.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DA.%26aulast%3DKomarnitsky%26aufirst%3DS.%26aulast%3DJancsics%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DB.%26aulast%3DCooper%26aufirst%3DC.%2BG.%2BF.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DKrumbholz%26aufirst%3DR.%26aulast%3DSchmid%26aufirst%3DS.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DBooker%26aufirst%3DM.%26aulast%3DLillie%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DK.%26atitle%3DSCD1%2520inhibition%2520causes%2520cancer%2520cell%2520death%2520by%2520depleting%2520mono-unsaturated%2520fatty%2520acids%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0033823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhill, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilevich, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glushkov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zilbershtein, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zautke, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunn, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chisholm, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2048</span>– <span class="NLM_lpage">2052</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.bmcl.2009.02.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=19249203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1arsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2048-2052&author=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=N.+I.+Vasilevichauthor=A.+I.+Glushkovauthor=T.+M.+Zilbershteinauthor=A.+V.+Ivanovauthor=A.+G.+Coleauthor=I.+Hendersonauthor=N.+A.+Zautkeauthor=S.+A.+Brunnauthor=N.+Mollovaauthor=K.+Leungauthor=J.+W.+Chisholmauthor=J.+Zablocki&title=Novel%2C+potent%2C+selective%2C+and+metabolically+stable+stearoyl-CoA+desaturase+%28SCD%29+inhibitors&doi=10.1016%2Fj.bmcl.2009.02.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors</span></div><div class="casAuthors">Koltun, Dmitry O.; Parkhill, Eric Q.; Vasilevich, Natalya I.; Glushkov, Andrei I.; Zilbershtein, Timur M.; Ivanov, Alexei V.; Cole, Andrew G.; Henderson, Ian; Zautke, Nathan A.; Brunn, Sandra A.; Mollova, Nevena; Leung, Kwan; Chisholm, Jeffrey W.; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2048-2052</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We identified a series of structurally novel SCD (Δ9 desaturase) inhibitors via high-throughput screening and follow-up SAR studies.  Modification of the central bicyclic scaffold has proven key to our potency optimization effort.  The most potent analog (8g) had IC50 value of 50 pM in a HEPG2 SCD assay and has been shown to be metabolically stable and selective against Δ5 and Δ6 desaturases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2IRcglbHz3LVg90H21EOLACvtfcHk0lh3nPeURmyRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1arsLc%253D&md5=c59e65fd61fd55c2d32bb1a6844ee696</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.019%26sid%3Dliteratum%253Aachs%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DVasilevich%26aufirst%3DN.%2BI.%26aulast%3DGlushkov%26aufirst%3DA.%2BI.%26aulast%3DZilbershtein%26aufirst%3DT.%2BM.%26aulast%3DIvanov%26aufirst%3DA.%2BV.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DZautke%26aufirst%3DN.%2BA.%26aulast%3DBrunn%26aufirst%3DS.%2BA.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DChisholm%26aufirst%3DJ.%2BW.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DNovel%252C%2520potent%252C%2520selective%252C%2520and%2520metabolically%2520stable%2520stearoyl-CoA%2520desaturase%2520%2528SCD%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2048%26epage%3D2052%26doi%3D10.1016%2Fj.bmcl.2009.02.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chisholm, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igal, R. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of stearoyl-CoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e11394</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0011394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1371%2Fjournal.pone.0011394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=20613975" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=D.+Hessauthor=J.+W.+Chisholmauthor=R.+A.+Igal&title=Inhibition+of+stearoyl-CoA+desaturase+activity+blocks+cell+cycle+progression+and+induces+programmed+cell+death+in+lung+cancer+cells&doi=10.1371%2Fjournal.pone.0011394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0011394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0011394%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DD.%26aulast%3DChisholm%26aufirst%3DJ.%2BW.%26aulast%3DIgal%26aufirst%3DR.%2BA.%26atitle%3DInhibition%2520of%2520stearoyl-CoA%2520desaturase%2520activity%2520blocks%2520cell%2520cycle%2520progression%2520and%2520induces%2520programmed%2520cell%2520death%2520in%2520lung%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0011394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokrovskaia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namdari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratkay, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mork, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dales, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of thiazolylpyridinone scd1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.bmcl.2013.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=24370012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVWh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=526-531&author=S.+Sunauthor=Z.+Zhangauthor=V.+Rainaauthor=N.+Pokrovskaiaauthor=D.+Houauthor=R.+Namdariauthor=K.+Khakhauthor=L.+G.+Ratkayauthor=D.+G.+McLarenauthor=M.+Morkauthor=J.+Fuauthor=S.+Ferreiraauthor=B.+Hubbardauthor=M.+D.+Wintherauthor=N.+Dales&title=Discovery+of+thiazolylpyridinone+scd1+inhibitors+with+preferential+liver+distribution+and+reduced+mechanism-based+adverse+effects&doi=10.1016%2Fj.bmcl.2013.12.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects</span></div><div class="casAuthors">Sun, Shaoyi; Zhang, Zaihui; Raina, Vandna; Pokrovskaia, Natalia; Hou, Duanjie; Namdari, Rostam; Khakh, Kuldip; Ratkay, Leslie G.; McLaren, David G.; Mork, Monica; Fu, Jianmin; Ferreira, Suzie; Hubbard, Brian; Winther, Michael D.; Dales, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">526-531</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We discovered a series of novel and potent thiazolylpyridinone-based SCD1 inhibitors based on a 2-aminothiazole HTS hit by replacing the amide bond with a pyridinone moiety.  Compd. 19 demonstrated good potency against SCD1 in vitro and in vivo.  The mouse liver microsomal SCD1 in vitro potency for 19 was improved by more than 240-fold compared to the original HTS hit.  Furthermore, 19 demonstrated a dose-dependent redn. of plasma desatn. index with an ED50 of 6.3 mg/kg.  Compd. 19 demonstrated high liver to plasma and liver to eyelid exposures, indicating preferential liver distribution.  The preliminary toxicol. study with compd. 19 did not demonstrate adverse effects related to SCD1 inhibition, suggesting a wide safety margin with respect to other known SCD1 inhibitors with wider distribution profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5UBgyvMHnfrVg90H21EOLACvtfcHk0lh3nPeURmyRKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVWh&md5=d8cd13963e5864a7a816c45d8138383a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRaina%26aufirst%3DV.%26aulast%3DPokrovskaia%26aufirst%3DN.%26aulast%3DHou%26aufirst%3DD.%26aulast%3DNamdari%26aufirst%3DR.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DRatkay%26aufirst%3DL.%2BG.%26aulast%3DMcLaren%26aufirst%3DD.%2BG.%26aulast%3DMork%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DFerreira%26aufirst%3DS.%26aulast%3DHubbard%26aufirst%3DB.%26aulast%3DWinther%26aufirst%3DM.%2BD.%26aulast%3DDales%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520thiazolylpyridinone%2520scd1%2520inhibitors%2520with%2520preferential%2520liver%2520distribution%2520and%2520reduced%2520mechanism-based%2520adverse%2520effects%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D526%26epage%3D531%26doi%3D10.1016%2Fj.bmcl.2013.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belair, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleasby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desroches, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamelin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normandin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pocai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramtohul, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skorey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sørensen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturkenboom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styhler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddleton, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5082</span>– <span class="NLM_lpage">5096</span>, <span class="refDoi"> DOI: 10.1021/jm200319u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200319u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFShsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5082-5096&author=R.+M.+Oballaauthor=L.+Belairauthor=W.+C.+Blackauthor=K.+Bleasbyauthor=C.+C.+Chanauthor=C.+Desrochesauthor=X.+Duauthor=R.+Gordonauthor=J.+Guayauthor=S.+Guiralauthor=M.+J.+Hafeyauthor=E.+Hamelinauthor=Z.+Huangauthor=B.+Kennedyauthor=N.+Lachanceauthor=F.+Landryauthor=C.+S.+Liauthor=J.+Manciniauthor=D.+Normandinauthor=A.+Pocaiauthor=D.+A.+Powellauthor=Y.+K.+Ramtohulauthor=K.+Skoreyauthor=D.+S%C3%B8rensenauthor=W.+Sturkenboomauthor=A.+Styhlerauthor=D.+M.+Waddletonauthor=H.+Wangauthor=S.+Wongauthor=L.+Xuauthor=L.+Zhang&title=Development+of+a+liver-targeted+stearoyl-CoA+desaturase+%28SCD%29+inhibitor+%28MK-8245%29+to+establish+a+therapeutic+window+for+the+treatment+of+diabetes+and+dyslipidemia&doi=10.1021%2Fjm200319u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia</span></div><div class="casAuthors">Oballa, Renata M.; Belair, Liette; Black, W. Cameron; Bleasby, Kelly; Chan, Chi Chung; Desroches, Carole; Du, Xiaobing; Gordon, Robert; Guay, Jocelyne; Guiral, Sebastien; Hafey, Michael J.; Hamelin, Emelie; Huang, Zheng; Kennedy, Brian; Lachance, Nicolas; Landry, France; Li, Chun Sing; Mancini, Joseph; Normandin, Denis; Pocai, Alessandro; Powell, David A.; Ramtohul, Yeeman K.; Skorey, Kathryn; Sorensen, Dan; Sturkenboom, Wayne; Styhler, Angela; Waddleton, Deena M.; Wang, Hao; Wong, Simon; Xu, Lijing; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5082-5096</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The potential use of SCD inhibitors for the chronic treatment of diabetes and dyslipidemia has been limited by preclin. adverse events assocd. with inhibition of SCD in skin and eye tissues.  To establish a therapeutic window, we embarked on designing liver-targeted SCD inhibitors by utilizing mol. recognition by liver-specific org. anion transporting polypeptides (OATPs).  In doing so, we set out to target the SCD inhibitor to the organ believed to be responsible for the therapeutic efficacy (liver) while minimizing its exposure in the tissues assocd. with mechanism-based SCD depletion of essential lubricating lipids (skin and eye).  These efforts led to the discovery of MK-8245 (7), a potent, liver-targeted SCD inhibitor with preclin. antidiabetic and antidyslipidemic efficacy with a significantly improved therapeutic window.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ3Zro2czsCLVg90H21EOLACvtfcHk0lj1B9VpM_hCew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFShsrc%253D&md5=0b2967e2097b127fb7994f0165c682a6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm200319u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200319u%26sid%3Dliteratum%253Aachs%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DBelair%26aufirst%3DL.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DBleasby%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DC.%2BC.%26aulast%3DDesroches%26aufirst%3DC.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DGuiral%26aufirst%3DS.%26aulast%3DHafey%26aufirst%3DM.%2BJ.%26aulast%3DHamelin%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DKennedy%26aufirst%3DB.%26aulast%3DLachance%26aufirst%3DN.%26aulast%3DLandry%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DNormandin%26aufirst%3DD.%26aulast%3DPocai%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DD.%2BA.%26aulast%3DRamtohul%26aufirst%3DY.%2BK.%26aulast%3DSkorey%26aufirst%3DK.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DD.%26aulast%3DSturkenboom%26aufirst%3DW.%26aulast%3DStyhler%26aufirst%3DA.%26aulast%3DWaddleton%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520a%2520liver-targeted%2520stearoyl-CoA%2520desaturase%2520%2528SCD%2529%2520inhibitor%2520%2528MK-8245%2529%2520to%2520establish%2520a%2520therapeutic%2520window%2520for%2520the%2520treatment%2520of%2520diabetes%2520and%2520dyslipidemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5082%26epage%3D5096%26doi%3D10.1021%2Fjm200319u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodumuru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sviridov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratkay, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gschwend, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamboj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1021/jm301661h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301661h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=568-583&author=Z.+Zhangauthor=S.+Sunauthor=V.+Kodumuruauthor=D.+Houauthor=S.+Liuauthor=N.+Chakkaauthor=S.+Sviridovauthor=S.+Chowdhuryauthor=D.+G.+McLarenauthor=L.+G.+Ratkayauthor=K.+Khakhauthor=X.+Chengauthor=H.+W.+Gschwendauthor=R.+Kambojauthor=J.+Fuauthor=M.+D.+Winther&title=Discovery+of+piperazin-1-ylpyridazine-based+potent+and+selective+stearoyl-CoA+desaturase-1+inhibitors+for+the+treatment+of+obesity+and+metabolic+syndrome&doi=10.1021%2Fjm301661h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Piperazin-1-ylpyridazine-Based Potent and Selective Stearoyl-CoA Desaturase-1 Inhibitors for the Treatment of Obesity and Metabolic Syndrome</span></div><div class="casAuthors">Zhang, Zaihui; Sun, Shaoyi; Kodumuru, Vishnumurthy; Hou, Duanjie; Liu, Shifeng; Chakka, Nagasree; Sviridov, Serguei; Chowdhury, Sultan; McLaren, David G.; Ratkay, Leslie G.; Khakh, Kuldip; Cheng, Xing; Gschwend, Heinz W.; Kamboj, Rajender; Fu, Jianmin; Winther, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">568-583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stearoyl-CoA desaturase-1 (SCD1) catalyzes de novo synthesis of monounsatd. fatty acids from satd. fatty acids.  Studies have demonstrated that rodents lacking a functional SCD1 gene have an improved metabolic profile, including reduced wt. gain, lower triglycerides, and improved insulin response.  In this study, we discovered a series of piperazinylpyridazine-based highly potent, selective, and orally bioavailable compds.  Particularly, compd. I (XEN103) was highly active in vitro (mSCD1 IC50 = 14 nM and HepG2 IC50 = 12 nM) and efficacious in vivo (ED50 = 0.8 mg/kg).  It also demonstrated striking redn. of wt. gain in a rodent model.  Our findings with small-mol. SCD1 inhibitors confirm the importance of this target in metabolic regulation, describe novel models for assessing SCD1 inhibitors for efficacy and tolerability and demonstrate an opportunity to develop a novel therapy for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz3sZgrA2_C7Vg90H21EOLACvtfcHk0lj1B9VpM_hCew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCqsL%252FO&md5=1a4119b8547864b1bab3b05e362f9d18</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301661h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301661h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DKodumuru%26aufirst%3DV.%26aulast%3DHou%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DSviridov%26aufirst%3DS.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DMcLaren%26aufirst%3DD.%2BG.%26aulast%3DRatkay%26aufirst%3DL.%2BG.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DGschwend%26aufirst%3DH.%2BW.%26aulast%3DKamboj%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DWinther%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520of%2520piperazin-1-ylpyridazine-based%2520potent%2520and%2520selective%2520stearoyl-CoA%2520desaturase-1%2520inhibitors%2520for%2520the%2520treatment%2520of%2520obesity%2520and%2520metabolic%2520syndrome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D568%26epage%3D583%26doi%3D10.1021%2Fjm301661h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntambi, J. M.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid</span>. <i>J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">2260</span>– <span class="NLM_lpage">2268</span>, <span class="refDoi"> DOI: 10.1093/jn/131.9.2260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1093%2Fjn%2F131.9.2260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=11533264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmslGmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2001&pages=2260-2268&author=M.+Miyazakiauthor=W.+C.+Manauthor=J.+M.+Ntambi&title=Targeted+disruption+of+stearoyl-CoA+desaturase1+gene+in+mice+causes+atrophy+of+sebaceous+and+meibomian+glands+and+depletion+of+wax+esters+in+the+eyelid&doi=10.1093%2Fjn%2F131.9.2260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid</span></div><div class="casAuthors">Miyazaki, Makoto; Man, Weng Chi; Ntambi, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutrition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2260-2268</span>CODEN:
                <span class="NLM_cas:coden">JONUAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-3166</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutritional Sciences</span>)
        </div><div class="casAbstract">Stearoyl-CoA desaturase (SCD) is a microsomal rate-limiting enzyme in the cellular synthesis of monounsatd. fatty acids (MUFA), mainly oleate (18:1) and palmitoleate (16:1), which are the major MUFA of membrane phospholipids, cholesterol esters and triglycerides.  Three well-characterized isoforms of SCD, SCD1, SCD2 and SCD3, exist in mice.  To investigate the physiol. functions of SCD1, we generated SCD1 null (SCD1-/-) mice.  The skin and eyelid of SCD1-/- mice are deficient in triglycerides and cholesterol esters, and the eyelid also is deficient in wax esters.  Furthermore, the eyelid and skin of SCD1-/- mice have higher levels of free cholesterol.  SCD1-/- mice develop cutaneous abnormalities and narrow eye fissure with atrophic sebaceous and meibomian glands.  Consumption of diets contg. high levels of oleate, failed to restore the levels of triglycerides, cholesterol esters and wax esters in SCD1-/- mice to the levels found in the eyelid of wild-type mice.  These results reveal a physiol. role of SCD in cholesterol homeostasis as well as in the de novo biosynthesis of cholesterol esters, triglycerides and wax esters required for normal skin and eyelid function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhUicg2unZLLVg90H21EOLACvtfcHk0lhKYXYLGXsFSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmslGmtrc%253D&md5=d33bfcce300df71019684f2c4a779d40</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1093%2Fjn%2F131.9.2260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjn%252F131.9.2260%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DMan%26aufirst%3DW.%2BC.%26aulast%3DNtambi%26aufirst%3DJ.%2BM.%26atitle%3DTargeted%2520disruption%2520of%2520stearoyl-CoA%2520desaturase1%2520gene%2520in%2520mice%2520causes%2520atrophy%2520of%2520sebaceous%2520and%2520meibomian%2520glands%2520and%2520depletion%2520of%2520wax%2520esters%2520in%2520the%2520eyelid%26jtitle%3DJ.%2520Nutr.%26date%3D2001%26volume%3D131%26spage%3D2260%26epage%3D2268%26doi%3D10.1093%2Fjn%2F131.9.2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meingassner, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aschauer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dales, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stütz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of stearoyl-CoA desaturase in the skin induces atrophy of the sebaceous glands</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">2091</span>– <span class="NLM_lpage">2094</span>, <span class="refDoi"> DOI: 10.1038/jid.2013.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1038%2Fjid.2013.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=23446987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltFClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=2091-2094&author=J.+G.+Meingassnerauthor=H.+Aschauerauthor=A.+P.+Winiskiauthor=N.+Dalesauthor=D.+Yoweauthor=M.+D.+Wintherauthor=Z.+Zhangauthor=A.+St%C3%BCtzauthor=A.+Billich&title=Pharmacological+inhibition+of+stearoyl-CoA+desaturase+in+the+skin+induces+atrophy+of+the+sebaceous+glands&doi=10.1038%2Fjid.2013.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Inhibition of Stearoyl CoA Desaturase in the Skin Induces Atrophy of the Sebaceous Glands</span></div><div class="casAuthors">Meingassner, Josef G.; Aschauer, Heinrich; Winiski, Anthony P.; Dales, Natalie; Yowe, David; Winther, Michael D.; Zhang, Zaihui; Stuetz, Anton; Billich, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2091-2094</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acne is a multifactorial disease of the pilosebaceous unit resulting from increased sebum prodn., altered keratinization, inflammation, and bacterial hypercolonization.  With respect to hyperseborrhea as one of the contributing factors, it is of interest to study pathways that regulate sebaceous gland differentiation.  Interestingly, mouse strains deficient in the enzyme stearoyl-CoA desaturase 1 (SCD1) exhibit severe hypoplasia of sebaceous glands (Zheng et al., 1999; Sundberg et al., 2000; Miyazaki et al., 2001; Georgel et al., 2005).  SCDs are microsomal enzymes that catalyze the biosynthesis of monounsatd. fatty acids from satd. acyl-CoAs (Ntambi and Miyazaki, 2003); specifically they introduce cis-double bonds in the Δ9 position, the preferred substrates being palmitoyl-CoA and stearoyl-CoA.  Here, we asked whether pharmacol. inhibition of SCD activity would have an impact on sebaceous glands.  From a series of novel SCD1 inhibitors (Zhang et al., 2013), compd. XEN103, (6-[4-(5-fluoro-2-trifluoromethylbenzoyl)-piperazin-1-yl]pyridazine-3-carboxylic acid (2-cyclopropylethyl)amide (Figure 1a), was chosen for further characterization.  XEN103 inhibited SCD1 activity in mouse liver microsomes with IC50=14 nM.  The compd. featured 700-fold selectivity for mouse SCD1 activity relative to the closely related Δ5- and Δ6-desaturases (FADS1 and FADS2), indicating low potential for blockade of essential fatty acid and sapienic acid biosynthesis, in which these enzymes are involved.  In human HepG2 cells, XEN103 blocked SCD1 activity with IC50=12 nM.  Furthermore, XEN103 treatment of human SZ95 sebocytes led to redn. of monounsatd. acyl chains in phosphatidylcholine with IC50=11 nM (Figure 1b); these cells express SCD1 (Harrison et al., 2007) but not SCD5 (our unpublished data), the only other known human Δ9-desaturase.  Expression of SCD1 in SZ95 cells is increased by treatment with testosterone and linoleic acid; this increase was shown previously to be blocked by XEN103 using a semiquant. method (Zouboulis et al., 2011).  Quant. reverse transcriptase-PCR showed half-maximal inhibition between 10 and 100 nM XEN103 (Figure 1c).  Thus, XEN103 not only acts as an enzyme inhibitor but also blocks androgen-induced transcription of the gene.  One may speculate that a product of SCD1 required for SCD1 transcription is involved in a pos. feedback loop.  We assessed the effect of XEN103 on mouse skin after topical application.  Mice were treated for 8 days on the shaved back with solns. contg. 0.1% or 1% XEN103 in propylene glycol/ethanol 7:3, to assess local tolerance and activity.  There were no signs of skin irritation at the test sites during the treatment period visible by macroscopic inspection or by histol. examn.  As assessed by histomorphometry, application of 1% XEN103 reduced the nos. of sebaceous glands by∼65% (P<0.001) and the size of the remaining glands by∼50% (P<0.01) (Figure 2a).  In a total of three independent studies, redn. of sebaceous gland nos. and size varied in the range of 50-75%.  Representative photographs of vehicle- and XEN103-treated skin samples stained with hematoxylin-eosin or with oil red O are shown in Figure 2b and c, resp.  While numerous normally sized and lipid-loaded sebaceous glands were seen at vehicle-treated sites, only very small atrophic sebaceous glands with hardly any assocd. lipid staining were visible at XEN103-treated sites.  Thus, the SCD1 inhibitor XEN103 clearly induces an atrophogenic effect on the sebaceous glands in mouse skin, which should consequently result in reduced sebum lipids.  When XEN103 was applied in soln. at a concn. of 0.1%, XEN103 induced little atrophogenic effect (Figure 2a); in a sep. study we detd. the minimal effective concn. to 0.5% (data not shown).  While a trend toward a decrease in sebaceous gland size was already obsd. after 2 days, the effect increased with time and was statistically significant after 6 days for both size and nos. (Figure 2d).  When treatment was stopped after 7 days, sebaceous gland nos. and size reverted to normal values within 2 wk (data not shown).  At skin areas distant from the XEN103-treated sites, there was no significant redn. in the no. of sebaceous glands (Figure 2a).  This indicates that efficacy is restricted to the topically treated area, excluding activity at distant sites due to percutaneous absorption.  This observation is in line with the obsd. low plasma exposure with XEN103, while at least 1000-fold higher concns. of XEN103 were found in the skin (Supplementary Table S1).  To det. whether topical application of XEN103 indeed blocked SCD activity in the skin, we detd. the ratio of palmitoleic and palmitic acid as a measure of Δ9-desaturase activity.  The desatn. of fatty acids in the triglycerides was reduced by about 50% when mice were treated with 1% XEN103 (Figure 2e).  In the 0.1% XEN103-treated group, redn. was by 20%.  This result correlates well with the sebaceous glands' atrophy end point and the skin exposure to XEN103.  To summarize, XEN103 is a potent inhibitor of SCD activity as shown in microsomal prepns., cultured cells, and in rodents in vivo.  The compd. is active on its target enzyme across species and, importantly, it also reduces both the activity and the androgen-induced expression of SCD1 in human sebocytes.  Using this tool compd., we show that pharmacol. inhibition of SCD in mouse skin rapidly induces pronounced sebaceous gland atrophy after topical application in a dose- and time-dependent manner.  The effect is due to the local action of the compd. on SCD activity in the skin and occurs in the presence of only minimal plasma exposure, thus excluding any potentially undesirable effects of systemic SCD inhibition.  In mice, there are three Δ9-desaturases apart from SCD1, namely SCD2-4, which potentially could be inhibited by XEN103; however, Scd2-deficient mice have normal sebaceous glands (Miyazaki et al., 2005), the Scd3 gene cannot compensate Scd1 deficiency in asebia mice (Zheng et al., 2001), and Scd4 expression is restricted to the heart (Miyazaki et al., 2003).  Thus, we consider that sebaceous gland atrophy in mouse skin is most likely due to inhibition of SCD1.  In human skin, SCD1 is present as the only Δ9-desaturase.  It will be interesting to learn from a clin. study whether an SCD1 inhibitor such as XEN103 also induces human sebaceous gland atrophy when applied in a topical formulation allowing for adequate exposure at the target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlYGhbZSkxQLVg90H21EOLACvtfcHk0lhKYXYLGXsFSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltFClsbo%253D&md5=ef8dfc6aab84cb89094eb90f7a67a229</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1038%2Fjid.2013.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjid.2013.89%26sid%3Dliteratum%253Aachs%26aulast%3DMeingassner%26aufirst%3DJ.%2BG.%26aulast%3DAschauer%26aufirst%3DH.%26aulast%3DWiniski%26aufirst%3DA.%2BP.%26aulast%3DDales%26aufirst%3DN.%26aulast%3DYowe%26aufirst%3DD.%26aulast%3DWinther%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSt%25C3%25BCtz%26aufirst%3DA.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DPharmacological%2520inhibition%2520of%2520stearoyl-CoA%2520desaturase%2520in%2520the%2520skin%2520induces%2520atrophy%2520of%2520the%2520sebaceous%2520glands%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2013%26volume%3D133%26spage%3D2091%26epage%3D2094%26doi%3D10.1038%2Fjid.2013.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrzyn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrzyn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntambi, J. M.</span></span> <span> </span><span class="NLM_article-title">Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1674</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1194/jlr.M400039-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1194%2Fjlr.M400039-JLR200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=1674-1682&author=S.-H.+Leeauthor=A.+Dobrzynauthor=P.+Dobrzynauthor=S.+M.+Rahmanauthor=M.+Miyazakiauthor=J.+M.+Ntambi&title=Lack+of+stearoyl-CoA+desaturase+1+upregulates+basal+thermogenesis+but+causes+hypothermia+in+a+cold+environment&doi=10.1194%2Fjlr.M400039-JLR200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M400039-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M400039-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-H.%26aulast%3DDobrzyn%26aufirst%3DA.%26aulast%3DDobrzyn%26aufirst%3DP.%26aulast%3DRahman%26aufirst%3DS.%2BM.%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DNtambi%26aufirst%3DJ.%2BM.%26atitle%3DLack%2520of%2520stearoyl-CoA%2520desaturase%25201%2520upregulates%2520basal%2520thermogenesis%2520but%2520causes%2520hypothermia%2520in%2520a%2520cold%2520environment%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2004%26volume%3D45%26spage%3D1674%26epage%3D1682%26doi%3D10.1194%2Fjlr.M400039-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flowers, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otzelberger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntambi, J. M.</span></span> <span> </span><span class="NLM_article-title">Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2007.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.cmet.2007.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=18054317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVektb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=484-496&author=M.+Miyazakiauthor=M.+T.+Flowersauthor=H.+Sampathauthor=K.+Chuauthor=C.+Otzelbergerauthor=X.+Liuauthor=J.+M.+Ntambi&title=Hepatic+stearoyl-CoA+desaturase-1+deficiency+protects+mice+from+carbohydrate-induced+adiposity+and+hepatic+steatosis&doi=10.1016%2Fj.cmet.2007.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis</span></div><div class="casAuthors">Miyazaki, Makoto; Flowers, Matthew T.; Sampath, Harini; Chu, Kiki; Otzelberger, Carolin; Liu, Xueqing; Ntambi, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">484-496</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Stearoyl-CoA desaturase-1 (SCD1), a crit. regulator of energy metab., catalyzes the synthesis of monounsatd. fats.  To understand the tissue-specific role of SCD1 in energy homeostasis, we used Cre-Iox technol. to generate mice with a liver-specific knockout of Scd1 (LKO).  LKO mice were protected from high-carbohydrate, but not high-fat (HF), diet-induced adiposity and hepatic steatosis.  Addnl., on a high-sucrose, very low-fat (HSVLF) diet, lipogenesis and levels of nuclear SREBP-1 and ChREBP were significantly decreased in the livers of LKO relative to Scd1lox/lox (Lox) mice.  HSVLF feeding in LKO mice caused hypoglycemia and hepatic carbohydrate redn. due to an impairment of gluconeogenesis.  Oleate, but not sterate, supplementation normalized adiposity, gluconeogenesis, triglyceride secretion, and hepatic lipogenesis of LKO mice.  These results indicate that hepatic SCD1 expression (and thus, oleate) is required for carbohydrate-induced adiposity, but SCD1 inhibition in extrahepatic tissues is required to protect mice from HF-induced obesity and insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqTz4b2jYuobVg90H21EOLACvtfcHk0lhKYXYLGXsFSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVektb%252FL&md5=b72dd6c635ca9cf4ae3892dda78b6c7c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DFlowers%26aufirst%3DM.%2BT.%26aulast%3DSampath%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DOtzelberger%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNtambi%26aufirst%3DJ.%2BM.%26atitle%3DHepatic%2520stearoyl-CoA%2520desaturase-1%2520deficiency%2520protects%2520mice%2520from%2520carbohydrate-induced%2520adiposity%2520and%2520hepatic%2520steatosis%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D6%26spage%3D484%26epage%3D496%26doi%3D10.1016%2Fj.cmet.2007.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Merck Sharp
& Dhome Corporation</span>. <span> </span><span class="NLM_article-title">Pharmacokinetics
and Pharmacodynamics
of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)</span>. <a href="https://clinicaltrials.gov/ct2/show/results/NCT00972322" class="extLink">https://clinicaltrials.gov/ct2/show/results/NCT00972322</a> (accessed
May 1, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Merck+Sharp%0A%26+Dhome+Corporation&title=Pharmacokinetics%0Aand+Pharmacodynamics%0Aof+MK-8245+in+Participants+With+Type+2+Diabetes+%28MK-8245-012%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DPharmacokinetics%250Aand%2520Pharmacodynamics%250Aof%2520MK-8245%2520in%2520Participants%2520With%2520Type%25202%2520Diabetes%2520%2528MK-8245-012%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Theodoropoulos, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterton, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Navas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morlock, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzaei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ready, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijhawan, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1038%2Fnchembio.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=26829472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=218-225&author=P.+C.+Theodoropoulosauthor=S.+S.+Gonzalesauthor=S.+E.+Wintertonauthor=C.+Rodriguez-Navasauthor=J.+S.+McKnightauthor=L.+K.+Morlockauthor=J.+M.+Hansonauthor=B.+Crossauthor=A.+E.+Owenauthor=Y.+Duanauthor=J.+R.+Morenoauthor=A.+Lemoffauthor=H.+Mirzaeiauthor=B.+A.+Posnerauthor=N.+S.+Williamsauthor=J.+M.+Readyauthor=D.+Nijhawan&title=Discovery+of+tumor-specific+irreversible+inhibitors+of+stearoyl+CoA+desaturase&doi=10.1038%2Fnchembio.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase</span></div><div class="casAuthors">Theodoropoulos, Panayotis C.; Gonzales, Stephen S.; Winterton, Sarah E.; Rodriguez-Navas, Carlos; McKnight, John S.; Morlock, Lorraine K.; Hanson, Jordan M.; Cross, Bethany; Owen, Amy E.; Duan, Yingli; Moreno, Jose R.; Lemoff, Andrew; Mirzaei, Hamid; Posner, Bruce A.; Williams, Noelle S.; Ready, Joseph M.; Nijhawan, Deepak</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">218-225</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A hallmark of targeted cancer therapies is selective toxicity among cancer cell lines.  The authors evaluated results from a viability screen of over 200,000 small mols. to identify two chem. series, oxalamides and benzothiazoles, that were selectively toxic at low nanomolar concns. to the same 4 of 12 human lung cancer cell lines.  Sensitive cell lines expressed cytochrome P 450 (CYP) 4F11, which metabolized the compds. into irreversible inhibitors of stearoyl CoA desaturase (SCD).  SCD is recognized as a promising biol. target in cancer and metabolic disease.  However, SCD is essential to sebocytes, and accordingly SCD inhibitors cause skin toxicity.  Mouse sebocytes did not activate the benzothiazoles or oxalamides into SCD inhibitors, providing a therapeutic window for inhibiting SCD in vivo.  The authors thus offer a strategy to target SCD in cancer by taking advantage of high CYP expression in a subset of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiNJKPw3Sb2bVg90H21EOLACvtfcHk0lgL19yetdfCAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFyis7w%253D&md5=5e8b28ef9f69c5060f660e17e0f1e07f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2016%26sid%3Dliteratum%253Aachs%26aulast%3DTheodoropoulos%26aufirst%3DP.%2BC.%26aulast%3DGonzales%26aufirst%3DS.%2BS.%26aulast%3DWinterton%26aufirst%3DS.%2BE.%26aulast%3DRodriguez-Navas%26aufirst%3DC.%26aulast%3DMcKnight%26aufirst%3DJ.%2BS.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DHanson%26aufirst%3DJ.%2BM.%26aulast%3DCross%26aufirst%3DB.%26aulast%3DOwen%26aufirst%3DA.%2BE.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DMoreno%26aufirst%3DJ.%2BR.%26aulast%3DLemoff%26aufirst%3DA.%26aulast%3DMirzaei%26aufirst%3DH.%26aulast%3DPosner%26aufirst%3DB.%2BA.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DReady%26aufirst%3DJ.%2BM.%26aulast%3DNijhawan%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520tumor-specific%2520irreversible%2520inhibitors%2520of%2520stearoyl%2520CoA%2520desaturase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D218%26epage%3D225%26doi%3D10.1038%2Fnchembio.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>The results
published here are fully or partially based upon data generated by
the Cancer Target Discovery and Development (CTD2) Network established
by the National Cancer Institute’s Office of Cancer Genomics.
See ‘Lung Cancer Oncogenotype-Selective Drug Target Discovery’
at <a href="https://ctd2.nci.nih.gov/dataPortal/" class="extLink">https://ctd2.nci.nih.gov/dataPortal/</a> (accessed May 1, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+results%0Apublished+here+are+fully+or+partially+based+upon+data+generated+by%0Athe+Cancer+Target+Discovery+and+Development+%28CTD2%29+Network+established%0Aby+the+National+Cancer+Institute%E2%80%99s+Office+of+Cancer+Genomics.%0ASee+%E2%80%98Lung+Cancer+Oncogenotype-Selective+Drug+Target+Discovery%E2%80%99%0Aat+https%3A%2F%2Fctd2.nci.nih.gov%2FdataPortal%2F+%28accessed+May+1%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McMillan, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diep, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiratta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemenceau, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaden, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoyaji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covington, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallipeddi, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voruganti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudderth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSevo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzny, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doddapaneni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazdar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymach, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistuba, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombes, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deberardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span> <span> </span><span class="NLM_article-title">Chemistry-first approach for nomination of personalized treatment in lung cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.cell.2018.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=29681454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFejtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2018&pages=864-878&author=E.+A.+McMillanauthor=M.-J.+Ryuauthor=C.+H.+Diepauthor=S.+Mendirattaauthor=J.+R.+Clemenceauauthor=R.+M.+Vadenauthor=J.-H.+Kimauthor=T.+Motoyajiauthor=K.+R.+Covingtonauthor=M.+Peytonauthor=K.+Huffmanauthor=X.+Wuauthor=L.+Girardauthor=Y.+Sungauthor=P.-H.+Chenauthor=P.+L.+Mallipeddiauthor=J.+Y.+Leeauthor=J.+Hansonauthor=S.+Vorugantiauthor=Y.+Yuauthor=S.+Parkauthor=J.+Sudderthauthor=C.+DeSevoauthor=D.+M.+Muznyauthor=H.+Doddapaneniauthor=A.+Gazdarauthor=R.+A.+Gibbsauthor=T.-H.+Hwangauthor=J.+V.+Heymachauthor=I.+Wistubaauthor=K.+R.+Coombesauthor=N.+S.+Williamsauthor=D.+A.+Wheelerauthor=J.+B.+MacMillanauthor=R.+J.+Deberardinisauthor=M.+G.+Rothauthor=B.+A.+Posnerauthor=J.+D.+Minnaauthor=H.+S.+Kimauthor=M.+A.+White&title=Chemistry-first+approach+for+nomination+of+personalized+treatment+in+lung+cancer&doi=10.1016%2Fj.cell.2018.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer</span></div><div class="casAuthors">McMillan, Elizabeth A.; Ryu, Myung-Jeom; Diep, Caroline H.; Mendiratta, Saurabh; Clemenceau, Jean R.; Vaden, Rachel M.; Kim, Ju-Hwa; Motoyaji, Takashi; Covington, Kyle R.; Peyton, Michael; Huffman, Kenneth; Wu, Xiaofeng; Girard, Luc; Sung, Yeojin; Chen, Pei-Hsaun; Mallipeddi, Prema L.; Lee, Joo Young; Hanson, Jordan; Voruganti, Sukesh; Yu, Yunku; Park, Sunho; Sudderth, Jessica; De Sevo, Christopher; Muzny, Donna M.; Doddapaneni, Harsha Vardhan; Gazdar, Adi; Gibbs, Richard A.; Hwang, Tae-Hyun; Heymach, John V.; Wistuba, Ignacio; Coombes, Kevin R.; Williams, Noelle S.; Wheeler, David A.; MacMillan, John B.; Deberardinis, Ralph J.; Roth, Michael G.; Posner, Bruce A.; Minna, John D.; Kim, Hyun Seok; White, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">864-878.e29</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diversity in the genetic lesions that cause cancer is extreme.  In consequence, a pressing challenge is the development of drugs that target patient-specific disease mechanisms.  To address this challenge, we employed a chem.-first discovery paradigm for de novo identification of druggable targets linked to robust patient selection hypotheses.  In particular, a 200,000 compd. diversity-oriented chem. library was profiled across a heavily annotated test-bed of >100 cellular models representative of the diverse and characteristic somatic lesions for lung cancer.  This approach led to the delineation of 171 chem.-genetic assocns., shedding light on the targetability of mechanistic vulnerabilities corresponding to a range of oncogenotypes present in patient populations lacking effective therapy.  Chem. addressable addictions to ciliogenesis in TTC21B mutants and GLUT8-dependent serine biosynthesis in KRAS/KEAP1 double mutants are prominent examples.  These observations indicate a wealth of actionable opportunities within the complex mol. etiol. of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow_Hmm03uZN7Vg90H21EOLACvtfcHk0lgL19yetdfCAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFejtrs%253D&md5=41e3d8dda5a1e005277b501a1f83a543</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DMcMillan%26aufirst%3DE.%2BA.%26aulast%3DRyu%26aufirst%3DM.-J.%26aulast%3DDiep%26aufirst%3DC.%2BH.%26aulast%3DMendiratta%26aufirst%3DS.%26aulast%3DClemenceau%26aufirst%3DJ.%2BR.%26aulast%3DVaden%26aufirst%3DR.%2BM.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DMotoyaji%26aufirst%3DT.%26aulast%3DCovington%26aufirst%3DK.%2BR.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DHuffman%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DSung%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DP.-H.%26aulast%3DMallipeddi%26aufirst%3DP.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DHanson%26aufirst%3DJ.%26aulast%3DVoruganti%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DSudderth%26aufirst%3DJ.%26aulast%3DDeSevo%26aufirst%3DC.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DDoddapaneni%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26aulast%3DHwang%26aufirst%3DT.-H.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DWistuba%26aufirst%3DI.%26aulast%3DCoombes%26aufirst%3DK.%2BR.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DMacMillan%26aufirst%3DJ.%2BB.%26aulast%3DDeberardinis%26aufirst%3DR.%2BJ.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DPosner%26aufirst%3DB.%2BA.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26atitle%3DChemistry-first%2520approach%2520for%2520nomination%2520of%2520personalized%2520treatment%2520in%2520lung%2520cancer%26jtitle%3DCell%26date%3D2018%26volume%3D173%26spage%3D864%26epage%3D878%26doi%3D10.1016%2Fj.cell.2018.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Antona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelman-Sundberg, M.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 pharmacogenetics and cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1691</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1209377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1038%2Fsj.onc.1209377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=16550168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFyhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=1679-1691&author=C.+Rodriguez-Antonaauthor=M.+Ingelman-Sundberg&title=Cytochrome+P450+pharmacogenetics+and+cancer&doi=10.1038%2Fsj.onc.1209377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 pharmacogenetics and cancer</span></div><div class="casAuthors">Rodriguez-Antona, C.; Ingelman-Sundberg, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1679-1691</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cytochromes P 450 (CYPs) are key enzymes in cancer formation and cancer treatment.  They mediate the metabolic activation of numerous precarcinogens and participate in the inactivation and activation of anticancer drugs.  Since all CYPs that metabolize xenobiotics are polymorphic, much emphasis has been put on the investigation of a relationship between the distribution of specific variant CYP alleles and risk for different types of cancer, but a consistent view does not yet exist.  This is to a great extent explained by the fact that the CYPs involved in activation of precarcinogens are in general not functionally polymorphic.  This is in contrast to CYPs that are active in drug biotransformation where large interindividual differences in the capacity to metabolize therapeutic drugs are seen as a consequence of polymorphic alleles with altered function.  This includes also some anticancer drugs like tamoxifen and cyclophosphamide metabolized by CYP2D6, CYP2C19 and CYP2B6.  Some P 450 forms are also selectively expressed in tumors, and this could provide a mechanism for drug resistance, but also future therapies using these enzymes as drug targets can be envisioned.  This review gives an up-to-date description of our current knowledge in these areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp09TREI0n_HLVg90H21EOLACvtfcHk0lhDzvPXmPjymg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFyhtbY%253D&md5=455f85682f7cdfbdd54fdd4df33dc10b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209377%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Antona%26aufirst%3DC.%26aulast%3DIngelman-Sundberg%26aufirst%3DM.%26atitle%3DCytochrome%2520P450%2520pharmacogenetics%2520and%2520cancer%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D1679%26epage%3D1691%26doi%3D10.1038%2Fsj.onc.1209377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">The 95% confidence intervals for the EC<sub>50</sub> values are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_001.csv" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">We speculate that the two bands vary in terms of post-translational modifications.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Intracellular compound concentration was determined after a 24 h incubation with 500 nM drug in H1155 cells to avoid complications from toxicity. Although differences in accumulation were observed, the most highly accumulated compounds in this study showed little toxicity to H1155 cells, ruling out poor permeability as an explanation for lack of toxicity. <b>58</b>: 80 ± 40 nM, <b>80</b>: 340 ± 100 nM, <b>106</b>: 1670 ± 560 nM, <b>15</b>: 870 ± 200.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martell, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamer, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deerinck, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellisman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mootha, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A. Y.</span></span> <span> </span><span class="NLM_article-title">Directed evolution of APEX2 for electron microscopy and proximity labeling</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1038/nmeth.3179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1038%2Fnmeth.3179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=25419960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=51-54&author=S.+S.+Lamauthor=J.+D.+Martellauthor=K.+J.+Kamerauthor=T.+J.+Deerinckauthor=M.+H.+Ellismanauthor=V.+K.+Moothaauthor=A.+Y.+Ting&title=Directed+evolution+of+APEX2+for+electron+microscopy+and+proximity+labeling&doi=10.1038%2Fnmeth.3179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Directed evolution of APEX2 for electron microscopy and proximity labeling</span></div><div class="casAuthors">Lam, Stephanie S.; Martell, Jeffrey D.; Kamer, Kimberli J.; Deerinck, Thomas J.; Ellisman, Mark H.; Mootha, Vamsi K.; Ting, Alice Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-54</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">APEX is an engineered peroxidase that functions as an electron microscopy tag and a promiscuous labeling enzyme for live-cell proteomics.  Because limited sensitivity precludes applications requiring low APEX expression, the authors used yeast-display evolution to improve its catalytic efficiency.  APEX2 is far more active in cells, enabling the use of electron microscopy to resolve the submitochondrial localization of calcium uptake regulatory protein MICU1.  APEX2 also permits superior enrichment of endogenous mitochondrial and endoplasmic reticulum membrane proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryNYEMYL_nC7Vg90H21EOLACvtfcHk0lhDzvPXmPjymg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrzJ&md5=dbcff967a82934bb8cfe872cba6132b4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.3179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.3179%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DS.%2BS.%26aulast%3DMartell%26aufirst%3DJ.%2BD.%26aulast%3DKamer%26aufirst%3DK.%2BJ.%26aulast%3DDeerinck%26aufirst%3DT.%2BJ.%26aulast%3DEllisman%26aufirst%3DM.%2BH.%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DTing%26aufirst%3DA.%2BY.%26atitle%3DDirected%2520evolution%2520of%2520APEX2%2520for%2520electron%2520microscopy%2520and%2520proximity%2520labeling%26jtitle%3DNat.%2520Methods%26date%3D2015%26volume%3D12%26spage%3D51%26epage%3D54%26doi%3D10.1038%2Fnmeth.3179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcantoni, E.</span></span> <span> </span><span class="NLM_article-title">Cerium(III) chloride mediated Michael addition of RMgX to nitroenes: A very efficient access to complex nitroalkanes</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">8651</span>– <span class="NLM_lpage">8654</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)78462-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2FS0040-4039%2800%2978462-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=8651-8654&author=G.+Bartoliauthor=M.+Boscoauthor=L.+Sambriauthor=E.+Marcantoni&title=Cerium%28III%29+chloride+mediated+Michael+addition+of+RMgX+to+nitroenes%3A+A+very+efficient+access+to+complex+nitroalkanes&doi=10.1016%2FS0040-4039%2800%2978462-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2978462-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252978462-0%26sid%3Dliteratum%253Aachs%26aulast%3DBartoli%26aufirst%3DG.%26aulast%3DBosco%26aufirst%3DM.%26aulast%3DSambri%26aufirst%3DL.%26aulast%3DMarcantoni%26aufirst%3DE.%26atitle%3DCerium%2528III%2529%2520chloride%2520mediated%2520Michael%2520addition%2520of%2520RMgX%2520to%2520nitroenes%253A%2520A%2520very%2520efficient%2520access%2520to%2520complex%2520nitroalkanes%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D8651%26epage%3D8654%26doi%3D10.1016%2FS0040-4039%2800%2978462-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehmlow, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebi, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolidon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von der
Mark, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morand, O. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3354</span>– <span class="NLM_lpage">3370</span>, <span class="refDoi"> DOI: 10.1021/jm021120f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021120f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3354-3370&author=H.+Dehmlowauthor=J.+D.+Aebiauthor=S.+Jolidonauthor=Y.-H.+Jiauthor=E.+M.+von+der%0AMarkauthor=J.+Himberauthor=O.+H.+Morand&title=Synthesis+and+structure%E2%80%93activity+studies+of+novel+orally+active+non-terpenoic+2%2C3-oxidosqualene+cyclase+inhibitors&doi=10.1021%2Fjm021120f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm021120f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021120f%26sid%3Dliteratum%253Aachs%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DY.-H.%26aulast%3Dvon%2Bder%2BMark%26aufirst%3DE.%2BM.%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520studies%2520of%2520novel%2520orally%2520active%2520non-terpenoic%25202%252C3-oxidosqualene%2520cyclase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3354%26epage%3D3370%26doi%3D10.1021%2Fjm021120f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somu, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, C. C.</span></span> <span> </span><span class="NLM_article-title">5‘-O-[(<i>N</i>-acyl)sulfamoyl]adenosines as antitubercular agents that inhibit MbtA:  An adenylation enzyme required for siderophore biosynthesis of the mycobactins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6080</span>– <span class="NLM_lpage">6094</span>, <span class="refDoi"> DOI: 10.1021/jm070905o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070905o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6080-6094&author=C.+Qiaoauthor=A.+Gupteauthor=H.+I.+Boshoffauthor=D.+J.+Wilsonauthor=E.+M.+Bennettauthor=R.+V.+Somuauthor=C.+E.+Barryauthor=C.+C.+Aldrich&title=5%E2%80%98-O-%5B%28N-acyl%29sulfamoyl%5Dadenosines+as+antitubercular+agents+that+inhibit+MbtA%3A%E2%80%89+An+adenylation+enzyme+required+for+siderophore+biosynthesis+of+the+mycobactins&doi=10.1021%2Fjm070905o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm070905o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070905o%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DC.%26aulast%3DGupte%26aufirst%3DA.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DSomu%26aufirst%3DR.%2BV.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DAldrich%26aufirst%3DC.%2BC.%26atitle%3D5%25E2%2580%2598-O-%255B%2528N-acyl%2529sulfamoyl%255Dadenosines%2520as%2520antitubercular%2520agents%2520that%2520inhibit%2520MbtA%253A%25E2%2580%2589%2520An%2520adenylation%2520enzyme%2520required%2520for%2520siderophore%2520biosynthesis%2520of%2520the%2520mycobactins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6080%26epage%3D6094%26doi%3D10.1021%2Fjm070905o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livshitz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biran, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1504</span>– <span class="NLM_lpage">1511</span>, <span class="refDoi"> DOI: 10.1021/jm00148a022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00148a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1504-1511&author=J.+Shaniauthor=A.+Gazitauthor=T.+Livshitzauthor=S.+Biran&title=Synthesis+and+receptor-binding+affinity+of+fluorotamoxifen%2C+a+possible+estrogen-receptor+imaging+agent&doi=10.1021%2Fjm00148a022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00148a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00148a022%26sid%3Dliteratum%253Aachs%26aulast%3DShani%26aufirst%3DJ.%26aulast%3DGazit%26aufirst%3DA.%26aulast%3DLivshitz%26aufirst%3DT.%26aulast%3DBiran%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520receptor-binding%2520affinity%2520of%2520fluorotamoxifen%252C%2520a%2520possible%2520estrogen-receptor%2520imaging%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D1504%26epage%3D1511%26doi%3D10.1021%2Fjm00148a022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Short and efficient total synthesis of luotonin a and 22-hydroxyacuminatine using a common cascade strategy</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">6270</span>– <span class="NLM_lpage">6272</span>, <span class="refDoi"> DOI: 10.1021/jo070837d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo070837d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVCqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=6270-6272&author=H.-B.+Zhouauthor=G.-S.+Liuauthor=Z.-J.+Yao&title=Short+and+efficient+total+synthesis+of+luotonin+a+and+22-hydroxyacuminatine+using+a+common+cascade+strategy&doi=10.1021%2Fjo070837d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Short and Efficient Total Synthesis of Luotonin A and 22-Hydroxyacuminatine Using A Common Cascade Strategy</span></div><div class="casAuthors">Zhou, Hai-Bin; Liu, Guan-Sai; Yao, Zhu-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6270-6272</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Total syntheses of 22-hydroxyacuminatine and luotonin A were achieved in direct fashion and high overall yields (16% in eight steps and 47% in five steps, resp.).  A mild cascade methodol. was successfully applied in both syntheses as a common strategy.  The new approach presents the advantages of short routes, high overall yields, use of stable intermediates, and ease of operations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkM6TxYtbCTbVg90H21EOLACvtfcHk0lhVrn1lXNtVeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVCqs7s%253D&md5=e131c8affaf19dd2c226a09774ab2116</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo070837d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo070837d%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.-B.%26aulast%3DLiu%26aufirst%3DG.-S.%26aulast%3DYao%26aufirst%3DZ.-J.%26atitle%3DShort%2520and%2520efficient%2520total%2520synthesis%2520of%2520luotonin%2520a%2520and%252022-hydroxyacuminatine%2520using%2520a%2520common%2520cascade%2520strategy%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D6270%26epage%3D6272%26doi%3D10.1021%2Fjo070837d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosch, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, A.</span></span> <span> </span><span class="NLM_article-title">Enzymatic enantiomeric resolution of phenylethylamines structurally related to amphetamine</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">8171</span>– <span class="NLM_lpage">8177</span>, <span class="refDoi"> DOI: 10.1039/c1ob06251d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1039%2Fc1ob06251d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=8171-8177&author=L.+Munozauthor=A.+M.+Rodriguezauthor=G.+Rosellauthor=M.+P.+Boschauthor=A.+Guerrero&title=Enzymatic+enantiomeric+resolution+of+phenylethylamines+structurally+related+to+amphetamine&doi=10.1039%2Fc1ob06251d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fc1ob06251d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1ob06251d%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DRodriguez%26aufirst%3DA.%2BM.%26aulast%3DRosell%26aufirst%3DG.%26aulast%3DBosch%26aufirst%3DM.%2BP.%26aulast%3DGuerrero%26aufirst%3DA.%26atitle%3DEnzymatic%2520enantiomeric%2520resolution%2520of%2520phenylethylamines%2520structurally%2520related%2520to%2520amphetamine%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D8171%26epage%3D8177%26doi%3D10.1039%2Fc1ob06251d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsh, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molino, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astakhova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiss, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sargent, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usyatinsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyle, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. R.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers:  Drugs for cystic fibrosis and chronic bronchitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4098</span>– <span class="NLM_lpage">4115</span>, <span class="refDoi"> DOI: 10.1021/jm051134w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051134w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4098-4115&author=A.+J.+Hirshauthor=B.+F.+Molinoauthor=J.+Zhangauthor=N.+Astakhovaauthor=W.+B.+Geissauthor=B.+J.+Sargentauthor=B.+D.+Swensonauthor=A.+Usyatinskyauthor=M.+J.+Wyleauthor=R.+C.+Boucherauthor=R.+T.+Smithauthor=A.+Zamursauthor=M.+R.+Johnson&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+of+novel+2-substituted+pyrazinoylguanidine+epithelial+sodium+channel+blockers%3A%E2%80%89+Drugs+for+cystic+fibrosis+and+chronic+bronchitis&doi=10.1021%2Fjm051134w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm051134w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051134w%26sid%3Dliteratum%253Aachs%26aulast%3DHirsh%26aufirst%3DA.%2BJ.%26aulast%3DMolino%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAstakhova%26aufirst%3DN.%26aulast%3DGeiss%26aufirst%3DW.%2BB.%26aulast%3DSargent%26aufirst%3DB.%2BJ.%26aulast%3DSwenson%26aufirst%3DB.%2BD.%26aulast%3DUsyatinsky%26aufirst%3DA.%26aulast%3DWyle%26aufirst%3DM.%2BJ.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DSmith%26aufirst%3DR.%2BT.%26aulast%3DZamurs%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%25202-substituted%2520pyrazinoylguanidine%2520epithelial%2520sodium%2520channel%2520blockers%253A%25E2%2580%2589%2520Drugs%2520for%2520cystic%2520fibrosis%2520and%2520chronic%2520bronchitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4098%26epage%3D4115%26doi%3D10.1021%2Fjm051134w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22','cit22b'],'ref23':['cit23'],'ref24':[],'ref25':[],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Noelle S. Williams, Stephen Gonzales, Jacinth Naidoo, Giomar Rivera-Cancel, Sukesh Voruganti, Prema Mallipeddi, Panayotis C. Theodoropoulos, Sophie Geboers, Hong Chen, Francisco Ortiz, Bruce Posner, Deepak Nijhawan, <span class="NLM_string-name hlFld-ContribAuthor">Joseph M. Ready</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor-Activated Benzothiazole Inhibitors of Stearoyl-CoA Desaturase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9773-9786. <a href="https://doi.org/10.1021/acs.jmedchem.0c00899" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00899%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTumor-Activated%252BBenzothiazole%252BInhibitors%252Bof%252BStearoyl-CoA%252BDesaturase%26aulast%3DWilliams%26aufirst%3DNoelle%2BS.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03062020%26date%3D19082020%26date%3D05082020%26volume%3D63%26issue%3D17%26spage%3D9773%26epage%3D9786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel Yu.  Ushakov</span>, <span class="hlFld-ContribAuthor ">Alexey Yu.  Sukhorukov</span>, <span class="hlFld-ContribAuthor ">Sema L.  Ioffe</span>, <span class="hlFld-ContribAuthor ">Andrey A.  Tabolin</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential Formal [4+1]‐Cycloaddition, C−H Functionalization and Suzuki–Miyaura Cross‐Coupling for the Synthesis of Trisubstituted Isoxazolines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (18)
                                     , 2680-2693. <a href="https://doi.org/10.1002/ejoc.202100313" title="DOI URL">https://doi.org/10.1002/ejoc.202100313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202100313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202100313%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSequential%252BFormal%252B%25255B4%25252B1%25255D%2525E2%252580%252590Cycloaddition%25252C%252BC%2525E2%252588%252592H%252BFunctionalization%252Band%252BSuzuki%2525E2%252580%252593Miyaura%252BCross%2525E2%252580%252590Coupling%252Bfor%252Bthe%252BSynthesis%252Bof%252BTrisubstituted%252BIsoxazolines%26aulast%3DUshakov%26aufirst%3DPavel%2BYu.%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D18%26spage%3D2680%26epage%3D2693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongtai  Chen</span>, <span class="hlFld-ContribAuthor ">Lianxin  Wang</span>, <span class="hlFld-ContribAuthor ">Yujie  Liu</span>, <span class="hlFld-ContribAuthor ">Minjie  Guo</span>, <span class="hlFld-ContribAuthor ">Wentao  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiangyang  Tang</span>, <span class="hlFld-ContribAuthor ">Guangwei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper Catalyzed Direct Synthesis of Unsymmetrically Substituted Oxalamides From Bromodifluoroacetamide and Tertiary Amines. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>10 </em>
                                    (4)
                                     , 780-783. <a href="https://doi.org/10.1002/ajoc.202100044" title="DOI URL">https://doi.org/10.1002/ajoc.202100044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202100044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202100044%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper%252BCatalyzed%252BDirect%252BSynthesis%252Bof%252BUnsymmetrically%252BSubstituted%252BOxalamides%252BFrom%252BBromodifluoroacetamide%252Band%252BTertiary%252BAmines%26aulast%3DChen%26aufirst%3DHongtai%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D4%26spage%3D780%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md  Ashraf-Uz-Zaman</span>, <span class="hlFld-ContribAuthor ">Sadisna  Shahi</span>, <span class="hlFld-ContribAuthor ">Racheal  Akwii</span>, <span class="hlFld-ContribAuthor ">Md Sanaullah  Sajib</span>, <span class="hlFld-ContribAuthor ">Mohammad Jodeiri  Farshbaf</span>, <span class="hlFld-ContribAuthor ">Raja Reddy  Kallem</span>, <span class="hlFld-ContribAuthor ">William  Putnam</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Ruiwen  Zhang</span>, <span class="hlFld-ContribAuthor ">Karina  Alvina</span>, <span class="hlFld-ContribAuthor ">Paul C.  Trippier</span>, <span class="hlFld-ContribAuthor ">Constantinos M.  Mikelis</span>, <span class="hlFld-ContribAuthor ">Nadezhda A.  German</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112866. <a href="https://doi.org/10.1016/j.ejmech.2020.112866" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112866</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112866%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bstructure-activity%252Brelationship%252Bstudy%252Bof%252Bnovel%252Burea%252Bcompounds%252Bas%252BFGFR1%252Binhibitors%252Bto%252Btreat%252Bmetastatic%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DAshraf-Uz-Zaman%26aufirst%3DMd%26date%3D2021%26volume%3D209%26spage%3D112866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiemin  Shen</span>, <span class="hlFld-ContribAuthor ">Gang  Wu</span>, <span class="hlFld-ContribAuthor ">Ah-Lim  Tsai</span>, <span class="hlFld-ContribAuthor ">Ming  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Structure and Mechanism of a Unique Diiron Center in Mammalian Stearoyl-CoA Desaturase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2020,</strong> <em>432 </em>
                                    (18)
                                     , 5152-5161. <a href="https://doi.org/10.1016/j.jmb.2020.05.017" title="DOI URL">https://doi.org/10.1016/j.jmb.2020.05.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2020.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2020.05.017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DStructure%252Band%252BMechanism%252Bof%252Ba%252BUnique%252BDiiron%252BCenter%252Bin%252BMammalian%252BStearoyl-CoA%252BDesaturase%26aulast%3DShen%26aufirst%3DJiemin%26date%3D2020%26volume%3D432%26issue%3D18%26spage%3D5152%26epage%3D5161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuzanna  Tracz-Gaszewska</span>, <span class="hlFld-ContribAuthor ">Pawel  Dobrzyn</span>. </span><span class="cited-content_cbyCitation_article-title">Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (7)
                                     , 948. <a href="https://doi.org/10.3390/cancers11070948" title="DOI URL">https://doi.org/10.3390/cancers11070948</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11070948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11070948%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DStearoyl-CoA%252BDesaturase%252B1%252Bas%252Ba%252BTherapeutic%252BTarget%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DTracz-Gaszewska%26aufirst%3DZuzanna%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D7%26spage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. SCD enzymatic reaction and inhibition by tumor-activated oxalamides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibitors of SCD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose–response curves for H2122 and H1155 cells. H1155 Cyp4F11 cells stably express CYP4F11, and H1155 pLVX cells contain the empty vector.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Oxalamides</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>15</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Varying the Linker between the Anilide and the 4-Methoxyphenyl Ring</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/medium/jm-2018-00052u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <i>N</i>-Acyl Ureas</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00052/20180622/images/large/jm-2018-00052u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00052&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i182">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">Hypoxia, lipids, and cancer: Surviving the harsh tumor microenvironment</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2014.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.tcb.2014.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=24985940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWis7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=472-478&author=D.+Ackermanauthor=M.+C.+Simon&title=Hypoxia%2C+lipids%2C+and+cancer%3A+Surviving+the+harsh+tumor+microenvironment&doi=10.1016%2Fj.tcb.2014.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment</span></div><div class="casAuthors">Ackerman, Daniel; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">472-478</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Solid tumors typically develop hostile microenvironments characterized by irregular vascularization and poor oxygen (O2) and nutrient supply.  Whereas normal cells modulate anabolic and catabolic pathways in response to changes in nutrient availability, cancer cells exhibit unregulated growth even under nutrient scarcity.  Recent studies have demonstrated that constitutive activation of growth-promoting pathways results in dependence on unsatd. fatty acids for survival under O2 deprivation.  In cancer cells, this dependence represents a crit. metabolic vulnerability that could be exploited therapeutically.  Here we review how this dependence on unsatd. lipids is affected by the microenvironmental conditions faced by cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFWrZ3BgqjUrVg90H21EOLACvtfcHk0lgbFQBDjJLWsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWis7bO&md5=af539e0fc502e760a99b3417c2919a6d</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2014.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2014.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DAckerman%26aufirst%3DD.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DHypoxia%252C%2520lipids%252C%2520and%2520cancer%253A%2520Surviving%2520the%2520harsh%2520tumor%2520microenvironment%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2014%26volume%3D24%26spage%3D472%26epage%3D478%26doi%3D10.1016%2Fj.tcb.2014.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Listenberger, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cases, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farese, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ory, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, J. E.</span></span> <span> </span><span class="NLM_article-title">Triglyceride accumulation protects against fatty acid-induced lipotoxicity</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">3077</span>– <span class="NLM_lpage">3082</span>, <span class="refDoi"> DOI: 10.1073/pnas.0630588100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1073%2Fpnas.0630588100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=12629214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVCnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=3077-3082&author=L.+L.+Listenbergerauthor=X.+Hanauthor=S.+E.+Lewisauthor=S.+Casesauthor=R.+V.+Fareseauthor=D.+S.+Oryauthor=J.+E.+Schaffer&title=Triglyceride+accumulation+protects+against+fatty+acid-induced+lipotoxicity&doi=10.1073%2Fpnas.0630588100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Triglyceride accumulation protects against fatty acid-induced lipotoxicity</span></div><div class="casAuthors">Listenberger, Laura L.; Han, Xianlin; Lewis, Sarah E.; Cases, Sylvaine; Farese, Robert V., Jr.; Ory, Daniel S.; Schaffer, Jean E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3077-3082</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Excess lipid accumulation in non-adipose tissues is assocd. with insulin resistance, pancreatic β-cell apoptosis and heart failure.  Here, we demonstrate in cultured cells that the relative toxicity of two common dietary long chain fatty acids is related to channeling of these lipids to distinct cellular metabolic fates.  Oleic acid supplementation leads to triglyceride accumulation and is well tolerated, whereas excess palmitic acid is poorly incorporated into triglyceride and causes apoptosis.  Unsatd. fatty acids rescue palmitate-induced apoptosis by channeling palmitate into triglyceride pools and away from pathways leading to apoptosis.  Moreover, in the setting of impaired triglyceride synthesis, oleate induces lipotoxicity.  Our findings support a model of cellular lipid metab. in which unsatd. fatty acids serve a protective function against lipotoxicity though promotion of triglyceride accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpVjeAQxiRBbVg90H21EOLACvtfcHk0lgbFQBDjJLWsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVCnsLs%253D&md5=eb9429653cd3fee65308c5811ccb617e</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0630588100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0630588100%26sid%3Dliteratum%253Aachs%26aulast%3DListenberger%26aufirst%3DL.%2BL.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DLewis%26aufirst%3DS.%2BE.%26aulast%3DCases%26aufirst%3DS.%26aulast%3DFarese%26aufirst%3DR.%2BV.%26aulast%3DOry%26aufirst%3DD.%2BS.%26aulast%3DSchaffer%26aufirst%3DJ.%2BE.%26atitle%3DTriglyceride%2520accumulation%2520protects%2520against%2520fatty%2520acid-induced%2520lipotoxicity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D3077%26epage%3D3082%26doi%3D10.1073%2Fpnas.0630588100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paton, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntambi, J. M.</span></span> <span> </span><span class="NLM_article-title">Biochemical and physiological function of stearoyl-coA desaturase</span>. <i>Am. J. Physiol. Endocrinol. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">E28</span>– <span class="NLM_lpage">E37</span>, <span class="refDoi"> DOI: 10.1152/ajpendo.90897.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1152%2Fajpendo.90897.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=19066317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVKjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2009&pages=E28-E37&author=C.+M.+Patonauthor=J.+M.+Ntambi&title=Biochemical+and+physiological+function+of+stearoyl-coA+desaturase&doi=10.1152%2Fajpendo.90897.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and physiological function of stearoyl-CoA desaturase</span></div><div class="casAuthors">Paton, Chad M.; Ntambi, James M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">1, Pt. 1</span>),
    <span class="NLM_cas:pages">E28-E37</span>CODEN:
                <span class="NLM_cas:coden">AJPHAP</span>;
        ISSN:<span class="NLM_cas:issn">0002-9513</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  A key and highly regulated enzyme that is required for the biosynthesis of monounsatd. fatty acids is stearoyl-CoA desaturase (SCD), which catalyzes the Δ9-cis desatn. of a range of fatty acyl-CoA substrates.  The preferred substrates are palmitoyl- and stearoyl-CoA, which are converted into palmitoleoyl- and oleoyl-CoA resp.  Oleate is the most abundant monounsatd. fatty acid in dietary fat and is therefore readily available.  Studies of mice that have a naturally occurring mutation in the SCD-1 gene isoform as well as a mouse model with a targeted disruption of the SCD gene (SCD-1-/-) have revealed the role of de novo synthesized oleate and thus the physiol. importance of SCD-1 expression.  SCD-1 deficiency results in reduced body adiposity, increased insulin sensitivity, and resistance to diet-induced obesity.  The expression of several genes of lipid oxidn. are up-regulated, whereas lipid synthesis genes are down-regulated.  SCD-1 was also found to be a component of the novel metabolic response to the hormone, leptin.  Therefore, SCD-1 appears to be an important metabolic control point, and inhibition of its expression could be of benefit for the treatment of obesity, diabetes, and other metabolic diseases.  Here, the authors summarize the recent and timely advances concerning the important role of SCD in the biochem. and physiol. of lipid metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBLqSZKQsyjrVg90H21EOLACvtfcHk0lgbFQBDjJLWsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVKjtro%253D&md5=a717a295113e91c3aa17fd628b67b53a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.90897.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.90897.2008%26sid%3Dliteratum%253Aachs%26aulast%3DPaton%26aufirst%3DC.%2BM.%26aulast%3DNtambi%26aufirst%3DJ.%2BM.%26atitle%3DBiochemical%2520and%2520physiological%2520function%2520of%2520stearoyl-coA%2520desaturase%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2009%26volume%3D297%26spage%3DE28%26epage%3DE37%26doi%3D10.1152%2Fajpendo.90897.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parimoo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prouty, S. M.</span></span> <span> </span><span class="NLM_article-title">Human stearoyl-CoA desaturase: Alternative transcripts generated from a single gene by usage of tandem polyadenylation sites</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">264</span>, <span class="refDoi"> DOI: 10.1042/bj3400255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1042%2Fbj3400255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10229681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADyaK1MXjs12ks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=1999&pages=255-264&author=L.+Zhangauthor=L.+Geauthor=S.+Parimooauthor=K.+Stennauthor=S.+M.+Prouty&title=Human+stearoyl-CoA+desaturase%3A+Alternative+transcripts+generated+from+a+single+gene+by+usage+of+tandem+polyadenylation+sites&doi=10.1042%2Fbj3400255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Human stearoyl-CoA desaturase: alternative transcripts generated from a single gene by usage of tandem polyadenylation sites</span></div><div class="casAuthors">Zhang, Lin; Ge, Lan; Parimoo, Satish; Stenn, Kurt; Prouty, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">255-264</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A crit. step in the synthesis of unsatd. fatty acids is catalyzed by stearoyl-CoA desaturase (Scd).  To det. the regulation of human Scd, we characterized the gene and its transcripts.  Screening a human keratinocyte cDNA library and anal. of 3'-RACE (rapid amplification of cDNA ends) products from various tissues yielded a 5.2 kb cDNA encoding a 359 amino acid protein with a calcd. mol. mass of 41.5 kDa.  Anal. of 3'-RACE products suggested that alternative usage of polyadenylation sites generates two transcripts of 3.9 and 5.2 kb, a result consistent with Northern anal.  Southern anal. demonstrated the existence of two SCD loci in the human genome.  Chromosomal mapping localized one locus to chromosome 10, and the second locus to chromosome 17.  Characterization of genomic clones isolated from chromosome-specific libraries revealed that only the locus on chromosome 10 contained introns.  Sequence anal. of the intron-less locus displayed multiple nucleotide insertions and deletions, as well as in-frame stop codons.  Reverse transcriptase-PCR anal. performed with primers specific to the intron-less locus failed to produce a PCR product from brain, liver and skin RNA, indicating that the locus on chromosome 17 is most likely a transcriptionally inactive, fully processed pseudogene.  These results suggest strongly that there is one structural SCD gene in the human genome, and that it generates two transcripts by use of alternative polyadenylation sites.  Although the primary sequence and intron-exon structure of SCD is phylogenetically conserved, divergence between rodent and human is seen in the no. of SCD genes and in the generation of alternative transcripts, suggesting a species-specific component of SCD regulation and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzP4Q_IyqhYbVg90H21EOLACvtfcHk0lgNBNvPqDTJeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs12ks7g%253D&md5=938b723707d751e84c544e60f3e4f08a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1042%2Fbj3400255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3400255%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGe%26aufirst%3DL.%26aulast%3DParimoo%26aufirst%3DS.%26aulast%3DStenn%26aufirst%3DK.%26aulast%3DProuty%26aufirst%3DS.%2BM.%26atitle%3DHuman%2520stearoyl-CoA%2520desaturase%253A%2520Alternative%2520transcripts%2520generated%2520from%2520a%2520single%2520gene%2520by%2520usage%2520of%2520tandem%2520polyadenylation%2520sites%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D340%26spage%3D255%26epage%3D264%26doi%3D10.1042%2Fbj3400255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schug, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dankworth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smethurst, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer-Dene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamp, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGarry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shanks, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aboagye, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Critchlow, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakelam, M. J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottlieb, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulze, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments</span>. <i>Cancer Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1186/s40170-016-0146-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1186%2Fs40170-016-0146-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=1-18&author=B.+Peckauthor=Z.+T.+Schugauthor=Q.+Zhangauthor=B.+Dankworthauthor=D.+T.+Jonesauthor=E.+Smethurstauthor=R.+Patelauthor=S.+Masonauthor=M.+Jiangauthor=R.+Saundersauthor=M.+Howellauthor=R.+Mitterauthor=B.+Spencer-Deneauthor=G.+Stampauthor=L.+McGarryauthor=D.+Jamesauthor=E.+Shanksauthor=E.+O.+Aboagyeauthor=S.+E.+Critchlowauthor=H.+Y.+Leungauthor=A.+L.+Harrisauthor=M.+J.+O.+Wakelamauthor=E.+Gottliebauthor=A.+Schulze&title=Inhibition+of+fatty+acid+desaturation+is+detrimental+to+cancer+cell+survival+in+metabolically+compromised+environments&doi=10.1186%2Fs40170-016-0146-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1186%2Fs40170-016-0146-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40170-016-0146-8%26sid%3Dliteratum%253Aachs%26aulast%3DPeck%26aufirst%3DB.%26aulast%3DSchug%26aufirst%3DZ.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DDankworth%26aufirst%3DB.%26aulast%3DJones%26aufirst%3DD.%2BT.%26aulast%3DSmethurst%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DMason%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DSaunders%26aufirst%3DR.%26aulast%3DHowell%26aufirst%3DM.%26aulast%3DMitter%26aufirst%3DR.%26aulast%3DSpencer-Dene%26aufirst%3DB.%26aulast%3DStamp%26aufirst%3DG.%26aulast%3DMcGarry%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DD.%26aulast%3DShanks%26aufirst%3DE.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DCritchlow%26aufirst%3DS.%2BE.%26aulast%3DLeung%26aufirst%3DH.%2BY.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DWakelam%26aufirst%3DM.%2BJ.%2BO.%26aulast%3DGottlieb%26aufirst%3DE.%26aulast%3DSchulze%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520fatty%2520acid%2520desaturation%2520is%2520detrimental%2520to%2520cancer%2520cell%2520survival%2520in%2520metabolically%2520compromised%2520environments%26jtitle%3DCancer%2520Metab.%26date%3D2016%26volume%3D4%26spage%3D1%26epage%3D18%26doi%3D10.1186%2Fs40170-016-0146-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Navas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollipara, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedrosa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugarolas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span> <span> </span><span class="NLM_article-title">Unsaturated fatty acids stimulate tumor growth through stabilization of β-catenin</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.celrep.2015.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=26456834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=495-503&author=H.+Kimauthor=C.+Rodriguez-Navasauthor=R.+K.+Kolliparaauthor=P.+Kapurauthor=I.+Pedrosaauthor=J.+Brugarolasauthor=R.+Kittlerauthor=J.+Ye&title=Unsaturated+fatty+acids+stimulate+tumor+growth+through+stabilization+of+%CE%B2-catenin&doi=10.1016%2Fj.celrep.2015.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Unsaturated Fatty Acids Stimulate Tumor Growth through Stabilization of β-Catenin</span></div><div class="casAuthors">Kim, Hyeonwoo; Rodriguez-Navas, Carlos; Kollipara, Rahul K.; Kapur, Payal; Pedrosa, Ivan; Brugarolas, James; Kittler, Ralf; Ye, Jin</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-503</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Some cancer cells exhibit elevated levels of free fatty acids (FAs) as well as high levels of β-catenin, a transcriptional co-activator that promotes their growth.  Here, we link these two phenomena by showing that unsatd. FAs inhibit degrdn. of β-catenin.  Unsatd. FAs bind to the UAS domain of Fas-assocd. factor 1 (FAF1), a protein known to bind β-catenin, accelerating its degrdn.  FA binding disrupts the FAF1/β-catenin complex, preventing proteasomal degrdn. of ubiquitinated β-catenin.  This mechanism for stabilization of β-catenin differs from that of Wnt signaling, which blocks ubiquitination of β-catenin.  In clear cell renal cell carcinoma (ccRCC) cells, unsatd. FAs stimulated cell proliferation through stabilization of β-catenin.  In tissues from biopsies of human ccRCC, elevated levels of unsatd. FAs correlated with increased levels of β-catenin.  Thus, targeting FAF1 may be an effective approach to treat cancers that exhibit elevated FAs and β-catenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkdpftiPLvWrVg90H21EOLACvtfcHk0lgNBNvPqDTJeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjE&md5=011813811573e946f25a65ab65373020</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DRodriguez-Navas%26aufirst%3DC.%26aulast%3DKollipara%26aufirst%3DR.%2BK.%26aulast%3DKapur%26aufirst%3DP.%26aulast%3DPedrosa%26aufirst%3DI.%26aulast%3DBrugarolas%26aufirst%3DJ.%26aulast%3DKittler%26aufirst%3DR.%26aulast%3DYe%26aufirst%3DJ.%26atitle%3DUnsaturated%2520fatty%2520acids%2520stimulate%2520tumor%2520growth%2520through%2520stabilization%2520of%2520%25CE%25B2-catenin%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D13%26spage%3D495%26epage%3D503%26doi%3D10.1016%2Fj.celrep.2015.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dales, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M. D.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5039</span>– <span class="NLM_lpage">5056</span>, <span class="refDoi"> DOI: 10.1021/jm401516c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401516c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5039-5056&author=Z.+Zhangauthor=N.+A.+Dalesauthor=M.+D.+Winther&title=Opportunities+and+challenges+in+developing+stearoyl-coenzyme+A+desaturase-1+inhibitors+as+novel+therapeutics+for+human+disease&doi=10.1021%2Fjm401516c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease</span></div><div class="casAuthors">Zhang, Zaihui; Dales, Natalie A.; Winther, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5039-5056</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This review provides an overview of stearoyl-CoA desaturase-1 (SCD1) as a novel therapeutic target for metabolic disorders and other indications.  Target validation is reviewed, and limitations due to incomplete knowledge of the relevant biol. systems are described.  Assay development, particularly for high throughput screening, and characterization of SCD1 inhibition are summarized.  The progress and evolution in medicinal chem. are discussed, specifically focusing on key attributes of the most advanced SCD1 inhibitors described in the primary literature and in patent applications.  This work culminated in numerous companies identifying potent selective inhibitors, some of which progressed to early clin. development.  The status of current SCD1 drug discovery programs is reviewed.  Challenges are discussed, and potential new directions are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkpUEA9vY2yLVg90H21EOLACvtfcHk0lgtk4pkb6MWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltrbM&md5=8c32a3269be75d9f758b8bf4dde30f74</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm401516c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401516c%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DDales%26aufirst%3DN.%2BA.%26aulast%3DWinther%26aufirst%3DM.%2BD.%26atitle%3DOpportunities%2520and%2520challenges%2520in%2520developing%2520stearoyl-coenzyme%2520A%2520desaturase-1%2520inhibitors%2520as%2520novel%2520therapeutics%2520for%2520human%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5039%26epage%3D5056%26doi%3D10.1021%2Fjm401516c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serby, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczepankiewicz, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, L. T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhar, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janis, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surowy, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of piperidine-aryl urea-based stearoyl-coa desaturase 1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4298</span>– <span class="NLM_lpage">4302</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.06.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.bmcl.2008.06.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=18632269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVeqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4298-4302&author=Z.+Xinauthor=H.+Zhaoauthor=M.+D.+Serbyauthor=B.+Liuauthor=M.+Liuauthor=B.+G.+Szczepankiewiczauthor=L.+T.+J.+Nelsonauthor=H.+T.+Smithauthor=T.+S.+Suharauthor=R.+S.+Janisauthor=N.+Caoauthor=H.+S.+Campauthor=C.+A.+Collinsauthor=H.+L.+Shamauthor=T.+K.+Surowyauthor=G.+Liu&title=Discovery+of+piperidine-aryl+urea-based+stearoyl-coa+desaturase+1+inhibitors&doi=10.1016%2Fj.bmcl.2008.06.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors</span></div><div class="casAuthors">Xin, Zhili; Zhao, Hongyu; Serby, Michael D.; Liu, Bo; Liu, Mei; Szczepankiewicz, Bruce G.; Nelson, Lissa T. J.; Smith, Harriet T.; Suhar, Tom S.; Janis, Rich S.; Cao, Ning; Camp, Heidi S.; Collins, Christine A.; Sham, Hing L.; Surowy, Teresa K.; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4298-4302</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of structurally novel stearoyl-Co-A desaturase 1 (SCD1) inhibitors has been identified via mol. scaffold manipulation.  Preliminary structure-activity relationship (SAR) studies led to the discovery of potent, and orally bioavailable piperidine-aryl urea-based SCD1 inhibitors.  4-(2-Chlorophenoxy)-N-[3-(Me carbamoyl)phenyl]piperidine-1-carboxamide (I) exhibited robust in vivo activity with dose-dependent desatn. index lowering effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4JuK5CeLSQrVg90H21EOLACvtfcHk0lgtk4pkb6MWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVeqtLk%253D&md5=0c64d7005bd418fd73563cc66ea515ba</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.06.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.06.088%26sid%3Dliteratum%253Aachs%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DSerby%26aufirst%3DM.%2BD.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DSzczepankiewicz%26aufirst%3DB.%2BG.%26aulast%3DNelson%26aufirst%3DL.%2BT.%2BJ.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DSuhar%26aufirst%3DT.%2BS.%26aulast%3DJanis%26aufirst%3DR.%2BS.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DCamp%26aufirst%3DH.%2BS.%26aulast%3DCollins%26aufirst%3DC.%2BA.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSurowy%26aufirst%3DT.%2BK.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DDiscovery%2520of%2520piperidine-aryl%2520urea-based%2520stearoyl-coa%2520desaturase%25201%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4298%26epage%3D4302%26doi%3D10.1016%2Fj.bmcl.2008.06.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roongta, U. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pabalan, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryseck, R.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fargnoli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henley, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madireddi, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rupnow, B. A.</span></span> <span> </span><span class="NLM_article-title">Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1551</span>– <span class="NLM_lpage">1561</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-11-0126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1158%2F1541-7786.MCR-11-0126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=21954435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOhtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1551-1561&author=U.+V.+Roongtaauthor=J.+G.+Pabalanauthor=X.+Wangauthor=R.-P.+Ryseckauthor=J.+Fargnoliauthor=B.+J.+Henleyauthor=W.-P.+Yangauthor=J.+Zhuauthor=M.+T.+Madireddiauthor=R.+M.+Lawrenceauthor=T.+W.+Wongauthor=B.+A.+Rupnow&title=Cancer+cell+dependence+on+unsaturated+fatty+acids+implicates+stearoyl-CoA+desaturase+as+a+target+for+cancer+therapy&doi=10.1158%2F1541-7786.MCR-11-0126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy</span></div><div class="casAuthors">Roongta, Urvashi V.; Pabalan, Jonathan G.; Wang, Xinyu; Ryseck, Rolf-Peter; Fargnoli, Joseph; Henley, Benjamin J.; Yang, Wen-Pin; Zhu, Jun; Madireddi, Malavi T.; Lawrence, R. Michael; Wong, Tai W.; Rupnow, Brent A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1551-1561</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Emerging literature suggests that metabolic pathways play an important role in the maintenance and progression of human cancers.  In particular, recent studies have implicated lipid biosynthesis and desatn. as a requirement for tumor cell survival.  In the studies reported here, we aimed to understand whether tumor cells require the activity of either human isoform of stearoyl-CoA-desaturase (SCD1 or SCD5) for survival.  Inhibition of SCD1 by siRNA or a small mol. antagonist results in strong induction of apoptosis and growth inhibition, when tumor cells are cultured in reduced (2%) serum conditions, but has little impact on cells cultured in 10% serum.  Depletion of SCD5 had minimal effects on cell growth or apoptosis.  Consistent with the obsd. dependence on SCD1, but not SCD5, levels of SCD1 protein increased in response to decreasing serum levels.  Both induction of SCD1 protein and sensitivity to growth inhibition by SCD1 inhibition could be reversed by supplementing growth media with unsatd. fatty acids, the product of the enzymic reaction catalyzed by SCD1.  Transcription profiling of cells treated with an SCD inhibitor revealed strong induction of markers of endoplasmic reticulum stress.  Underscoring its importance in cancer, SCD1 protein was found to be highly expressed in a large percentage of human cancer specimens.  SCD inhibition resulted in tumor growth delay in a human gastric cancer xenograft model.  Altogether, these results suggest that desatd. fatty acids are required for tumor cell survival and that SCD may represent a viable target for the development of novel agents for cancer therapy.  Mol Cancer Res; 9(11); 1551-61.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZd82MtZXeCLVg90H21EOLACvtfcHk0lgtk4pkb6MWYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOhtb%252FF&md5=4fff414d184620da7188ea95c1670994</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-11-0126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-11-0126%26sid%3Dliteratum%253Aachs%26aulast%3DRoongta%26aufirst%3DU.%2BV.%26aulast%3DPabalan%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRyseck%26aufirst%3DR.-P.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DHenley%26aufirst%3DB.%2BJ.%26aulast%3DYang%26aufirst%3DW.-P.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMadireddi%26aufirst%3DM.%2BT.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DWong%26aufirst%3DT.%2BW.%26aulast%3DRupnow%26aufirst%3DB.%2BA.%26atitle%3DCancer%2520cell%2520dependence%2520on%2520unsaturated%2520fatty%2520acids%2520implicates%2520stearoyl-CoA%2520desaturase%2520as%2520a%2520target%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2011%26volume%3D9%26spage%3D1551%26epage%3D1561%26doi%3D10.1158%2F1541-7786.MCR-11-0126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">von
Roemeling, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlow, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tun, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copland, J. A.</span></span> <span> </span><span class="NLM_article-title">Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2368</span>– <span class="NLM_lpage">2380</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-3249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1158%2F1078-0432.CCR-12-3249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=23633458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2368-2380&author=C.+A.+von%0ARoemelingauthor=L.+A.+Marlowauthor=J.+J.+Weiauthor=S.+J.+Cooperauthor=T.+R.+Caulfieldauthor=K.+Wuauthor=W.+W.+Tanauthor=H.+W.+Tunauthor=J.+A.+Copland&title=Stearoyl-CoA+desaturase+1+is+a+novel+molecular+therapeutic+target+for+clear+cell+renal+cell+carcinoma&doi=10.1158%2F1078-0432.CCR-12-3249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma</span></div><div class="casAuthors">von Roemeling, Christina A.; Marlow, Laura A.; Wei, Johnny J.; Cooper, Simon J.; Caulfield, Thomas R.; Wu, Kevin; Tan, Winston W.; Tun, Han W.; Copland, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2368-2380</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We set out to identify Stearoyl-CoA desaturase 1 (SCD1) as a novel mol. target in clear cell renal cell carcinoma (ccRCC) and examine its role in tumor cell growth and viability in vitro and in vivo independently as well as in combination with current U.S.  Food and Drug Administration (FDA)-approved regimens.  Exptl. Design: Patient normal and ccRCC tissue samples and cell lines were examd. for SCD1 expression.  Genetic knockdown models and targeted inhibition of SCD1 through use of a small mol. inhibitor, A939572, were analyzed for growth, apoptosis, and alterations in gene expression using gene array anal.  Therapeutic models of synergy were evaluated utilizing pharmacol. inhibition of SCD1 with the tyrosine kinase inhibitors (TKI) sunitinib and pazopanib, and the mTOR inhibitor temsirolimus.  Results: Our studies identify increased SCD1 expression in all stages of ccRCC.  Both genetic knockdown and pharmacol. inhibition of SCD1 decreased tumor cell proliferation and induced apoptosis in vitro and in vivo.  Upon gene array, quant. real-time PCR, and protein anal. of A939572-treated or SCD1 lentiviral knockdown samples, induction of endoplasmic reticulum stress response signaling was obsd., providing mechanistic insight for SCD1 activity in ccRCC.  Furthermore, combinatorial application of A939572 with temsirolimus synergistically inhibited tumor growth in vitro and in vivo.  Conclusions: Increased SCD1 expression supports ccRCC viability and therefore we propose it as a novel mol. target for therapy either independently or in combination with an mTOR inhibitor for patients whose disease cannot be remedied with surgical intervention, such as in cases of advanced or metastatic disease.  Clin Cancer Res; 19(9); 2368-80. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI19frRdyidrVg90H21EOLACvtfcHk0lgVwImorP9dJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrurg%253D&md5=557136bec3d76db58046752da651617e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-3249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-3249%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BRoemeling%26aufirst%3DC.%2BA.%26aulast%3DMarlow%26aufirst%3DL.%2BA.%26aulast%3DWei%26aufirst%3DJ.%2BJ.%26aulast%3DCooper%26aufirst%3DS.%2BJ.%26aulast%3DCaulfield%26aufirst%3DT.%2BR.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DTan%26aufirst%3DW.%2BW.%26aulast%3DTun%26aufirst%3DH.%2BW.%26aulast%3DCopland%26aufirst%3DJ.%2BA.%26atitle%3DStearoyl-CoA%2520desaturase%25201%2520is%2520a%2520novel%2520molecular%2520therapeutic%2520target%2520for%2520clear%2520cell%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D2368%26epage%3D2380%26doi%3D10.1158%2F1078-0432.CCR-12-3249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serby, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kym, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhar, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janis, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauser, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cepa, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, D. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sham, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surowy, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camp, H. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3086</span>– <span class="NLM_lpage">3100</span>, <span class="refDoi"> DOI: 10.1021/jm070219p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070219p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvVelsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3086-3100&author=G.+Liuauthor=J.+K.+Lynchauthor=J.+Freemanauthor=B.+Liuauthor=Z.+Xinauthor=H.+Zhaoauthor=M.+D.+Serbyauthor=P.+R.+Kymauthor=T.+S.+Suharauthor=H.+T.+Smithauthor=N.+Caoauthor=R.+Yangauthor=R.+S.+Janisauthor=J.+A.+Krauserauthor=S.+P.+Cepaauthor=D.+W.+A.+Benoauthor=H.+L.+Shamauthor=C.+A.+Collinsauthor=T.+K.+Surowyauthor=H.+S.+Camp&title=Discovery+of+potent%2C+selective%2C+orally+bioavailable+stearoyl-CoA+desaturase+1+inhibitors&doi=10.1021%2Fjm070219p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors</span></div><div class="casAuthors">Liu, Gang; Lynch, John K.; Freeman, Jennifer; Liu, Bo; Xin, Zhili; Zhao, Hongyu; Serby, Michael D.; Kym, Philip R.; Suhar, Tom S.; Smith, Harriet T.; Cao, Ning; Yang, Ruojing; Janis, Rich S.; Krauser, Joel A.; Cepa, Steven P.; Beno, David W. A.; Sham, Hing L.; Collins, Christine A.; Surowy, Teresa K.; Camp, Heidi S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3086-3100</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stearoyl-CoA desaturase 1 (SCD1) catalyzes the committed step in the biosynthesis of monounsatd. fatty acids from satd., long-chain fatty acids.  Studies with SCD1 knockout mice have established that these animals are lean and protected from leptin deficiency-induced and diet-induced obesity, with greater whole body insulin sensitivity than wild-type animals.  In this work, we have discovered a series of potent, selective, orally bioavailable SCD1 inhibitors based on a known pyridazine carboxamide template.  The representative lead inhibitor 28c also demonstrates excellent cellular activity in blocking the conversion of satd. long-chain fatty acid-CoAs (LCFA-CoAs) to monounsatd. LCFA-CoAs in HepG2 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC81HS5TOS87Vg90H21EOLACvtfcHk0lgVwImorP9dJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvVelsL8%253D&md5=12caa56ed9261e2de77ddfe9b7e2dddc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm070219p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070219p%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLynch%26aufirst%3DJ.%2BK.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DXin%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DSerby%26aufirst%3DM.%2BD.%26aulast%3DKym%26aufirst%3DP.%2BR.%26aulast%3DSuhar%26aufirst%3DT.%2BS.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DCao%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DJanis%26aufirst%3DR.%2BS.%26aulast%3DKrauser%26aufirst%3DJ.%2BA.%26aulast%3DCepa%26aufirst%3DS.%2BP.%26aulast%3DBeno%26aufirst%3DD.%2BW.%2BA.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DCollins%26aufirst%3DC.%2BA.%26aulast%3DSurowy%26aufirst%3DT.%2BK.%26aulast%3DCamp%26aufirst%3DH.%2BS.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520stearoyl-CoA%2520desaturase%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3086%26epage%3D3100%26doi%3D10.1021%2Fjm070219p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mason, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremgen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biemann, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komarnitsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jancsics, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krumbholz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lillie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, K.</span></span> <span> </span><span class="NLM_article-title">SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e33823</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0033823</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1371%2Fjournal.pone.0033823" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=22457791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1Churo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=P.+Masonauthor=B.+Liangauthor=L.+Liauthor=T.+Fremgenauthor=E.+Murphyauthor=A.+Quinnauthor=S.+L.+Maddenauthor=H.-P.+Biemannauthor=B.+Wangauthor=A.+Cohenauthor=S.+Komarnitskyauthor=K.+Jancsicsauthor=B.+Hirthauthor=C.+G.+F.+Cooperauthor=E.+Leeauthor=S.+Wilsonauthor=R.+Krumbholzauthor=S.+Schmidauthor=Y.+Xiangauthor=M.+Bookerauthor=J.+Lillieauthor=K.+Carter&title=SCD1+inhibition+causes+cancer+cell+death+by+depleting+mono-unsaturated+fatty+acids&doi=10.1371%2Fjournal.pone.0033823"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids</span></div><div class="casAuthors">Mason, Paul; Liang, Beirong; Li, Lingyun; Fremgen, Trisha; Murphy, Erin; Quinn, Angela; Madden, Stephen L.; Biemann, Hans-Peter; Wang, Bing; Cohen, Aharon; Komarnitsky, Svetlana; Jancsics, Kate; Hirth, Brad; Cooper, Christopher G. F.; Lee, Edward; Wilson, Sean; Krumbholz, Roy; Schmid, Steven; Xiang, Yibin; Booker, Michael; Lillie, James; Carter, Kara</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e33823</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Increased metab. is a requirement for tumor cell proliferation.  To understand the dependence of tumor cells on fatty acid metab., we evaluated various nodes of the fatty acid synthesis pathway.  Using RNAi we have demonstrated that depletion of fatty-acid synthesis pathway enzymes SCD1, FASN, or ACC1 in HCT116 colon cancer cells results in cytotoxicity that is reversible by addn. of exogenous fatty acids.  This conditional phenotype is most pronounced when SCD1 is depleted.  We used this fatty-acid rescue strategy to characterize several small-mol. inhibitors of fatty acid synthesis, including identification of TOFA as a potent SCD1 inhibitor, representing a previously undescribed activity for this compd.  Ref. FASN and ACC inhibitors show cytotoxicity that is less pronounced than that of TOFA, and fatty-acid rescue profiles consistent with their proposed enzyme targets.  Two ref. SCD1 inhibitors show low-nanomolar cytotoxicity that is offset by at least 2 orders of magnitude by exogenous oleate.  One of these inhibitors slows growth of HCT116 xenograft tumors.  These data outline an effective strategy for interrogation of on-mechanism potency and pathway-node-specificity of fatty acid synthesis inhibitors, establish an unambiguous link between fatty acid synthesis and cancer cell survival, and point toward SCD1 as a key target in this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUv6I0T_UMcbVg90H21EOLACvtfcHk0lgVwImorP9dJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1Churo%253D&md5=748deff029043c4201b201cc0a142623</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0033823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0033823%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DP.%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DFremgen%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DQuinn%26aufirst%3DA.%26aulast%3DMadden%26aufirst%3DS.%2BL.%26aulast%3DBiemann%26aufirst%3DH.-P.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DCohen%26aufirst%3DA.%26aulast%3DKomarnitsky%26aufirst%3DS.%26aulast%3DJancsics%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DB.%26aulast%3DCooper%26aufirst%3DC.%2BG.%2BF.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DKrumbholz%26aufirst%3DR.%26aulast%3DSchmid%26aufirst%3DS.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DBooker%26aufirst%3DM.%26aulast%3DLillie%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DK.%26atitle%3DSCD1%2520inhibition%2520causes%2520cancer%2520cell%2520death%2520by%2520depleting%2520mono-unsaturated%2520fatty%2520acids%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0033823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhill, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilevich, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glushkov, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zilbershtein, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zautke, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunn, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chisholm, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J.</span></span> <span> </span><span class="NLM_article-title">Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2048</span>– <span class="NLM_lpage">2052</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.bmcl.2009.02.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=19249203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1arsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2048-2052&author=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=N.+I.+Vasilevichauthor=A.+I.+Glushkovauthor=T.+M.+Zilbershteinauthor=A.+V.+Ivanovauthor=A.+G.+Coleauthor=I.+Hendersonauthor=N.+A.+Zautkeauthor=S.+A.+Brunnauthor=N.+Mollovaauthor=K.+Leungauthor=J.+W.+Chisholmauthor=J.+Zablocki&title=Novel%2C+potent%2C+selective%2C+and+metabolically+stable+stearoyl-CoA+desaturase+%28SCD%29+inhibitors&doi=10.1016%2Fj.bmcl.2009.02.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors</span></div><div class="casAuthors">Koltun, Dmitry O.; Parkhill, Eric Q.; Vasilevich, Natalya I.; Glushkov, Andrei I.; Zilbershtein, Timur M.; Ivanov, Alexei V.; Cole, Andrew G.; Henderson, Ian; Zautke, Nathan A.; Brunn, Sandra A.; Mollova, Nevena; Leung, Kwan; Chisholm, Jeffrey W.; Zablocki, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2048-2052</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We identified a series of structurally novel SCD (Δ9 desaturase) inhibitors via high-throughput screening and follow-up SAR studies.  Modification of the central bicyclic scaffold has proven key to our potency optimization effort.  The most potent analog (8g) had IC50 value of 50 pM in a HEPG2 SCD assay and has been shown to be metabolically stable and selective against Δ5 and Δ6 desaturases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2IRcglbHz3LVg90H21EOLACvtfcHk0likOp6cV4f7VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1arsLc%253D&md5=c59e65fd61fd55c2d32bb1a6844ee696</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.019%26sid%3Dliteratum%253Aachs%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DVasilevich%26aufirst%3DN.%2BI.%26aulast%3DGlushkov%26aufirst%3DA.%2BI.%26aulast%3DZilbershtein%26aufirst%3DT.%2BM.%26aulast%3DIvanov%26aufirst%3DA.%2BV.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DZautke%26aufirst%3DN.%2BA.%26aulast%3DBrunn%26aufirst%3DS.%2BA.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DChisholm%26aufirst%3DJ.%2BW.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DNovel%252C%2520potent%252C%2520selective%252C%2520and%2520metabolically%2520stable%2520stearoyl-CoA%2520desaturase%2520%2528SCD%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2048%26epage%3D2052%26doi%3D10.1016%2Fj.bmcl.2009.02.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hess, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chisholm, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igal, R. A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of stearoyl-CoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e11394</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0011394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1371%2Fjournal.pone.0011394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=20613975" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&author=D.+Hessauthor=J.+W.+Chisholmauthor=R.+A.+Igal&title=Inhibition+of+stearoyl-CoA+desaturase+activity+blocks+cell+cycle+progression+and+induces+programmed+cell+death+in+lung+cancer+cells&doi=10.1371%2Fjournal.pone.0011394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0011394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0011394%26sid%3Dliteratum%253Aachs%26aulast%3DHess%26aufirst%3DD.%26aulast%3DChisholm%26aufirst%3DJ.%2BW.%26aulast%3DIgal%26aufirst%3DR.%2BA.%26atitle%3DInhibition%2520of%2520stearoyl-CoA%2520desaturase%2520activity%2520blocks%2520cell%2520cycle%2520progression%2520and%2520induces%2520programmed%2520cell%2520death%2520in%2520lung%2520cancer%2520cells%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26doi%3D10.1371%2Fjournal.pone.0011394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokrovskaia, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namdari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratkay, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mork, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dales, N.</span></span> <span> </span><span class="NLM_article-title">Discovery of thiazolylpyridinone scd1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.bmcl.2013.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=24370012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVWh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=526-531&author=S.+Sunauthor=Z.+Zhangauthor=V.+Rainaauthor=N.+Pokrovskaiaauthor=D.+Houauthor=R.+Namdariauthor=K.+Khakhauthor=L.+G.+Ratkayauthor=D.+G.+McLarenauthor=M.+Morkauthor=J.+Fuauthor=S.+Ferreiraauthor=B.+Hubbardauthor=M.+D.+Wintherauthor=N.+Dales&title=Discovery+of+thiazolylpyridinone+scd1+inhibitors+with+preferential+liver+distribution+and+reduced+mechanism-based+adverse+effects&doi=10.1016%2Fj.bmcl.2013.12.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects</span></div><div class="casAuthors">Sun, Shaoyi; Zhang, Zaihui; Raina, Vandna; Pokrovskaia, Natalia; Hou, Duanjie; Namdari, Rostam; Khakh, Kuldip; Ratkay, Leslie G.; McLaren, David G.; Mork, Monica; Fu, Jianmin; Ferreira, Suzie; Hubbard, Brian; Winther, Michael D.; Dales, Natalie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">526-531</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We discovered a series of novel and potent thiazolylpyridinone-based SCD1 inhibitors based on a 2-aminothiazole HTS hit by replacing the amide bond with a pyridinone moiety.  Compd. 19 demonstrated good potency against SCD1 in vitro and in vivo.  The mouse liver microsomal SCD1 in vitro potency for 19 was improved by more than 240-fold compared to the original HTS hit.  Furthermore, 19 demonstrated a dose-dependent redn. of plasma desatn. index with an ED50 of 6.3 mg/kg.  Compd. 19 demonstrated high liver to plasma and liver to eyelid exposures, indicating preferential liver distribution.  The preliminary toxicol. study with compd. 19 did not demonstrate adverse effects related to SCD1 inhibition, suggesting a wide safety margin with respect to other known SCD1 inhibitors with wider distribution profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5UBgyvMHnfrVg90H21EOLACvtfcHk0liZXtAbZN5vIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVWh&md5=d8cd13963e5864a7a816c45d8138383a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRaina%26aufirst%3DV.%26aulast%3DPokrovskaia%26aufirst%3DN.%26aulast%3DHou%26aufirst%3DD.%26aulast%3DNamdari%26aufirst%3DR.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DRatkay%26aufirst%3DL.%2BG.%26aulast%3DMcLaren%26aufirst%3DD.%2BG.%26aulast%3DMork%26aufirst%3DM.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DFerreira%26aufirst%3DS.%26aulast%3DHubbard%26aufirst%3DB.%26aulast%3DWinther%26aufirst%3DM.%2BD.%26aulast%3DDales%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520thiazolylpyridinone%2520scd1%2520inhibitors%2520with%2520preferential%2520liver%2520distribution%2520and%2520reduced%2520mechanism-based%2520adverse%2520effects%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D526%26epage%3D531%26doi%3D10.1016%2Fj.bmcl.2013.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belair, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bleasby, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desroches, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiral, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafey, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamelin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachance, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normandin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pocai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramtohul, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skorey, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sørensen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturkenboom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styhler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waddleton, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5082</span>– <span class="NLM_lpage">5096</span>, <span class="refDoi"> DOI: 10.1021/jm200319u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200319u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFShsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5082-5096&author=R.+M.+Oballaauthor=L.+Belairauthor=W.+C.+Blackauthor=K.+Bleasbyauthor=C.+C.+Chanauthor=C.+Desrochesauthor=X.+Duauthor=R.+Gordonauthor=J.+Guayauthor=S.+Guiralauthor=M.+J.+Hafeyauthor=E.+Hamelinauthor=Z.+Huangauthor=B.+Kennedyauthor=N.+Lachanceauthor=F.+Landryauthor=C.+S.+Liauthor=J.+Manciniauthor=D.+Normandinauthor=A.+Pocaiauthor=D.+A.+Powellauthor=Y.+K.+Ramtohulauthor=K.+Skoreyauthor=D.+S%C3%B8rensenauthor=W.+Sturkenboomauthor=A.+Styhlerauthor=D.+M.+Waddletonauthor=H.+Wangauthor=S.+Wongauthor=L.+Xuauthor=L.+Zhang&title=Development+of+a+liver-targeted+stearoyl-CoA+desaturase+%28SCD%29+inhibitor+%28MK-8245%29+to+establish+a+therapeutic+window+for+the+treatment+of+diabetes+and+dyslipidemia&doi=10.1021%2Fjm200319u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia</span></div><div class="casAuthors">Oballa, Renata M.; Belair, Liette; Black, W. Cameron; Bleasby, Kelly; Chan, Chi Chung; Desroches, Carole; Du, Xiaobing; Gordon, Robert; Guay, Jocelyne; Guiral, Sebastien; Hafey, Michael J.; Hamelin, Emelie; Huang, Zheng; Kennedy, Brian; Lachance, Nicolas; Landry, France; Li, Chun Sing; Mancini, Joseph; Normandin, Denis; Pocai, Alessandro; Powell, David A.; Ramtohul, Yeeman K.; Skorey, Kathryn; Sorensen, Dan; Sturkenboom, Wayne; Styhler, Angela; Waddleton, Deena M.; Wang, Hao; Wong, Simon; Xu, Lijing; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5082-5096</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The potential use of SCD inhibitors for the chronic treatment of diabetes and dyslipidemia has been limited by preclin. adverse events assocd. with inhibition of SCD in skin and eye tissues.  To establish a therapeutic window, we embarked on designing liver-targeted SCD inhibitors by utilizing mol. recognition by liver-specific org. anion transporting polypeptides (OATPs).  In doing so, we set out to target the SCD inhibitor to the organ believed to be responsible for the therapeutic efficacy (liver) while minimizing its exposure in the tissues assocd. with mechanism-based SCD depletion of essential lubricating lipids (skin and eye).  These efforts led to the discovery of MK-8245 (7), a potent, liver-targeted SCD inhibitor with preclin. antidiabetic and antidyslipidemic efficacy with a significantly improved therapeutic window.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ3Zro2czsCLVg90H21EOLACvtfcHk0liZXtAbZN5vIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFShsrc%253D&md5=0b2967e2097b127fb7994f0165c682a6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm200319u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200319u%26sid%3Dliteratum%253Aachs%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DBelair%26aufirst%3DL.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DBleasby%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DC.%2BC.%26aulast%3DDesroches%26aufirst%3DC.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DGuiral%26aufirst%3DS.%26aulast%3DHafey%26aufirst%3DM.%2BJ.%26aulast%3DHamelin%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DKennedy%26aufirst%3DB.%26aulast%3DLachance%26aufirst%3DN.%26aulast%3DLandry%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DNormandin%26aufirst%3DD.%26aulast%3DPocai%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DD.%2BA.%26aulast%3DRamtohul%26aufirst%3DY.%2BK.%26aulast%3DSkorey%26aufirst%3DK.%26aulast%3DS%25C3%25B8rensen%26aufirst%3DD.%26aulast%3DSturkenboom%26aufirst%3DW.%26aulast%3DStyhler%26aufirst%3DA.%26aulast%3DWaddleton%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520a%2520liver-targeted%2520stearoyl-CoA%2520desaturase%2520%2528SCD%2529%2520inhibitor%2520%2528MK-8245%2529%2520to%2520establish%2520a%2520therapeutic%2520window%2520for%2520the%2520treatment%2520of%2520diabetes%2520and%2520dyslipidemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5082%26epage%3D5096%26doi%3D10.1021%2Fjm200319u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodumuru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sviridov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLaren, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratkay, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gschwend, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamboj, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1021/jm301661h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301661h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=568-583&author=Z.+Zhangauthor=S.+Sunauthor=V.+Kodumuruauthor=D.+Houauthor=S.+Liuauthor=N.+Chakkaauthor=S.+Sviridovauthor=S.+Chowdhuryauthor=D.+G.+McLarenauthor=L.+G.+Ratkayauthor=K.+Khakhauthor=X.+Chengauthor=H.+W.+Gschwendauthor=R.+Kambojauthor=J.+Fuauthor=M.+D.+Winther&title=Discovery+of+piperazin-1-ylpyridazine-based+potent+and+selective+stearoyl-CoA+desaturase-1+inhibitors+for+the+treatment+of+obesity+and+metabolic+syndrome&doi=10.1021%2Fjm301661h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Piperazin-1-ylpyridazine-Based Potent and Selective Stearoyl-CoA Desaturase-1 Inhibitors for the Treatment of Obesity and Metabolic Syndrome</span></div><div class="casAuthors">Zhang, Zaihui; Sun, Shaoyi; Kodumuru, Vishnumurthy; Hou, Duanjie; Liu, Shifeng; Chakka, Nagasree; Sviridov, Serguei; Chowdhury, Sultan; McLaren, David G.; Ratkay, Leslie G.; Khakh, Kuldip; Cheng, Xing; Gschwend, Heinz W.; Kamboj, Rajender; Fu, Jianmin; Winther, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">568-583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stearoyl-CoA desaturase-1 (SCD1) catalyzes de novo synthesis of monounsatd. fatty acids from satd. fatty acids.  Studies have demonstrated that rodents lacking a functional SCD1 gene have an improved metabolic profile, including reduced wt. gain, lower triglycerides, and improved insulin response.  In this study, we discovered a series of piperazinylpyridazine-based highly potent, selective, and orally bioavailable compds.  Particularly, compd. I (XEN103) was highly active in vitro (mSCD1 IC50 = 14 nM and HepG2 IC50 = 12 nM) and efficacious in vivo (ED50 = 0.8 mg/kg).  It also demonstrated striking redn. of wt. gain in a rodent model.  Our findings with small-mol. SCD1 inhibitors confirm the importance of this target in metabolic regulation, describe novel models for assessing SCD1 inhibitors for efficacy and tolerability and demonstrate an opportunity to develop a novel therapy for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz3sZgrA2_C7Vg90H21EOLACvtfcHk0liPVbi9TenPKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCqsL%252FO&md5=1a4119b8547864b1bab3b05e362f9d18</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm301661h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301661h%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DKodumuru%26aufirst%3DV.%26aulast%3DHou%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DSviridov%26aufirst%3DS.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DMcLaren%26aufirst%3DD.%2BG.%26aulast%3DRatkay%26aufirst%3DL.%2BG.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DGschwend%26aufirst%3DH.%2BW.%26aulast%3DKamboj%26aufirst%3DR.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DWinther%26aufirst%3DM.%2BD.%26atitle%3DDiscovery%2520of%2520piperazin-1-ylpyridazine-based%2520potent%2520and%2520selective%2520stearoyl-CoA%2520desaturase-1%2520inhibitors%2520for%2520the%2520treatment%2520of%2520obesity%2520and%2520metabolic%2520syndrome%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D568%26epage%3D583%26doi%3D10.1021%2Fjm301661h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntambi, J. M.</span></span> <span> </span><span class="NLM_article-title">Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid</span>. <i>J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">2260</span>– <span class="NLM_lpage">2268</span>, <span class="refDoi"> DOI: 10.1093/jn/131.9.2260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1093%2Fjn%2F131.9.2260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=11533264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmslGmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2001&pages=2260-2268&author=M.+Miyazakiauthor=W.+C.+Manauthor=J.+M.+Ntambi&title=Targeted+disruption+of+stearoyl-CoA+desaturase1+gene+in+mice+causes+atrophy+of+sebaceous+and+meibomian+glands+and+depletion+of+wax+esters+in+the+eyelid&doi=10.1093%2Fjn%2F131.9.2260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid</span></div><div class="casAuthors">Miyazaki, Makoto; Man, Weng Chi; Ntambi, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nutrition</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2260-2268</span>CODEN:
                <span class="NLM_cas:coden">JONUAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-3166</span>.
    
            (<span class="NLM_cas:orgname">American Society for Nutritional Sciences</span>)
        </div><div class="casAbstract">Stearoyl-CoA desaturase (SCD) is a microsomal rate-limiting enzyme in the cellular synthesis of monounsatd. fatty acids (MUFA), mainly oleate (18:1) and palmitoleate (16:1), which are the major MUFA of membrane phospholipids, cholesterol esters and triglycerides.  Three well-characterized isoforms of SCD, SCD1, SCD2 and SCD3, exist in mice.  To investigate the physiol. functions of SCD1, we generated SCD1 null (SCD1-/-) mice.  The skin and eyelid of SCD1-/- mice are deficient in triglycerides and cholesterol esters, and the eyelid also is deficient in wax esters.  Furthermore, the eyelid and skin of SCD1-/- mice have higher levels of free cholesterol.  SCD1-/- mice develop cutaneous abnormalities and narrow eye fissure with atrophic sebaceous and meibomian glands.  Consumption of diets contg. high levels of oleate, failed to restore the levels of triglycerides, cholesterol esters and wax esters in SCD1-/- mice to the levels found in the eyelid of wild-type mice.  These results reveal a physiol. role of SCD in cholesterol homeostasis as well as in the de novo biosynthesis of cholesterol esters, triglycerides and wax esters required for normal skin and eyelid function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhUicg2unZLLVg90H21EOLACvtfcHk0liPVbi9TenPKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmslGmtrc%253D&md5=d33bfcce300df71019684f2c4a779d40</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1093%2Fjn%2F131.9.2260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjn%252F131.9.2260%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DMan%26aufirst%3DW.%2BC.%26aulast%3DNtambi%26aufirst%3DJ.%2BM.%26atitle%3DTargeted%2520disruption%2520of%2520stearoyl-CoA%2520desaturase1%2520gene%2520in%2520mice%2520causes%2520atrophy%2520of%2520sebaceous%2520and%2520meibomian%2520glands%2520and%2520depletion%2520of%2520wax%2520esters%2520in%2520the%2520eyelid%26jtitle%3DJ.%2520Nutr.%26date%3D2001%26volume%3D131%26spage%3D2260%26epage%3D2268%26doi%3D10.1093%2Fjn%2F131.9.2260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Meingassner, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aschauer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winiski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dales, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winther, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stütz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of stearoyl-CoA desaturase in the skin induces atrophy of the sebaceous glands</span>. <i>J. Invest. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">2091</span>– <span class="NLM_lpage">2094</span>, <span class="refDoi"> DOI: 10.1038/jid.2013.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1038%2Fjid.2013.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=23446987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltFClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=2091-2094&author=J.+G.+Meingassnerauthor=H.+Aschauerauthor=A.+P.+Winiskiauthor=N.+Dalesauthor=D.+Yoweauthor=M.+D.+Wintherauthor=Z.+Zhangauthor=A.+St%C3%BCtzauthor=A.+Billich&title=Pharmacological+inhibition+of+stearoyl-CoA+desaturase+in+the+skin+induces+atrophy+of+the+sebaceous+glands&doi=10.1038%2Fjid.2013.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Inhibition of Stearoyl CoA Desaturase in the Skin Induces Atrophy of the Sebaceous Glands</span></div><div class="casAuthors">Meingassner, Josef G.; Aschauer, Heinrich; Winiski, Anthony P.; Dales, Natalie; Yowe, David; Winther, Michael D.; Zhang, Zaihui; Stuetz, Anton; Billich, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Investigative Dermatology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2091-2094</span>CODEN:
                <span class="NLM_cas:coden">JIDEAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-202X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Acne is a multifactorial disease of the pilosebaceous unit resulting from increased sebum prodn., altered keratinization, inflammation, and bacterial hypercolonization.  With respect to hyperseborrhea as one of the contributing factors, it is of interest to study pathways that regulate sebaceous gland differentiation.  Interestingly, mouse strains deficient in the enzyme stearoyl-CoA desaturase 1 (SCD1) exhibit severe hypoplasia of sebaceous glands (Zheng et al., 1999; Sundberg et al., 2000; Miyazaki et al., 2001; Georgel et al., 2005).  SCDs are microsomal enzymes that catalyze the biosynthesis of monounsatd. fatty acids from satd. acyl-CoAs (Ntambi and Miyazaki, 2003); specifically they introduce cis-double bonds in the Δ9 position, the preferred substrates being palmitoyl-CoA and stearoyl-CoA.  Here, we asked whether pharmacol. inhibition of SCD activity would have an impact on sebaceous glands.  From a series of novel SCD1 inhibitors (Zhang et al., 2013), compd. XEN103, (6-[4-(5-fluoro-2-trifluoromethylbenzoyl)-piperazin-1-yl]pyridazine-3-carboxylic acid (2-cyclopropylethyl)amide (Figure 1a), was chosen for further characterization.  XEN103 inhibited SCD1 activity in mouse liver microsomes with IC50=14 nM.  The compd. featured 700-fold selectivity for mouse SCD1 activity relative to the closely related Δ5- and Δ6-desaturases (FADS1 and FADS2), indicating low potential for blockade of essential fatty acid and sapienic acid biosynthesis, in which these enzymes are involved.  In human HepG2 cells, XEN103 blocked SCD1 activity with IC50=12 nM.  Furthermore, XEN103 treatment of human SZ95 sebocytes led to redn. of monounsatd. acyl chains in phosphatidylcholine with IC50=11 nM (Figure 1b); these cells express SCD1 (Harrison et al., 2007) but not SCD5 (our unpublished data), the only other known human Δ9-desaturase.  Expression of SCD1 in SZ95 cells is increased by treatment with testosterone and linoleic acid; this increase was shown previously to be blocked by XEN103 using a semiquant. method (Zouboulis et al., 2011).  Quant. reverse transcriptase-PCR showed half-maximal inhibition between 10 and 100 nM XEN103 (Figure 1c).  Thus, XEN103 not only acts as an enzyme inhibitor but also blocks androgen-induced transcription of the gene.  One may speculate that a product of SCD1 required for SCD1 transcription is involved in a pos. feedback loop.  We assessed the effect of XEN103 on mouse skin after topical application.  Mice were treated for 8 days on the shaved back with solns. contg. 0.1% or 1% XEN103 in propylene glycol/ethanol 7:3, to assess local tolerance and activity.  There were no signs of skin irritation at the test sites during the treatment period visible by macroscopic inspection or by histol. examn.  As assessed by histomorphometry, application of 1% XEN103 reduced the nos. of sebaceous glands by∼65% (P<0.001) and the size of the remaining glands by∼50% (P<0.01) (Figure 2a).  In a total of three independent studies, redn. of sebaceous gland nos. and size varied in the range of 50-75%.  Representative photographs of vehicle- and XEN103-treated skin samples stained with hematoxylin-eosin or with oil red O are shown in Figure 2b and c, resp.  While numerous normally sized and lipid-loaded sebaceous glands were seen at vehicle-treated sites, only very small atrophic sebaceous glands with hardly any assocd. lipid staining were visible at XEN103-treated sites.  Thus, the SCD1 inhibitor XEN103 clearly induces an atrophogenic effect on the sebaceous glands in mouse skin, which should consequently result in reduced sebum lipids.  When XEN103 was applied in soln. at a concn. of 0.1%, XEN103 induced little atrophogenic effect (Figure 2a); in a sep. study we detd. the minimal effective concn. to 0.5% (data not shown).  While a trend toward a decrease in sebaceous gland size was already obsd. after 2 days, the effect increased with time and was statistically significant after 6 days for both size and nos. (Figure 2d).  When treatment was stopped after 7 days, sebaceous gland nos. and size reverted to normal values within 2 wk (data not shown).  At skin areas distant from the XEN103-treated sites, there was no significant redn. in the no. of sebaceous glands (Figure 2a).  This indicates that efficacy is restricted to the topically treated area, excluding activity at distant sites due to percutaneous absorption.  This observation is in line with the obsd. low plasma exposure with XEN103, while at least 1000-fold higher concns. of XEN103 were found in the skin (Supplementary Table S1).  To det. whether topical application of XEN103 indeed blocked SCD activity in the skin, we detd. the ratio of palmitoleic and palmitic acid as a measure of Δ9-desaturase activity.  The desatn. of fatty acids in the triglycerides was reduced by about 50% when mice were treated with 1% XEN103 (Figure 2e).  In the 0.1% XEN103-treated group, redn. was by 20%.  This result correlates well with the sebaceous glands' atrophy end point and the skin exposure to XEN103.  To summarize, XEN103 is a potent inhibitor of SCD activity as shown in microsomal prepns., cultured cells, and in rodents in vivo.  The compd. is active on its target enzyme across species and, importantly, it also reduces both the activity and the androgen-induced expression of SCD1 in human sebocytes.  Using this tool compd., we show that pharmacol. inhibition of SCD in mouse skin rapidly induces pronounced sebaceous gland atrophy after topical application in a dose- and time-dependent manner.  The effect is due to the local action of the compd. on SCD activity in the skin and occurs in the presence of only minimal plasma exposure, thus excluding any potentially undesirable effects of systemic SCD inhibition.  In mice, there are three Δ9-desaturases apart from SCD1, namely SCD2-4, which potentially could be inhibited by XEN103; however, Scd2-deficient mice have normal sebaceous glands (Miyazaki et al., 2005), the Scd3 gene cannot compensate Scd1 deficiency in asebia mice (Zheng et al., 2001), and Scd4 expression is restricted to the heart (Miyazaki et al., 2003).  Thus, we consider that sebaceous gland atrophy in mouse skin is most likely due to inhibition of SCD1.  In human skin, SCD1 is present as the only Δ9-desaturase.  It will be interesting to learn from a clin. study whether an SCD1 inhibitor such as XEN103 also induces human sebaceous gland atrophy when applied in a topical formulation allowing for adequate exposure at the target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlYGhbZSkxQLVg90H21EOLACvtfcHk0ljmwDIV7WoZmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltFClsbo%253D&md5=ef8dfc6aab84cb89094eb90f7a67a229</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1038%2Fjid.2013.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjid.2013.89%26sid%3Dliteratum%253Aachs%26aulast%3DMeingassner%26aufirst%3DJ.%2BG.%26aulast%3DAschauer%26aufirst%3DH.%26aulast%3DWiniski%26aufirst%3DA.%2BP.%26aulast%3DDales%26aufirst%3DN.%26aulast%3DYowe%26aufirst%3DD.%26aulast%3DWinther%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DSt%25C3%25BCtz%26aufirst%3DA.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DPharmacological%2520inhibition%2520of%2520stearoyl-CoA%2520desaturase%2520in%2520the%2520skin%2520induces%2520atrophy%2520of%2520the%2520sebaceous%2520glands%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D2013%26volume%3D133%26spage%3D2091%26epage%3D2094%26doi%3D10.1038%2Fjid.2013.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrzyn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrzyn, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntambi, J. M.</span></span> <span> </span><span class="NLM_article-title">Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment</span>. <i>J. Lipid Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1674</span>– <span class="NLM_lpage">1682</span>, <span class="refDoi"> DOI: 10.1194/jlr.M400039-JLR200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1194%2Fjlr.M400039-JLR200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=1674-1682&author=S.-H.+Leeauthor=A.+Dobrzynauthor=P.+Dobrzynauthor=S.+M.+Rahmanauthor=M.+Miyazakiauthor=J.+M.+Ntambi&title=Lack+of+stearoyl-CoA+desaturase+1+upregulates+basal+thermogenesis+but+causes+hypothermia+in+a+cold+environment&doi=10.1194%2Fjlr.M400039-JLR200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1194%2Fjlr.M400039-JLR200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1194%252Fjlr.M400039-JLR200%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-H.%26aulast%3DDobrzyn%26aufirst%3DA.%26aulast%3DDobrzyn%26aufirst%3DP.%26aulast%3DRahman%26aufirst%3DS.%2BM.%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DNtambi%26aufirst%3DJ.%2BM.%26atitle%3DLack%2520of%2520stearoyl-CoA%2520desaturase%25201%2520upregulates%2520basal%2520thermogenesis%2520but%2520causes%2520hypothermia%2520in%2520a%2520cold%2520environment%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2004%26volume%3D45%26spage%3D1674%26epage%3D1682%26doi%3D10.1194%2Fjlr.M400039-JLR200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flowers, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otzelberger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ntambi, J. M.</span></span> <span> </span><span class="NLM_article-title">Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2007.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.cmet.2007.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=18054317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVektb%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=484-496&author=M.+Miyazakiauthor=M.+T.+Flowersauthor=H.+Sampathauthor=K.+Chuauthor=C.+Otzelbergerauthor=X.+Liuauthor=J.+M.+Ntambi&title=Hepatic+stearoyl-CoA+desaturase-1+deficiency+protects+mice+from+carbohydrate-induced+adiposity+and+hepatic+steatosis&doi=10.1016%2Fj.cmet.2007.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis</span></div><div class="casAuthors">Miyazaki, Makoto; Flowers, Matthew T.; Sampath, Harini; Chu, Kiki; Otzelberger, Carolin; Liu, Xueqing; Ntambi, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">484-496</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Stearoyl-CoA desaturase-1 (SCD1), a crit. regulator of energy metab., catalyzes the synthesis of monounsatd. fats.  To understand the tissue-specific role of SCD1 in energy homeostasis, we used Cre-Iox technol. to generate mice with a liver-specific knockout of Scd1 (LKO).  LKO mice were protected from high-carbohydrate, but not high-fat (HF), diet-induced adiposity and hepatic steatosis.  Addnl., on a high-sucrose, very low-fat (HSVLF) diet, lipogenesis and levels of nuclear SREBP-1 and ChREBP were significantly decreased in the livers of LKO relative to Scd1lox/lox (Lox) mice.  HSVLF feeding in LKO mice caused hypoglycemia and hepatic carbohydrate redn. due to an impairment of gluconeogenesis.  Oleate, but not sterate, supplementation normalized adiposity, gluconeogenesis, triglyceride secretion, and hepatic lipogenesis of LKO mice.  These results indicate that hepatic SCD1 expression (and thus, oleate) is required for carbohydrate-induced adiposity, but SCD1 inhibition in extrahepatic tissues is required to protect mice from HF-induced obesity and insulin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqTz4b2jYuobVg90H21EOLACvtfcHk0ljmwDIV7WoZmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVektb%252FL&md5=b72dd6c635ca9cf4ae3892dda78b6c7c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DM.%26aulast%3DFlowers%26aufirst%3DM.%2BT.%26aulast%3DSampath%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DOtzelberger%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNtambi%26aufirst%3DJ.%2BM.%26atitle%3DHepatic%2520stearoyl-CoA%2520desaturase-1%2520deficiency%2520protects%2520mice%2520from%2520carbohydrate-induced%2520adiposity%2520and%2520hepatic%2520steatosis%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D6%26spage%3D484%26epage%3D496%26doi%3D10.1016%2Fj.cmet.2007.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Merck Sharp
& Dhome Corporation</span>. <span> </span><span class="NLM_article-title">Pharmacokinetics
and Pharmacodynamics
of MK-8245 in Participants With Type 2 Diabetes (MK-8245-012)</span>. <a href="https://clinicaltrials.gov/ct2/show/results/NCT00972322" class="extLink">https://clinicaltrials.gov/ct2/show/results/NCT00972322</a> (accessed
May 1, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Merck+Sharp%0A%26+Dhome+Corporation&title=Pharmacokinetics%0Aand+Pharmacodynamics%0Aof+MK-8245+in+Participants+With+Type+2+Diabetes+%28MK-8245-012%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DPharmacokinetics%250Aand%2520Pharmacodynamics%250Aof%2520MK-8245%2520in%2520Participants%2520With%2520Type%25202%2520Diabetes%2520%2528MK-8245-012%2529%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Theodoropoulos, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winterton, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Navas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morlock, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzaei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ready, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijhawan, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1038%2Fnchembio.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=26829472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFyis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=218-225&author=P.+C.+Theodoropoulosauthor=S.+S.+Gonzalesauthor=S.+E.+Wintertonauthor=C.+Rodriguez-Navasauthor=J.+S.+McKnightauthor=L.+K.+Morlockauthor=J.+M.+Hansonauthor=B.+Crossauthor=A.+E.+Owenauthor=Y.+Duanauthor=J.+R.+Morenoauthor=A.+Lemoffauthor=H.+Mirzaeiauthor=B.+A.+Posnerauthor=N.+S.+Williamsauthor=J.+M.+Readyauthor=D.+Nijhawan&title=Discovery+of+tumor-specific+irreversible+inhibitors+of+stearoyl+CoA+desaturase&doi=10.1038%2Fnchembio.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase</span></div><div class="casAuthors">Theodoropoulos, Panayotis C.; Gonzales, Stephen S.; Winterton, Sarah E.; Rodriguez-Navas, Carlos; McKnight, John S.; Morlock, Lorraine K.; Hanson, Jordan M.; Cross, Bethany; Owen, Amy E.; Duan, Yingli; Moreno, Jose R.; Lemoff, Andrew; Mirzaei, Hamid; Posner, Bruce A.; Williams, Noelle S.; Ready, Joseph M.; Nijhawan, Deepak</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">218-225</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A hallmark of targeted cancer therapies is selective toxicity among cancer cell lines.  The authors evaluated results from a viability screen of over 200,000 small mols. to identify two chem. series, oxalamides and benzothiazoles, that were selectively toxic at low nanomolar concns. to the same 4 of 12 human lung cancer cell lines.  Sensitive cell lines expressed cytochrome P 450 (CYP) 4F11, which metabolized the compds. into irreversible inhibitors of stearoyl CoA desaturase (SCD).  SCD is recognized as a promising biol. target in cancer and metabolic disease.  However, SCD is essential to sebocytes, and accordingly SCD inhibitors cause skin toxicity.  Mouse sebocytes did not activate the benzothiazoles or oxalamides into SCD inhibitors, providing a therapeutic window for inhibiting SCD in vivo.  The authors thus offer a strategy to target SCD in cancer by taking advantage of high CYP expression in a subset of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiNJKPw3Sb2bVg90H21EOLACvtfcHk0ljPhea6P8klBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFyis7w%253D&md5=5e8b28ef9f69c5060f660e17e0f1e07f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2016%26sid%3Dliteratum%253Aachs%26aulast%3DTheodoropoulos%26aufirst%3DP.%2BC.%26aulast%3DGonzales%26aufirst%3DS.%2BS.%26aulast%3DWinterton%26aufirst%3DS.%2BE.%26aulast%3DRodriguez-Navas%26aufirst%3DC.%26aulast%3DMcKnight%26aufirst%3DJ.%2BS.%26aulast%3DMorlock%26aufirst%3DL.%2BK.%26aulast%3DHanson%26aufirst%3DJ.%2BM.%26aulast%3DCross%26aufirst%3DB.%26aulast%3DOwen%26aufirst%3DA.%2BE.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DMoreno%26aufirst%3DJ.%2BR.%26aulast%3DLemoff%26aufirst%3DA.%26aulast%3DMirzaei%26aufirst%3DH.%26aulast%3DPosner%26aufirst%3DB.%2BA.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DReady%26aufirst%3DJ.%2BM.%26aulast%3DNijhawan%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520tumor-specific%2520irreversible%2520inhibitors%2520of%2520stearoyl%2520CoA%2520desaturase%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D218%26epage%3D225%26doi%3D10.1038%2Fnchembio.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>The results
published here are fully or partially based upon data generated by
the Cancer Target Discovery and Development (CTD2) Network established
by the National Cancer Institute’s Office of Cancer Genomics.
See ‘Lung Cancer Oncogenotype-Selective Drug Target Discovery’
at <a href="https://ctd2.nci.nih.gov/dataPortal/" class="extLink">https://ctd2.nci.nih.gov/dataPortal/</a> (accessed May 1, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+results%0Apublished+here+are+fully+or+partially+based+upon+data+generated+by%0Athe+Cancer+Target+Discovery+and+Development+%28CTD2%29+Network+established%0Aby+the+National+Cancer+Institute%E2%80%99s+Office+of+Cancer+Genomics.%0ASee+%E2%80%98Lung+Cancer+Oncogenotype-Selective+Drug+Target+Discovery%E2%80%99%0Aat+https%3A%2F%2Fctd2.nci.nih.gov%2FdataPortal%2F+%28accessed+May+1%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McMillan, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryu, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diep, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendiratta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemenceau, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaden, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoyaji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covington, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huffman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallipeddi, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voruganti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudderth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSevo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzny, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doddapaneni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazdar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymach, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistuba, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombes, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deberardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. A.</span></span> <span> </span><span class="NLM_article-title">Chemistry-first approach for nomination of personalized treatment in lung cancer</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">864</span>– <span class="NLM_lpage">878</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2Fj.cell.2018.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=29681454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFejtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2018&pages=864-878&author=E.+A.+McMillanauthor=M.-J.+Ryuauthor=C.+H.+Diepauthor=S.+Mendirattaauthor=J.+R.+Clemenceauauthor=R.+M.+Vadenauthor=J.-H.+Kimauthor=T.+Motoyajiauthor=K.+R.+Covingtonauthor=M.+Peytonauthor=K.+Huffmanauthor=X.+Wuauthor=L.+Girardauthor=Y.+Sungauthor=P.-H.+Chenauthor=P.+L.+Mallipeddiauthor=J.+Y.+Leeauthor=J.+Hansonauthor=S.+Vorugantiauthor=Y.+Yuauthor=S.+Parkauthor=J.+Sudderthauthor=C.+DeSevoauthor=D.+M.+Muznyauthor=H.+Doddapaneniauthor=A.+Gazdarauthor=R.+A.+Gibbsauthor=T.-H.+Hwangauthor=J.+V.+Heymachauthor=I.+Wistubaauthor=K.+R.+Coombesauthor=N.+S.+Williamsauthor=D.+A.+Wheelerauthor=J.+B.+MacMillanauthor=R.+J.+Deberardinisauthor=M.+G.+Rothauthor=B.+A.+Posnerauthor=J.+D.+Minnaauthor=H.+S.+Kimauthor=M.+A.+White&title=Chemistry-first+approach+for+nomination+of+personalized+treatment+in+lung+cancer&doi=10.1016%2Fj.cell.2018.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer</span></div><div class="casAuthors">McMillan, Elizabeth A.; Ryu, Myung-Jeom; Diep, Caroline H.; Mendiratta, Saurabh; Clemenceau, Jean R.; Vaden, Rachel M.; Kim, Ju-Hwa; Motoyaji, Takashi; Covington, Kyle R.; Peyton, Michael; Huffman, Kenneth; Wu, Xiaofeng; Girard, Luc; Sung, Yeojin; Chen, Pei-Hsaun; Mallipeddi, Prema L.; Lee, Joo Young; Hanson, Jordan; Voruganti, Sukesh; Yu, Yunku; Park, Sunho; Sudderth, Jessica; De Sevo, Christopher; Muzny, Donna M.; Doddapaneni, Harsha Vardhan; Gazdar, Adi; Gibbs, Richard A.; Hwang, Tae-Hyun; Heymach, John V.; Wistuba, Ignacio; Coombes, Kevin R.; Williams, Noelle S.; Wheeler, David A.; MacMillan, John B.; Deberardinis, Ralph J.; Roth, Michael G.; Posner, Bruce A.; Minna, John D.; Kim, Hyun Seok; White, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">864-878.e29</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Diversity in the genetic lesions that cause cancer is extreme.  In consequence, a pressing challenge is the development of drugs that target patient-specific disease mechanisms.  To address this challenge, we employed a chem.-first discovery paradigm for de novo identification of druggable targets linked to robust patient selection hypotheses.  In particular, a 200,000 compd. diversity-oriented chem. library was profiled across a heavily annotated test-bed of >100 cellular models representative of the diverse and characteristic somatic lesions for lung cancer.  This approach led to the delineation of 171 chem.-genetic assocns., shedding light on the targetability of mechanistic vulnerabilities corresponding to a range of oncogenotypes present in patient populations lacking effective therapy.  Chem. addressable addictions to ciliogenesis in TTC21B mutants and GLUT8-dependent serine biosynthesis in KRAS/KEAP1 double mutants are prominent examples.  These observations indicate a wealth of actionable opportunities within the complex mol. etiol. of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow_Hmm03uZN7Vg90H21EOLACvtfcHk0ljPhea6P8klBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFejtrs%253D&md5=41e3d8dda5a1e005277b501a1f83a543</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DMcMillan%26aufirst%3DE.%2BA.%26aulast%3DRyu%26aufirst%3DM.-J.%26aulast%3DDiep%26aufirst%3DC.%2BH.%26aulast%3DMendiratta%26aufirst%3DS.%26aulast%3DClemenceau%26aufirst%3DJ.%2BR.%26aulast%3DVaden%26aufirst%3DR.%2BM.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DMotoyaji%26aufirst%3DT.%26aulast%3DCovington%26aufirst%3DK.%2BR.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DHuffman%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DSung%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DP.-H.%26aulast%3DMallipeddi%26aufirst%3DP.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DHanson%26aufirst%3DJ.%26aulast%3DVoruganti%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DSudderth%26aufirst%3DJ.%26aulast%3DDeSevo%26aufirst%3DC.%26aulast%3DMuzny%26aufirst%3DD.%2BM.%26aulast%3DDoddapaneni%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DGibbs%26aufirst%3DR.%2BA.%26aulast%3DHwang%26aufirst%3DT.-H.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DWistuba%26aufirst%3DI.%26aulast%3DCoombes%26aufirst%3DK.%2BR.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DWheeler%26aufirst%3DD.%2BA.%26aulast%3DMacMillan%26aufirst%3DJ.%2BB.%26aulast%3DDeberardinis%26aufirst%3DR.%2BJ.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DPosner%26aufirst%3DB.%2BA.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DWhite%26aufirst%3DM.%2BA.%26atitle%3DChemistry-first%2520approach%2520for%2520nomination%2520of%2520personalized%2520treatment%2520in%2520lung%2520cancer%26jtitle%3DCell%26date%3D2018%26volume%3D173%26spage%3D864%26epage%3D878%26doi%3D10.1016%2Fj.cell.2018.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Antona, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingelman-Sundberg, M.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 pharmacogenetics and cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1691</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1209377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1038%2Fsj.onc.1209377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=16550168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFyhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=1679-1691&author=C.+Rodriguez-Antonaauthor=M.+Ingelman-Sundberg&title=Cytochrome+P450+pharmacogenetics+and+cancer&doi=10.1038%2Fsj.onc.1209377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 pharmacogenetics and cancer</span></div><div class="casAuthors">Rodriguez-Antona, C.; Ingelman-Sundberg, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1679-1691</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The cytochromes P 450 (CYPs) are key enzymes in cancer formation and cancer treatment.  They mediate the metabolic activation of numerous precarcinogens and participate in the inactivation and activation of anticancer drugs.  Since all CYPs that metabolize xenobiotics are polymorphic, much emphasis has been put on the investigation of a relationship between the distribution of specific variant CYP alleles and risk for different types of cancer, but a consistent view does not yet exist.  This is to a great extent explained by the fact that the CYPs involved in activation of precarcinogens are in general not functionally polymorphic.  This is in contrast to CYPs that are active in drug biotransformation where large interindividual differences in the capacity to metabolize therapeutic drugs are seen as a consequence of polymorphic alleles with altered function.  This includes also some anticancer drugs like tamoxifen and cyclophosphamide metabolized by CYP2D6, CYP2C19 and CYP2B6.  Some P 450 forms are also selectively expressed in tumors, and this could provide a mechanism for drug resistance, but also future therapies using these enzymes as drug targets can be envisioned.  This review gives an up-to-date description of our current knowledge in these areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp09TREI0n_HLVg90H21EOLACvtfcHk0ljPhea6P8klBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFyhtbY%253D&md5=455f85682f7cdfbdd54fdd4df33dc10b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209377%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Antona%26aufirst%3DC.%26aulast%3DIngelman-Sundberg%26aufirst%3DM.%26atitle%3DCytochrome%2520P450%2520pharmacogenetics%2520and%2520cancer%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D1679%26epage%3D1691%26doi%3D10.1038%2Fsj.onc.1209377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">The 95% confidence intervals for the EC<sub>50</sub> values are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_001.csv" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">We speculate that the two bands vary in terms of post-translational modifications.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Intracellular compound concentration was determined after a 24 h incubation with 500 nM drug in H1155 cells to avoid complications from toxicity. Although differences in accumulation were observed, the most highly accumulated compounds in this study showed little toxicity to H1155 cells, ruling out poor permeability as an explanation for lack of toxicity. <b>58</b>: 80 ± 40 nM, <b>80</b>: 340 ± 100 nM, <b>106</b>: 1670 ± 560 nM, <b>15</b>: 870 ± 200.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lam, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martell, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamer, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deerinck, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellisman, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mootha, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ting, A. Y.</span></span> <span> </span><span class="NLM_article-title">Directed evolution of APEX2 for electron microscopy and proximity labeling</span>. <i>Nat. Methods</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1038/nmeth.3179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1038%2Fnmeth.3179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=25419960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=51-54&author=S.+S.+Lamauthor=J.+D.+Martellauthor=K.+J.+Kamerauthor=T.+J.+Deerinckauthor=M.+H.+Ellismanauthor=V.+K.+Moothaauthor=A.+Y.+Ting&title=Directed+evolution+of+APEX2+for+electron+microscopy+and+proximity+labeling&doi=10.1038%2Fnmeth.3179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Directed evolution of APEX2 for electron microscopy and proximity labeling</span></div><div class="casAuthors">Lam, Stephanie S.; Martell, Jeffrey D.; Kamer, Kimberli J.; Deerinck, Thomas J.; Ellisman, Mark H.; Mootha, Vamsi K.; Ting, Alice Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Methods</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-54</span>CODEN:
                <span class="NLM_cas:coden">NMAEA3</span>;
        ISSN:<span class="NLM_cas:issn">1548-7091</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">APEX is an engineered peroxidase that functions as an electron microscopy tag and a promiscuous labeling enzyme for live-cell proteomics.  Because limited sensitivity precludes applications requiring low APEX expression, the authors used yeast-display evolution to improve its catalytic efficiency.  APEX2 is far more active in cells, enabling the use of electron microscopy to resolve the submitochondrial localization of calcium uptake regulatory protein MICU1.  APEX2 also permits superior enrichment of endogenous mitochondrial and endoplasmic reticulum membrane proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryNYEMYL_nC7Vg90H21EOLACvtfcHk0lhXrC-DmXsegw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKlsrzJ&md5=dbcff967a82934bb8cfe872cba6132b4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnmeth.3179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmeth.3179%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DS.%2BS.%26aulast%3DMartell%26aufirst%3DJ.%2BD.%26aulast%3DKamer%26aufirst%3DK.%2BJ.%26aulast%3DDeerinck%26aufirst%3DT.%2BJ.%26aulast%3DEllisman%26aufirst%3DM.%2BH.%26aulast%3DMootha%26aufirst%3DV.%2BK.%26aulast%3DTing%26aufirst%3DA.%2BY.%26atitle%3DDirected%2520evolution%2520of%2520APEX2%2520for%2520electron%2520microscopy%2520and%2520proximity%2520labeling%26jtitle%3DNat.%2520Methods%26date%3D2015%26volume%3D12%26spage%3D51%26epage%3D54%26doi%3D10.1038%2Fnmeth.3179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcantoni, E.</span></span> <span> </span><span class="NLM_article-title">Cerium(III) chloride mediated Michael addition of RMgX to nitroenes: A very efficient access to complex nitroalkanes</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">8651</span>– <span class="NLM_lpage">8654</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)78462-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1016%2FS0040-4039%2800%2978462-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1994&pages=8651-8654&author=G.+Bartoliauthor=M.+Boscoauthor=L.+Sambriauthor=E.+Marcantoni&title=Cerium%28III%29+chloride+mediated+Michael+addition+of+RMgX+to+nitroenes%3A+A+very+efficient+access+to+complex+nitroalkanes&doi=10.1016%2FS0040-4039%2800%2978462-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2978462-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252978462-0%26sid%3Dliteratum%253Aachs%26aulast%3DBartoli%26aufirst%3DG.%26aulast%3DBosco%26aufirst%3DM.%26aulast%3DSambri%26aufirst%3DL.%26aulast%3DMarcantoni%26aufirst%3DE.%26atitle%3DCerium%2528III%2529%2520chloride%2520mediated%2520Michael%2520addition%2520of%2520RMgX%2520to%2520nitroenes%253A%2520A%2520very%2520efficient%2520access%2520to%2520complex%2520nitroalkanes%26jtitle%3DTetrahedron%2520Lett.%26date%3D1994%26volume%3D35%26spage%3D8651%26epage%3D8654%26doi%3D10.1016%2FS0040-4039%2800%2978462-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehmlow, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebi, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolidon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von der
Mark, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morand, O. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3354</span>– <span class="NLM_lpage">3370</span>, <span class="refDoi"> DOI: 10.1021/jm021120f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm021120f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3354-3370&author=H.+Dehmlowauthor=J.+D.+Aebiauthor=S.+Jolidonauthor=Y.-H.+Jiauthor=E.+M.+von+der%0AMarkauthor=J.+Himberauthor=O.+H.+Morand&title=Synthesis+and+structure%E2%80%93activity+studies+of+novel+orally+active+non-terpenoic+2%2C3-oxidosqualene+cyclase+inhibitors&doi=10.1021%2Fjm021120f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm021120f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm021120f%26sid%3Dliteratum%253Aachs%26aulast%3DDehmlow%26aufirst%3DH.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DJolidon%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DY.-H.%26aulast%3Dvon%2Bder%2BMark%26aufirst%3DE.%2BM.%26aulast%3DHimber%26aufirst%3DJ.%26aulast%3DMorand%26aufirst%3DO.%2BH.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520studies%2520of%2520novel%2520orally%2520active%2520non-terpenoic%25202%252C3-oxidosqualene%2520cyclase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3354%26epage%3D3370%26doi%3D10.1021%2Fjm021120f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boshoff, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somu, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barry, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich, C. C.</span></span> <span> </span><span class="NLM_article-title">5‘-O-[(<i>N</i>-acyl)sulfamoyl]adenosines as antitubercular agents that inhibit MbtA:  An adenylation enzyme required for siderophore biosynthesis of the mycobactins</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6080</span>– <span class="NLM_lpage">6094</span>, <span class="refDoi"> DOI: 10.1021/jm070905o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070905o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6080-6094&author=C.+Qiaoauthor=A.+Gupteauthor=H.+I.+Boshoffauthor=D.+J.+Wilsonauthor=E.+M.+Bennettauthor=R.+V.+Somuauthor=C.+E.+Barryauthor=C.+C.+Aldrich&title=5%E2%80%98-O-%5B%28N-acyl%29sulfamoyl%5Dadenosines+as+antitubercular+agents+that+inhibit+MbtA%3A%E2%80%89+An+adenylation+enzyme+required+for+siderophore+biosynthesis+of+the+mycobactins&doi=10.1021%2Fjm070905o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm070905o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070905o%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DC.%26aulast%3DGupte%26aufirst%3DA.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26aulast%3DWilson%26aufirst%3DD.%2BJ.%26aulast%3DBennett%26aufirst%3DE.%2BM.%26aulast%3DSomu%26aufirst%3DR.%2BV.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DAldrich%26aufirst%3DC.%2BC.%26atitle%3D5%25E2%2580%2598-O-%255B%2528N-acyl%2529sulfamoyl%255Dadenosines%2520as%2520antitubercular%2520agents%2520that%2520inhibit%2520MbtA%253A%25E2%2580%2589%2520An%2520adenylation%2520enzyme%2520required%2520for%2520siderophore%2520biosynthesis%2520of%2520the%2520mycobactins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6080%26epage%3D6094%26doi%3D10.1021%2Fjm070905o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livshitz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biran, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and receptor-binding affinity of fluorotamoxifen, a possible estrogen-receptor imaging agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1504</span>– <span class="NLM_lpage">1511</span>, <span class="refDoi"> DOI: 10.1021/jm00148a022</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00148a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=1504-1511&author=J.+Shaniauthor=A.+Gazitauthor=T.+Livshitzauthor=S.+Biran&title=Synthesis+and+receptor-binding+affinity+of+fluorotamoxifen%2C+a+possible+estrogen-receptor+imaging+agent&doi=10.1021%2Fjm00148a022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm00148a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00148a022%26sid%3Dliteratum%253Aachs%26aulast%3DShani%26aufirst%3DJ.%26aulast%3DGazit%26aufirst%3DA.%26aulast%3DLivshitz%26aufirst%3DT.%26aulast%3DBiran%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520receptor-binding%2520affinity%2520of%2520fluorotamoxifen%252C%2520a%2520possible%2520estrogen-receptor%2520imaging%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D1504%26epage%3D1511%26doi%3D10.1021%2Fjm00148a022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.-J.</span></span> <span> </span><span class="NLM_article-title">Short and efficient total synthesis of luotonin a and 22-hydroxyacuminatine using a common cascade strategy</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">6270</span>– <span class="NLM_lpage">6272</span>, <span class="refDoi"> DOI: 10.1021/jo070837d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo070837d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnsVCqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=6270-6272&author=H.-B.+Zhouauthor=G.-S.+Liuauthor=Z.-J.+Yao&title=Short+and+efficient+total+synthesis+of+luotonin+a+and+22-hydroxyacuminatine+using+a+common+cascade+strategy&doi=10.1021%2Fjo070837d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Short and Efficient Total Synthesis of Luotonin A and 22-Hydroxyacuminatine Using A Common Cascade Strategy</span></div><div class="casAuthors">Zhou, Hai-Bin; Liu, Guan-Sai; Yao, Zhu-Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6270-6272</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Total syntheses of 22-hydroxyacuminatine and luotonin A were achieved in direct fashion and high overall yields (16% in eight steps and 47% in five steps, resp.).  A mild cascade methodol. was successfully applied in both syntheses as a common strategy.  The new approach presents the advantages of short routes, high overall yields, use of stable intermediates, and ease of operations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkM6TxYtbCTbVg90H21EOLACvtfcHk0lj-aVu-fDIv8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnsVCqs7s%253D&md5=e131c8affaf19dd2c226a09774ab2116</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo070837d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo070837d%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DH.-B.%26aulast%3DLiu%26aufirst%3DG.-S.%26aulast%3DYao%26aufirst%3DZ.-J.%26atitle%3DShort%2520and%2520efficient%2520total%2520synthesis%2520of%2520luotonin%2520a%2520and%252022-hydroxyacuminatine%2520using%2520a%2520common%2520cascade%2520strategy%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D6270%26epage%3D6272%26doi%3D10.1021%2Fjo070837d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosch, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, A.</span></span> <span> </span><span class="NLM_article-title">Enzymatic enantiomeric resolution of phenylethylamines structurally related to amphetamine</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">8171</span>– <span class="NLM_lpage">8177</span>, <span class="refDoi"> DOI: 10.1039/c1ob06251d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;key=10.1039%2Fc1ob06251d" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=8171-8177&author=L.+Munozauthor=A.+M.+Rodriguezauthor=G.+Rosellauthor=M.+P.+Boschauthor=A.+Guerrero&title=Enzymatic+enantiomeric+resolution+of+phenylethylamines+structurally+related+to+amphetamine&doi=10.1039%2Fc1ob06251d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1039%2Fc1ob06251d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1ob06251d%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz%26aufirst%3DL.%26aulast%3DRodriguez%26aufirst%3DA.%2BM.%26aulast%3DRosell%26aufirst%3DG.%26aulast%3DBosch%26aufirst%3DM.%2BP.%26aulast%3DGuerrero%26aufirst%3DA.%26atitle%3DEnzymatic%2520enantiomeric%2520resolution%2520of%2520phenylethylamines%2520structurally%2520related%2520to%2520amphetamine%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2011%26volume%3D9%26spage%3D8171%26epage%3D8177%26doi%3D10.1039%2Fc1ob06251d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsh, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molino, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astakhova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiss, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sargent, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swenson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usyatinsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyle, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. R.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and structure–activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers:  Drugs for cystic fibrosis and chronic bronchitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4098</span>– <span class="NLM_lpage">4115</span>, <span class="refDoi"> DOI: 10.1021/jm051134w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051134w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4098-4115&author=A.+J.+Hirshauthor=B.+F.+Molinoauthor=J.+Zhangauthor=N.+Astakhovaauthor=W.+B.+Geissauthor=B.+J.+Sargentauthor=B.+D.+Swensonauthor=A.+Usyatinskyauthor=M.+J.+Wyleauthor=R.+C.+Boucherauthor=R.+T.+Smithauthor=A.+Zamursauthor=M.+R.+Johnson&title=Design%2C+synthesis%2C+and+structure%E2%80%93activity+relationships+of+novel+2-substituted+pyrazinoylguanidine+epithelial+sodium+channel+blockers%3A%E2%80%89+Drugs+for+cystic+fibrosis+and+chronic+bronchitis&doi=10.1021%2Fjm051134w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm051134w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051134w%26sid%3Dliteratum%253Aachs%26aulast%3DHirsh%26aufirst%3DA.%2BJ.%26aulast%3DMolino%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAstakhova%26aufirst%3DN.%26aulast%3DGeiss%26aufirst%3DW.%2BB.%26aulast%3DSargent%26aufirst%3DB.%2BJ.%26aulast%3DSwenson%26aufirst%3DB.%2BD.%26aulast%3DUsyatinsky%26aufirst%3DA.%26aulast%3DWyle%26aufirst%3DM.%2BJ.%26aulast%3DBoucher%26aufirst%3DR.%2BC.%26aulast%3DSmith%26aufirst%3DR.%2BT.%26aulast%3DZamurs%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%25202-substituted%2520pyrazinoylguanidine%2520epithelial%2520sodium%2520channel%2520blockers%253A%25E2%2580%2589%2520Drugs%2520for%2520cystic%2520fibrosis%2520and%2520chronic%2520bronchitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4098%26epage%3D4115%26doi%3D10.1021%2Fjm051134w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i179"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00052">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71001"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00052">10.1021/acs.jmedchem.8b00052</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra for synthetic compounds, 95% confidence intervals for EC<sub>50</sub> values, and time-course studies for conversion from drug to prodrug forms (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_001.csv">CSV</a>)</p></li><li><p class="inline">Molecular-formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_001.csv">jm8b00052_si_001.csv (10.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00052/suppl_file/jm8b00052_si_002.pdf">jm8b00052_si_002.pdf (10.88 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00052&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00052%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00052" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999c4faeb63ddd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
